Evidence	O
for	O
distinct	O
intracellular	O
signaling	O
pathways	O
in	O
CD34+	B-cell_type
progenitor	I-cell_type
to	O
dendritic	O
cell	O
differentiation	O
from	O
a	O
human	O
cell	O
line	O
model	O
.	O

Intracellular	O
signals	O
that	O
mediate	O
differentiation	O
of	O
pluripotent	B-cell_type
hemopoietic	I-cell_type
progenitors	I-cell_type
to	O
dendritic	B-cell_type
cells	I-cell_type
(	O
DC	B-cell_type
)	O
are	O
largely	O
undefined	O
.	O

We	O
have	O
previously	O
shown	O
that	O
protein	B-protein
kinase	I-protein
C	I-protein
(	O
PKC	B-protein
)	O
activation	O
(	O
with	O
phorbol	O
ester	O
(	O
PMA	O
)	O
alone	O
)	O
specifically	O
induces	O
differentiation	O
of	O
primary	B-cell_line
human	I-cell_line
CD34+	I-cell_line
hemopoietic	I-cell_line
progenitor	I-cell_line
cells	I-cell_line
(	O
HPC	B-cell_line
)	O
to	O
mature	B-cell_type
DC	I-cell_type
.	O

We	O
now	O
find	O
that	O
cytokine-driven	O
(	O
granulocyte-macrophage	O
CSF	O
and	O
TNF-alpha	O
)	O
CD34+	O
HPC	B-cell_line
--	O
>	O
DC	O
differentiation	O
is	O
preferentially	O
blocked	O
by	O
inhibitors	O
of	O
PKC	B-protein
activation	O
.	O

To	O
further	O
identify	O
intracellular	O
signals	O
and	O
downstream	O
events	O
important	O
in	O
CD34+	B-cell_line
HPC	I-cell_line
--	O
>	O
DC	B-cell_type
differentiation	O
we	O
have	O
characterized	O
a	O
human	O
leukemic	O
cell	O
line	O
model	O
of	O
this	O
process	O
.	O

The	O
CD34+	B-cell_line
myelomonocytic	I-cell_line
cell	I-cell_line
line	I-cell_line
KG1	B-cell_line
differentiates	O
into	O
dendritic-like	O
cells	O
in	O
response	O
to	O
granulocyte-macrophage	B-protein
CSF	I-protein
plus	O
TNF-alpha	B-protein
,	O
or	O
PMA	O
(	O
with	O
or	O
without	O
the	O
calcium	O
ionophore	O
ionomycin	O
,	O
or	O
TNF-alpha	B-protein
)	O
,	O
with	O
different	O
stimuli	O
mediating	O
different	O
aspects	O
of	O
the	O
process	O
.	O

Phenotypic	O
DC	B-cell_type
characteristics	O
of	O
KG1	B-cell_line
dendritic-like	I-cell_line
cells	I-cell_line
include	O
morphology	O
(	O
loosely	B-cell_type
adherent	I-cell_type
cells	I-cell_type
with	O
long	O
neurite	O
processes	O
)	O
,	O
MHC	B-protein
I+/	O
MHC	B-protein
IIbright/CD83+/CD86+/	O
CD14	B-protein
-	O
surface	O
Ag	O
expression	O
,	O
and	O
RelB	B-protein
and	O
DC	B-cell_type
-CK1	O
gene	O
expression	O
.	O

Functional	O
DC	B-cell_type
characteristics	O
include	O
fluid	O
phase	O
macromolecule	O
uptake	O
(	O
FITC-dextran	O
)	O
and	O
activation	O
of	O
resting	B-cell_type
T	I-cell_type
cells	I-cell_type
.	O

Comparison	O
of	O
KG1	B-cell_line
to	O
the	O
PMA-unresponsive	B-cell_line
subline	I-cell_line
KG1a	I-cell_line
reveals	O
differences	O
in	O
expression	O
of	O
TNF	B-protein
receptors	I-protein
1	I-protein
and	I-protein
2	I-protein
;	O
PKC	B-protein
isoforms	I-protein
alpha	I-protein
,	I-protein
beta	I-protein
I	I-protein
,	I-protein
beta	I-protein
II	I-protein
,	I-protein
and	I-protein
mu	I-protein
;	O
and	O
RelB	B-protein
,	O
suggesting	O
that	O
these	O
components/pathways	O
are	O
important	O
for	O
DC	B-cell_type
differentiation	O
.	O

Together	O
,	O
these	O
findings	O
demonstrate	O
that	O
cytokine	O
or	O
phorbol	O
ester	O
stimulation	O
of	O
KG1	B-cell_line
is	O
a	O
model	O
of	O
human	B-cell_line
CD34+	I-cell_line
HPC	I-cell_line
to	O
DC	B-cell_type
differentiation	O
and	O
suggest	O
that	O
specific	O
intracellular	O
signaling	O
pathways	O
mediate	O
specific	O
events	O
in	O
DC	B-cell_type
lineage	O
commitment	O
.	O

Reporter	NULL
Cell	NULL
Lines	NULL
a	NULL
a	NULL
a	NULL
The	NULL
family	NULL
keeps	NULL
growing	NULL
Learn	NULL
more	NULL
3	NULL
<	NULL
.	NULL

<	NULL
e	NULL
]	NULL
(	NULL
ap	NULL
)	NULL
D	NULL
3	NULL
meJournal	NULL
c	NULL
yr	NULL
Evidence	NULL
for	NULL
Dlstlnct	NULL
Intracellular	NULL
Signaling	NULL
Aﬁ	NULL
Immunolo	NULL
gy	NULL
Pathways	NULL
in	NULL
CD34	NULL
*	NULL
Progenitor	NULL
to	NULL
Dendritic	NULL
Cell	NULL
Differentiation	NULL
from	NULL
a	NULL
Human	NULL
Cell	NULL
Line	NULL
Model	NULL
This	NULL
information	NULL
is	NULL
current	NULL
as	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

Daniel	NULL
C.	NULL
St.	NULL
Louis	NULL
,	NULL
Juliana	NULL
B.	NULL
Woodcock	NULL
,	NULL
Guido	NULL
Fransozo	NULL
,	NULL
Patrick	NULL
J.	NULL
Blair	NULL
,	NULL
Louise	NULL
M.	NULL
Carlson	NULL
,	NULL
Maria	NULL
Murillo	NULL
,	NULL
Mark	NULL
R.	NULL
Wells	NULL
,	NULL
Amanda	NULL
J.	NULL
Williams	NULL
,	NULL
Douglas	NULL
S.	NULL
Smoot	NULL
,	NULL
Sumesh	NULL
Kaushal	NULL
,	NULL
Janelle	NULL
L.	NULL
Grimes	NULL
,	NULL
David	NULL
M.	NULL
Harlan	NULL
,	NULL
John	NULL
P.	NULL
Chute	NULL
,	NULL
Carl	NULL
H.	NULL
June	NULL
,	NULL
Ulrich	NULL
Siebenlist	NULL
and	NULL
Kelvin	NULL
P.	NULL
Lee	NULL
J	NULL
Immunol	NULL
1999	NULL
;	NULL
162	NULL
;	NULL
:3237-3248	NULL
;	NULL
;	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/162/6/3237	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
75	NULL
articles	NULL
,	NULL
50	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/162/6/3237	NULL
.	NULL

full	NULL
#	NULL
ref-list-1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
Errata	NULL
-	NULL
An	NULL
erratum	NULL
has	NULL
been	NULL
published	NULL
regarding	NULL
this	NULL
article	NULL
.	NULL

Please	NULL
see	NULL
next	NULL
page	NULL
or	NULL
:	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
Evidence	NULL
for	NULL
Distinct	NULL
Intracellular	NULL
Signaling	NULL
Pathways	NULL
in	NULL
CD34*	NULL
Progenitor	NULL
to	NULL
Dendritic	NULL
Cell	NULL
Differentiation	NULL
from	NULL
a	NULL
Human	NULL
Cell	NULL
Line	NULL
Model	NULL
'	NULL
Daniel	NULL
C.	NULL
St.	NULL
Louis	NULL
,	NULL
*	NULL
``	NULL
Juliana	NULL
B.	NULL
Woodcock	NULL
,	NULL
*	NULL
Guido	NULL
Fransozo	NULL
,	NULL
*	NULL
Patrick	NULL
J.	NULL
Blair	NULL
,	NULL
*	NULL
Louise	NULL
M.	NULL
Carlson	NULL
,	NULL
*	NULL
Maria	NULL
Murillo	NULL
,	NULL
*	NULL
Mark	NULL
R.	NULL
Wells	NULL
,	NULL
*	NULL
Amanda	NULL
J.	NULL
Williams	NULL
,	NULL
*	NULL
Douglas	NULL
S.	NULL
Smoot	NULL
,	NULL
*	NULL
Sumesh	NULL
Kaushal	NULL
,	NULL
*	NULL
``	NULL
Janelle	NULL
L.	NULL
Grimes	NULL
,	NULL
*	NULL
David	NULL
M.	NULL
Harlan	NULL
,	NULL
**	NULL
John	NULL
P.	NULL
Chute	NULL
,	NULL
**	NULL
Carl	NULL
H.	NULL
June	NULL
,	NULL
**	NULL
Ulrich	NULL
Siebenlist	NULL
,	NULL
*	NULL
and	NULL
Kelvin	NULL
P.	NULL
Lee	NULL
``	NULL
**	NULL
Intracellular	NULL
signals	NULL
that	NULL
mediate	NULL
differentiation	NULL
of	NULL
pluripotent	NULL
hemopoietic	NULL
progenitors	NULL
to	NULL
dendritic	NULL
cells	NULL
(	NULL
DC	NULL
)	NULL
are	NULL
largely	NULL
unde-fined	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
PKC	NULL
)	NULL
activation	NULL
(	NULL
with	NULL
phorbol	NULL
ester	NULL
(	NULL
PMA	NULL
)	NULL
alone	NULL
)	NULL
specifically	NULL
induces	NULL
differentiation	NULL
of	NULL
primary	NULL
human	NULL
CD34+*	NULL
hemopoietic	NULL
progenitor	NULL
cells	NULL
(	NULL
HPC	NULL
)	NULL
to	NULL
mature	NULL
DC	NULL
.	NULL

We	NULL
now	NULL
find	NULL
that	NULL
cytokine-driven	NULL
(	NULL
granulocyte-macrophage	NULL
CSF	NULL
and	NULL
TNF-a	NULL
)	NULL
CD34¢*	NULL
HPC-DC	NULL
differentiation	NULL
is	NULL
preferentially	NULL
blocked	NULL
by	NULL
inhibitors	NULL
of	NULL
PKC	NULL
activation	NULL
.	NULL

To	NULL
further	NULL
identify	NULL
intracellular	NULL
signals	NULL
and	NULL
downstream	NULL
events	NULL
important	NULL
in	NULL
CD34*	NULL
HPC-DC	NULL
differentiation	NULL
we	NULL
have	NULL
characterized	NULL
a	NULL
human	NULL
leukemic	NULL
cell	NULL
line	NULL
model	NULL
of	NULL
this	NULL
process	NULL
.	NULL

The	NULL
CD34~*	NULL
myelomonocytic	NULL
cell	NULL
line	NULL
KG1	NULL
differentiates	NULL
into	NULL
dendritic-like	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
granulocyte-macrophage	NULL
CSF	NULL
plus	NULL
TNF-a	NULL
,	NULL
or	NULL
PMA	NULL
(	NULL
with	NULL
or	NULL
without	NULL
the	NULL
calcium	NULL
ionophore	NULL
ionomycin	NULL
,	NULL
or	NULL
TNF-a	NULL
)	NULL
,	NULL
with	NULL
different	NULL
stimuli	NULL
mediating	NULL
different	NULL
aspects	NULL
of	NULL
the	NULL
process	NULL
.	NULL

Phenotypic	NULL
DC	NULL
characteristics	NULL
of	NULL
KG1	NULL
dendritic-like	NULL
cells	NULL
include	NULL
morphology	NULL
(	NULL
loosely	NULL
adherent	NULL
cells	NULL
with	NULL
long	NULL
neurite	NULL
processes	NULL
)	NULL
,	NULL
MHC	NULL
I+/MHC	NULL
+/	NULL
CD14~	NULL
surface	NULL
Ag	NULL
expression	NULL
,	NULL
and	NULL
RelB	NULL
and	NULL
DC-CK1	NULL
gene	NULL
expression	NULL
.	NULL

Functional	NULL
DC	NULL
characteristics	NULL
include	NULL
fluid	NULL
phase	NULL
macromolecule	NULL
uptake	NULL
(	NULL
FITC-dextran	NULL
)	NULL
and	NULL
activation	NULL
of	NULL
resting	NULL
T	NULL
cells	NULL
.	NULL

Comparison	NULL
of	NULL
KG1	NULL
to	NULL
the	NULL
PMA-unresponsive	NULL
subline	NULL
KG1la	NULL
reveals	NULL
differences	NULL
in	NULL
expression	NULL
of	NULL
TNF	NULL
receptors	NULL
1	NULL
and	NULL
2	NULL
;	NULL
PKC	NULL
isoforms	NULL
a	NULL
,	NULL
BI	NULL
,	NULL
BII	NULL
,	NULL
and	NULL
p	NULL
;	NULL
and	NULL
RelB	NULL
,	NULL
suggesting	NULL
that	NULL
these	NULL
components/pathways	NULL
are	NULL
important	NULL
for	NULL
DC	NULL
differentiation	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
findings	NULL
demonstrate	NULL
that	NULL
cytokine	NULL
or	NULL
phorbol	NULL
ester	NULL
stimulation	NULL
of	NULL
KG1	NULL
is	NULL
a	NULL
model	NULL
of	NULL
human	NULL
CD34*	NULL
HPC	NULL
to	NULL
DC	NULL
differentiation	NULL
and	NULL
suggest	NULL
that	NULL
specific	NULL
intracellular	NULL
signaling	NULL
pathways	NULL
mediate	NULL
specific	NULL
events	NULL
in	NULL
DC	NULL
lineage	NULL
commitment	NULL
.	NULL

ow	NULL
multipotential	NULL
hemopoietic	NULL
stem	NULL
cells	NULL
become	NULL
ma-H	NULL
ture	NULL
blood	NULL
cells	NULL
is	NULL
a	NULL
paradigm	NULL
of	NULL
cellular	NULL
differentiation	NULL
and	NULL
lineage	NULL
commitment	NULL
.	NULL

Complex	NULL
hemopoiesis	NULL
underlies	NULL
the	NULL
generation	NULL
of	NULL
each	NULL
component	NULL
of	NULL
the	NULL
immune	NULL
system	NULL
,	NULL
including	NULL
T	NULL
,	NULL
B	NULL
,	NULL
and	NULL
professional	NULL
APCs	NULL
(	NULL
such	NULL
as	NULL
monocyte/macrophages	NULL
and	NULL
dendritic	NULL
cells	NULL
(	NULL
DC	NULL
)	NULL
``	NULL
)	NULL
.	NULL

Evidence	NULL
now	NULL
suggests	NULL
that	NULL
DC	NULL
play	NULL
the	NULL
central	NULL
and	NULL
critical	NULL
role	NULL
in	NULL
both	NULL
initiating	NULL
and	NULL
controlling	NULL
the	NULL
primary	NULL
immune	NULL
response	NULL
via	NULL
cognate	NULL
interactions	NULL
with	NULL
T	NULL
and	NULL
*Immune	NULL
Cell	NULL
Biology	NULL
Program	NULL
,	NULL
Naval	NULL
Medical	NULL
Research	NULL
Institute	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
20889	NULL
;	NULL
*The	NULL
Henry	NULL
M.	NULL
Jackson	NULL
Foundation	NULL
for	NULL
the	NULL
Advancement	NULL
of	NULL
Military	NULL
Medicine	NULL
,	NULL
U.S.	NULL
Military	NULL
HIV	NULL
Research	NULL
Program	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
20889	NULL
;	NULL
*Laboratory	NULL
of	NULL
Immunoregulation	NULL
,	NULL
National	NULL
Institute	NULL
of	NULL
Allergy	NULL
and	NULL
Infectious	NULL
Disease	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
20892	NULL
;	NULL
and	NULL
*Department	NULL
of	NULL
Internal	NULL
Medicine	NULL
,	NULL
Uniformed	NULL
Services	NULL
University	NULL
of	NULL
the	NULL
Health	NULL
Sciences	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
20889	NULL
Received	NULL
for	NULL
publication	NULL
August	NULL
11	NULL
,	NULL
1998	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
December	NULL
11	NULL
,	NULL
1998	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
advertisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
Naval	NULL
Medical	NULL
Research	NULL
and	NULL
Development	NULL
Com-mand	NULL
,	NULL
Research	NULL
Task	NULL
62233N.MM33C30.1402.HD402.1412	NULL
.	NULL

Views	NULL
presented	NULL
in	NULL
this	NULL
paper	NULL
are	NULL
those	NULL
of	NULL
the	NULL
authors	NULL
;	NULL
no	NULL
endorsement	NULL
by	NULL
the	NULL
Department	NULL
of	NULL
Navy	NULL
,	NULL
the	NULL
Department	NULL
of	NULL
the	NULL
Army	NULL
,	NULL
or	NULL
the	NULL
Department	NULL
of	NULL
Defense	NULL
has	NULL
been	NULL
given	NULL
or	NULL
should	NULL
be	NULL
inferred	NULL
.	NULL

2	NULL
Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Kelvin	NULL
P.	NULL
Lee	NULL
,	NULL
Immune	NULL
Cell	NULL
Biology	NULL
Program	NULL
,	NULL
Immune	NULL
Suppression	NULL
Branch	NULL
,	NULL
Building	NULL
17	NULL
,	NULL
Room	NULL
214	NULL
,	NULL
Naval	NULL
Medical	NULL
Research	NULL
Institute	NULL
,	NULL
8901	NULL
Wisconsin	NULL
Ave.	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
20889-5067	NULL
.	NULL

E-mail	NULL
address	NULL
:	NULL
leck	NULL
@	NULL
nmripo.nmri.anmc.navy.mil	NULL
3	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
DC	NULL
,	NULL
dendritic	NULL
cell	NULL
;	NULL
HPC	NULL
,	NULL
hemopoietic	NULL
progenitor	NULL
cell	NULL
;	NULL
CD34+	NULL
HPC	NULL
,	NULL
CD34	NULL
hemopoietic	NULL
progenitor	NULL
cell	NULL
;	NULL
GM-CSF	NULL
,	NULL
granulocyte-macrophage	NULL
CSF	NULL
;	NULL
PKC	NULL
,	NULL
protein	NULL
kinase	NULL
C	NULL
;	NULL
DLC	NULL
,	NULL
dendritic-like	NULL
cell	NULL
;	NULL
IMDM	NULL
,	NULL
Iscove	NULL
's	NULL
modified	NULL
Dulbecco	NULL
's	NULL
medium	NULL
;	NULL
SCF	NULL
,	NULL
stem	NULL
cell	NULL
factor	NULL
;	NULL
bis	NULL
,	NULL
bisindolylmaleimide	NULL
I	NULL
.	NULL

Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
1999	NULL
,	NULL
162	NULL
:	NULL
3237-3248	NULL
.	NULL

B	NULL
cells	NULL
(	NULL
1	NULL
)	NULL
.	NULL

In	NULL
humans	NULL
,	NULL
dendritic	NULL
cells	NULL
are	NULL
a	NULL
heterogeneous	NULL
population	NULL
shown	NULL
in	NULL
vitro	NULL
to	NULL
arise	NULL
from	NULL
multiple	NULL
distinct	NULL
hemopoietic	NULL
progenitor	NULL
cells	NULL
(	NULL
HPC	NULL
)	NULL
along	NULL
distinct	NULL
differentiation	NULL
pathways	NULL
.	NULL

These	NULL
progenitors	NULL
include	NULL
CD14*	NULL
monocytes	NULL
(	NULL
2-5	NULL
)	NULL
and	NULL
CD34	NULL
*	NULL
bone	NULL
marrow	NULL
cells	NULL
(	NULL
in	NULL
humans	NULL
a	NULL
heterogeneous	NULL
population	NULL
of	NULL
multipotential	NULL
progenitors	NULL
of	NULL
which	NULL
the	NULL
true	NULL
pluripotent	NULL
stem	NULL
cell	NULL
is	NULL
a	NULL
subset	NULL
)	NULL
.	NULL

CD34	NULL
``	NULL
CD10	NULL
+	NULL
HPC	NULL
give	NULL
rise	NULL
to	NULL
the	NULL
lymphoid	NULL
DC	NULL
lineage	NULL
(	NULL
6	NULL
)	NULL
,	NULL
whereas	NULL
CD34	NULL
``	NULL
CD86	NULL
*~	NULL
HPC	NULL
are	NULL
progenitors	NULL
for	NULL
myeloid	NULL
DC	NULL
and	NULL
monocyte/macrophages	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Broadly	NULL
characterized	NULL
from	NULL
a	NULL
cellular	NULL
standpoint	NULL
,	NULL
there	NULL
are	NULL
two	NULL
stages	NULL
of	NULL
DC	NULL
differentiation	NULL
(	NULL
8	NULL
)	NULL
.	NULL

The	NULL
first	NULL
stage	NULL
involves	NULL
differentiation	NULL
of	NULL
multipotential	NULL
HPC	NULL
to	NULL
immature	NULL
(	NULL
or	NULL
unactivated	NULL
)	NULL
DC	NULL
,	NULL
cells	NULL
with	NULL
high	NULL
capacity	NULL
for	NULL
Ag	NULL
uptake	NULL
but	NULL
relatively	NULL
poor	NULL
ability	NULL
to	NULL
activate	NULL
T	NULL
cells	NULL
.	NULL

This	NULL
differentiation	NULL
is	NULL
induced	NULL
in	NULL
vitro	NULL
by	NULL
exogenous	NULL
cytokines	NULL
(	NULL
GM-CSF	NULL
and	NULL
TNF-	NULL
@	NULL
(	NULL
with	NULL
or	NULL
without	NULL
other	NULL
cytokines	NULL
)	NULL
for	NULL
CD34	NULL
*	NULL
HPC	NULL
(	NULL
9	NULL
)	NULL
,	NULL
and	NULL
GM-CSF	NULL
and	NULL
IL-4	NULL
for	NULL
monocytes	NULL
(	NULL
2-5	NULL
)	NULL
)	NULL
,	NULL
CD40	NULL
receptor	NULL
cross-linking	NULL
(	NULL
CD34*	NULL
HPC	NULL
)	NULL
(	NULL
10	NULL
)	NULL
,	NULL
or	NULL
calcium	NULL
ionophore	NULL
alone	NULL
(	NULL
monocytes	NULL
)	NULL
(	NULL
11	NULL
)	NULL
.	NULL

The	NULL
second	NULL
stage	NULL
involves	NULL
maturation	NULL
of	NULL
immature	NULL
to	NULL
mature	NULL
DC	NULL
,	NULL
cells	NULL
that	NULL
have	NULL
decreased	NULL
Ag	NULL
uptake	NULL
capability	NULL
but	NULL
are	NULL
much	NULL
more	NULL
potent	NULL
in	NULL
activating	NULL
T	NULL
cells	NULL
.	NULL

An	NULL
alternative	NULL
viewpoint	NULL
is	NULL
that	NULL
DC	NULL
maturation	NULL
is	NULL
actually	NULL
activation	NULL
of	NULL
resting	NULL
DC	NULL
.	NULL

In	NULL
vivo	NULL
this	NULL
second	NULL
stage	NULL
is	NULL
probably	NULL
triggered	NULL
by	NULL
``	NULL
danger	NULL
signals	NULL
,	NULL
``	NULL
which	NULL
may	NULL
include	NULL
live	NULL
bacteria	NULL
and	NULL
components	NULL
(	NULL
LPS	NULL
,	NULL
DNA	NULL
)	NULL
,	NULL
viral	NULL
infection	NULL
,	NULL
and	NULL
inflammatory	NULL
cytokines	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

1	NULL
)	NULL
.	NULL

In	NULL
vitro	NULL
,	NULL
maturation/activation	NULL
can	NULL
be	NULL
induced	NULL
by	NULL
a	NULL
number	NULL
of	NULL
stimuli	NULL
,	NULL
including	NULL
cytokines	NULL
(	NULL
TNF-a	NULL
with	NULL
or	NULL
without	NULL
other	NULL
cytokines	NULL
,	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

12	NULL
)	NULL
,	NULL
monocyte-conditioned	NULL
medium	NULL
(	NULL
13	NULL
)	NULL
,	NULL
or	NULL
CD40	NULL
receptor	NULL
cross-linking	NULL
(	NULL
10	NULL
)	NULL
.	NULL

0022-1767/99/	NULL
$	NULL
02.00	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
3238	NULL
We	NULL
have	NULL
previously	NULL
reported	NULL
that	NULL
the	NULL
phorbol	NULL
ester	NULL
PMA	NULL
alone	NULL
induces	NULL
differentiation	NULL
of	NULL
human	NULL
CD34	NULL
HPC	NULL
into	NULL
mature	NULL
and	NULL
fully	NULL
functional	NULL
DC	NULL
,	NULL
suggesting	NULL
that	NULL
direct	NULL
activation	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
PKC	NULL
)	NULL
by	NULL
itself	NULL
is	NULL
sufficient	NULL
to	NULL
trigger	NULL
this	NULL
lineage	NULL
commitment	NULL
(	NULL
14	NULL
)	NULL
.	NULL

PMA-driven	NULL
CD34*	NULL
HPC-DC	NULL
differentiation	NULL
is	NULL
specific	NULL
for	NULL
DC	NULL
(	NULL
no	NULL
other	NULL
lineages	NULL
are	NULL
generated	NULL
)	NULL
and	NULL
does	NULL
not	NULL
involve	NULL
proliferation	NULL
(	NULL
differentiation	NULL
is	NULL
complete	NULL
within	NULL
7	NULL
days	NULL
)	NULL
,	NULL
although	NULL
about	NULL
50	NULL
%	NULL
of	NULL
the	NULL
input	NULL
number	NULL
of	NULL
CD34	NULL
*	NULL
HPC	NULL
are	NULL
lost	NULL
(	NULL
in	NULL
part	NULL
via	NULL
apoptosis	NULL
)	NULL
.	NULL

All	NULL
these	NULL
characteristics	NULL
distinguish	NULL
PMA	NULL
from	NULL
receptor-mediated	NULL
differentiation	NULL
signals	NULL
(	NULL
cytokines	NULL
,	NULL
CD40	NULL
receptor	NULL
cross-linking	NULL
)	NULL
.	NULL

Since	NULL
exogenous	NULL
stimuli	NULL
(	NULL
including	NULL
TNF-	NULL
«	NULL
,	NULL
IL-1B	NULL
,	NULL
IL-4	NULL
,	NULL
and	NULL
CD40	NULL
)	NULL
(	NULL
15-19	NULL
)	NULL
used	NULL
to	NULL
induce	NULL
CD34	NULL
*HPC-DC	NULL
differentiation	NULL
also	NULL
activate	NULL
PKC	NULL
as	NULL
part	NULL
of	NULL
their	NULL
downstream	NULL
signaling	NULL
cascade	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
PMA	NULL
is	NULL
activating	NULL
the	NULL
component	NULL
of	NULL
this	NULL
cascade	NULL
that	NULL
specifically	NULL
initiates	NULL
DC	NULL
differentiation	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
,	NULL
we	NULL
now	NULL
report	NULL
that	NULL
inhibition	NULL
of	NULL
PKC	NULL
activation	NULL
suppresses	NULL
generation	NULL
of	NULL
DC	NULL
by	NULL
GM-CSF	NULL
and	NULL
TNF-a	NULL
@	NULL
stimulation	NULL
of	NULL
CD34	NULL
HPC	NULL
.	NULL

Aside	NULL
from	NULL
a	NULL
potential	NULL
role	NULL
for	NULL
PKC	NULL
activation	NULL
,	NULL
relatively	NULL
little	NULL
is	NULL
known	NULL
about	NULL
what	NULL
intracellular	NULL
signaling	NULL
pathways	NULL
(	NULL
and	NULL
the	NULL
genetic	NULL
programs	NULL
they	NULL
initiate	NULL
)	NULL
are	NULL
involved	NULL
in	NULL
HPC-DC	NULL
differentiation	NULL
.	NULL

Signaling	NULL
via	NULL
intracellular	NULL
calcium	NULL
flux	NULL
alone	NULL
(	NULL
by	NULL
calcium	NULL
ionophore	NULL
)	NULL
induces	NULL
monocyte-	NULL
>	NULL
DC	NULL
differentiation	NULL
(	NULL
11	NULL
)	NULL
,	NULL
although	NULL
we	NULL
have	NULL
not	NULL
observed	NULL
this	NULL
for	NULL
CD34*	NULL
HPC	NULL
(	NULL
D.C.S.L	NULL
and	NULL
K.P.L	NULL
,	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

The	NULL
downstream	NULL
components	NULL
involved	NULL
in	NULL
this	NULL
calcium	NULL
signaling	NULL
are	NULL
uncharacterized	NULL
.	NULL

Another	NULL
signaling	NULL
pathway	NULL
involves	NULL
the	NULL
lipid	NULL
second	NULL
messenger	NULL
ceramide	NULL
,	NULL
which	NULL
mediates	NULL
down-regulation	NULL
of	NULL
Ag	NULL
uptake	NULL
during	NULL
cytokine-driven	NULL
maturation/activation	NULL
of	NULL
DC	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Downstream	NULL
of	NULL
these	NULL
signaling	NULL
path-ways	NULL
,	NULL
the	NULL
transcription	NULL
factor	NULL
RelB	NULL
(	NULL
a	NULL
member	NULL
of	NULL
the	NULL
NFkB	NULL
family	NULL
)	NULL
appears	NULL
to	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
DC	NULL
differentiation	NULL
based	NULL
on	NULL
apparent	NULL
function	NULL
(	NULL
21-24	NULL
)	NULL
and	NULL
the	NULL
phenotype	NULL
of	NULL
RelB	NULL
knockout	NULL
mice	NULL
(	NULL
25	NULL
,	NULL
26	NULL
)	NULL
.	NULL

ReIB	NULL
expression	NULL
is	NULL
up-regulated	NULL
in	NULL
vitro	NULL
during	NULL
cytokine-	NULL
or	NULL
PMA-driven	NULL
DC	NULL
differentiation	NULL
(	NULL
2	NULL
,	NULL
14	NULL
)	NULL
.	NULL

What	NULL
genes	NULL
RelB	NULL
specifically	NULL
regulates	NULL
during	NULL
DC	NULL
differentiation	NULL
is	NULL
currently	NULL
unknown	NULL
.	NULL

Even	NULL
using	NULL
agents	NULL
that	NULL
directly	NULL
activate	NULL
signal	NULL
transduction	NULL
path-ways	NULL
,	NULL
a	NULL
number	NULL
of	NULL
obstacles	NULL
makes	NULL
study	NULL
of	NULL
the	NULL
intracellular	NULL
and	NULL
genetic	NULL
events	NULL
involved	NULL
in	NULL
DC	NULL
differentiation	NULL
difficult	NULL
.	NULL

The	NULL
rarity	NULL
of	NULL
CD34	NULL
*	NULL
HPC	NULL
(	NULL
0.1-1	NULL
%	NULL
of	NULL
bone	NULL
marrow	NULL
mononuclear	NULL
cells	NULL
)	NULL
makes	NULL
sufficient	NULL
isolation	NULL
for	NULL
larger	NULL
scale	NULL
studies	NULL
laborious	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
CD34+*	NULL
HPC	NULL
are	NULL
a	NULL
heterogeneous	NULL
population	NULL
of	NULL
progenitors	NULL
already	NULL
committed	NULL
to	NULL
different	NULL
lineages	NULL
(	NULL
for	NULL
example	NULL
,	NULL
see	NULL
Ref	NULL
.	NULL

6	NULL
)	NULL
,	NULL
which	NULL
makes	NULL
analysis	NULL
of	NULL
bulk	NULL
starting	NULL
populations	NULL
problematic	NULL
.	NULL

Receptor-mediated	NULL
CD34	NULL
*	NULL
HPC-DC	NULL
differentiation	NULL
involves	NULL
cell	NULL
proliferation	NULL
,	NULL
which	NULL
complicates	NULL
identification	NULL
of	NULL
differentiation-specific	NULL
processes	NULL
.	NULL

These	NULL
stimuli	NULL
also	NULL
generate	NULL
mixed	NULL
populations	NULL
of	NULL
cells	NULL
(	NULL
DC	NULL
,	NULL
monocytes	NULL
,	NULL
neutrophils	NULL
)	NULL
that	NULL
require	NULL
additional	NULL
purification	NULL
of	NULL
DC	NULL
before	NULL
definitive	NULL
analysis	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

12	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
CD34	NULL
*	NULL
HPC	NULL
have	NULL
traditionally	NULL
been	NULL
difficult	NULL
to	NULL
transfect/	NULL
transduce	NULL
(	NULL
27	NULL
)	NULL
,	NULL
making	NULL
genetic	NULL
manipulation	NULL
involving	NULL
these	NULL
approaches	NULL
less	NULL
effective	NULL
.	NULL

Many	NULL
of	NULL
these	NULL
problems	NULL
could	NULL
be	NULL
circumvented	NULL
in	NULL
a	NULL
cell	NULL
line	NULL
model	NULL
of	NULL
DC	NULL
differentiation	NULL
.	NULL

Czerniecki	NULL
et	NULL
al	NULL
.	NULL

have	NULL
suggested	NULL
that	NULL
the	NULL
pro-myelocytic	NULL
HL-60	NULL
cell	NULL
line	NULL
differentiates	NULL
into	NULL
DC	NULL
with	NULL
calcium	NULL
iono-phore	NULL
,	NULL
thus	NULL
representing	NULL
a	NULL
potential	NULL
model	NULL
of	NULL
monocyte-	NULL
>	NULL
DC	NULL
differentiation	NULL
(	NULL
11	NULL
)	NULL
.	NULL

It	NULL
has	NULL
recently	NULL
been	NULL
reported	NULL
that	NULL
committed	NULL
CD34	NULL
*	NULL
precursors	NULL
for	NULL
myeloid	NULL
DC	NULL
and	NULL
macrophages	NULL
are	NULL
CD86	NULL
positive	NULL
(	NULL
7	NULL
)	NULL
.	NULL

We	NULL
have	NULL
found	NULL
that	NULL
the	NULL
CD34*	NULL
human	NULL
myeloblastic	NULL
cell	NULL
line	NULL
KG1	NULL
(	NULL
28	NULL
)	NULL
also	NULL
expresses	NULL
CD86	NULL
.	NULL

KG1	NULL
is	NULL
a	NULL
cytokine-responsive	NULL
human	NULL
CD34	NULL
*	NULL
myelomonocytic	NULL
cell	NULL
line	NULL
derived	NULL
from	NULL
a	NULL
patient	NULL
with	NULL
eryth-roleukemia	NULL
.	NULL

KG1	NULL
was	NULL
originally	NULL
described	NULL
to	NULL
differentiate	NULL
to	NULL
the	NULL
monocyte/macrophage	NULL
lineage	NULL
(	NULL
based	NULL
on	NULL
morphologic	NULL
and	NULL
histochemical	NULL
assays	NULL
)	NULL
when	NULL
stimulated	NULL
with	NULL
phorbol	NULL
ester	NULL
(	NULL
29-31	NULL
)	NULL
,	NULL
A	NULL
CELL	NULL
LINE	NULL
MODEL	NULL
OF	NULL
HUMAN	NULL
DENDRITIC	NULL
CELL	NULL
DIFFERENTIATION	NULL
although	NULL
DC-specific	NULL
markers	NULL
were	NULL
not	NULL
available	NULL
at	NULL
that	NULL
time	NULL
.	NULL

The	NULL
KG1a	NULL
subline	NULL
of	NULL
KG1	NULL
was	NULL
indifferent	NULL
to	NULL
the	NULL
effects	NULL
of	NULL
PMA	NULL
(	NULL
and	NULL
cytokines	NULL
)	NULL
and	NULL
is	NULL
characterized	NULL
as	NULL
less	NULL
differentiated	NULL
than	NULL
KG1	NULL
(	NULL
29	NULL
,	NULL
30	NULL
,	NULL
32	NULL
)	NULL
.	NULL

KG1	NULL
and	NULL
KG1a	NULL
have	NULL
qualitative	NULL
differences	NULL
in	NULL
PKC	NULL
activation	NULL
and	NULL
substrate	NULL
phosphorylation	NULL
(	NULL
30	NULL
,	NULL
33	NULL
,	NULL
34	NULL
)	NULL
.	NULL

We	NULL
now	NULL
report	NULL
that	NULL
phorbol	NULL
ester	NULL
or	NULL
cytokine	NULL
(	NULL
GM-CSF	NULL
and	NULL
TNF-a	NULL
)	NULL
induces	NULL
KG1	NULL
to	NULL
differentiate	NULL
into	NULL
dendritic-like	NULL
cells	NULL
(	NULL
DLC	NULL
)	NULL
based	NULL
on	NULL
morphology	NULL
,	NULL
surface	NULL
Ag	NULL
phenotype	NULL
,	NULL
function	NULL
,	NULL
and	NULL
gene	NULL
expression	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
KG1a	NULL
do	NULL
not	NULL
differentiate	NULL
.	NULL

Characterization	NULL
of	NULL
stimuli	NULL
required	NULL
to	NULL
induce	NULL
DLC	NULL
differentiation	NULL
as	NULL
well	NULL
as	NULL
comparison	NULL
to	NULL
KG1a	NULL
provide	NULL
evidence	NULL
that	NULL
distinct	NULL
intracellular	NULL
signaling	NULL
pathways	NULL
are	NULL
involved	NULL
and	NULL
mediate	NULL
specific	NULL
components	NULL
of	NULL
differentiation	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Cells	NULL
and	NULL
culture	NULL
CD34*	NULL
HPC	NULL
were	NULL
isolated	NULL
from	NULL
organ	NULL
donor	NULL
bone	NULL
marrow	NULL
by	NULL
immuno-magnetic	NULL
selection	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Purified	NULL
cells	NULL
were	NULL
typically	NULL
>	NULL
95	NULL
%	NULL
CD34*	NULL
as	NULL
determined	NULL
by	NULL
FACS	NULL
analysis	NULL
with	NULL
a	NULL
second	NULL
non-cross-blocked	NULL
anti-CD34	NULL
mAb	NULL
.	NULL

For	NULL
generation	NULL
of	NULL
DC	NULL
,	NULL
CD34*	NULL
HPC	NULL
were	NULL
cultured	NULL
for	NULL
14	NULL
days	NULL
at	NULL
5	NULL
X	NULL
10*	NULL
cells/ml	NULL
in	NULL
complete	NULL
culture	NULL
medium	NULL
(	NULL
IMDM	NULL
,	NULL
Life	NULL
Technologies	NULL
,	NULL
Grand	NULL
Island	NULL
,	NULL
NY	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
heat-inactivated	NULL
FCS	NULL
(	NULL
HyClone	NULL
,	NULL
Logan	NULL
UT	NULL
)	NULL
,	NULL
100	NULL
mM	NULL
1-glutamine	NULL
,	NULL
and	NULL
100	NULL
U/ml	NULL
penicillin/streptomycin	NULL
solution	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
)	NULL
with	NULL
GM-CSF	NULL
(	NULL
200	NULL
U/ml	NULL
!	NULL
)	NULL

and	NULL
TNF-a	NULL
(	NULL
2.5	NULL
ng/ml	NULL
;	NULL
all	NULL
from	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
,	NULL
Minneapolis	NULL
,	NULL
MN	NULL
)	NULL
.	NULL

Where	NULL
indicated	NULL
,	NULL
staurosporine	NULL
(	NULL
Calbiochem	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
was	NULL
added	NULL
at	NULL
0.1	NULL
ng/ml	NULL
,	NULL
a	NULL
dose	NULL
sufficient	NULL
to	NULL
block	NULL
PMA-induced	NULL
proliferation	NULL
of	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

At	NULL
the	NULL
end	NULL
of	NULL
the	NULL
culture	NULL
period	NULL
,	NULL
nonadherent	NULL
cells	NULL
and	NULL
adherent	NULL
cells	NULL
were	NULL
resuspended	NULL
(	NULL
3	NULL
mM	NULL
EDTA	NULL
)	NULL
,	NULL
washed	NULL
,	NULL
and	NULL
concentrated	NULL
by	NULL
centrifugation	NULL
.	NULL

KG1	NULL
and	NULL
KG1a	NULL
cells	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
(	NULL
Manassas	NULL
,	NULL
VA	NULL
)	NULL
and	NULL
cultured	NULL
in	NULL
IMDM/20	NULL
%	NULL
FCS/100	NULL
mM	NULL
L-glutamine/100	NULL
U	NULL
penicillin/streptomycin	NULL
at	NULL
5	NULL
X	NULL
10	NULL
``	NULL
cells/ml	NULL
.	NULL

Cultures	NULL
were	NULL
stimulated	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
PMA	NULL
(	NULL
10	NULL
ng/ml	NULL
;	NULL
Sigma	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
,	NULL
GM-CSF	NULL
(	NULL
200	NULL
U/ml	NULL
)	NULL
,	NULL
TNF-a	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
,	NULL
ionomycin	NULL
(	NULL
100	NULL
ng/ml	NULL
;	NULL
Calbiochem	NULL
)	NULL
.	NULL

The	NULL
four-cytokine	NULL
combination	NULL
of	NULL
GM-CSF	NULL
(	NULL
2	NULL
ng/	NULL
ml	NULL
)	NULL
,	NULL
IL-3	NULL
(	NULL
5	NULL
ng/ml	NULL
)	NULL
,	NULL
IL-6	NULL
(	NULL
5	NULL
ng/ml	NULL
)	NULL
,	NULL
stem	NULL
cell	NULL
factor	NULL
(	NULL
SCF	NULL
;	NULL
120	NULL
ng/m	NULL
!	NULL
)	NULL

has	NULL
previously	NULL
been	NULL
found	NULL
to	NULL
induce	NULL
robust	NULL
proliferation	NULL
of	NULL
primary	NULL
CD34	NULL
*	NULL
HPC	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Where	NULL
indicated	NULL
,	NULL
bisindolylmaleimide	NULL
I	NULL
(	NULL
bis	NULL
;	NULL
Calbiochem	NULL
)	NULL
was	NULL
used	NULL
at	NULL
5	NULL
M.	NULL
Flow	NULL
cytometric	NULL
analysis	NULL
and	NULL
mAbs	NULL
Adherent	NULL
and	NULL
loosely	NULL
adherent	NULL
cells	NULL
were	NULL
harvested	NULL
with	NULL
3	NULL
mM	NULL
EDTA	NULL
,	NULL
washed	NULL
twice	NULL
,	NULL
and	NULL
resuspended	NULL
in	NULL
staining	NULL
medium	NULL
(	NULL
PBS	NULL
,	NULL
5	NULL
%	NULL
FCS	NULL
,	NULL
2	NULL
%	NULL
BSA	NULL
,	NULL
and	NULL
0.1	NULL
%	NULL
sodium	NULL
azide	NULL
)	NULL
.	NULL

Phenotypic	NULL
analysis	NULL
of	NULL
cells	NULL
(	NULL
2	NULL
X	NULL
10°	NULL
)	NULL
was	NULL
performed	NULL
by	NULL
flow	NULL
cytometry	NULL
using	NULL
saturating	NULL
concentrations	NULL
of	NULL
the	NULL
following	NULL
mAbs	NULL
:	NULL
CD1a	NULL
(	NULL
clone	NULL
SK9	NULL
)	NULL
,	NULL
CD2	NULL
(	NULL
$	NULL
5.2	NULL
)	NULL
,	NULL
CD4	NULL
(	NULL
SK3	NULL
)	NULL
,	NULL
CD13	NULL
(	NULL
L138	NULL
)	NULL
,	NULL
CD14	NULL
(	NULL
MOP9	NULL
)	NULL
,	NULL
CD34	NULL
(	NULL
8G12	NULL
)	NULL
,	NULL
CD80	NULL
(	NULL
L307.4	NULL
)	NULL
,	NULL
and	NULL
CD154	NULL
(	NULL
89-76	NULL
;	NULL
all	NULL
from	NULL
Becton	NULL
Dickinson	NULL
,	NULL
San	NULL
Jose	NULL
,	NULL
CA	NULL
)	NULL
;	NULL
CD10	NULL
(	NULL
HI10A	NULL
)	NULL
,	NULL
CD33	NULL
(	NULL
WM53	NULL
)	NULL
,	NULL
CD40	NULL
(	NULL
5C3	NULL
)	NULL
,	NULL
CD45RA	NULL
(	NULL
HI100	NULL
)	NULL
,	NULL
CD86	NULL
(	NULL
IT2.2	NULL
)	NULL
,	NULL
and	NULL
CD90	NULL
(	NULL
5E10	NULL
;	NULL
all	NULL
from	NULL
PharMingen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
;	NULL
CD83	NULL
(	NULL
HB15	NULL
,	NULL
Immunotech	NULL
,	NULL
Westbrook	NULL
,	NULL
ME	NULL
)	NULL
;	NULL
MHC	NULL
class	NULL
I	NULL
(	NULL
H58A	NULL
)	NULL
and	NULL
MHC	NULL
class	NULL
II	NULL
(	NULL
H42A	NULL
,	NULL
both	NULL
from	NULL
Veterinary	NULL
Medical	NULL
Research	NULL
Development	NULL
,	NULL
Pullman	NULL
,	NULL
WA	NULL
)	NULL
;	NULL
¢-fms	NULL
(	NULL
3-4A4	NULL
)	NULL
,	NULL
TNF	NULL
receptor	NULL
1	NULL
(	NULL
N-20	NULL
)	NULL
,	NULL
and	NULL
TNF	NULL
receptor	NULL
2	NULL
(	NULL
C-20	NULL
;	NULL
all	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Appropriate	NULL
conjugated	NULL
isotype-matched	NULL
Abs	NULL
were	NULL
used	NULL
as	NULL
controls	NULL
.	NULL

Ten	NULL
thousand	NULL
cells	NULL
were	NULL
analyzed	NULL
on	NULL
a	NULL
Coulter	NULL
Elite	NULL
flow	NULL
cytometer	NULL
(	NULL
Coulter	NULL
,	NULL
Hialeah	NULL
,	NULL
FL	NULL
)	NULL
through	NULL
a	NULL
viable	NULL
cell	NULL
gate	NULL
as	NULL
determined	NULL
by	NULL
forward	NULL
and	NULL
right	NULL
angle	NULL
light	NULL
scatter	NULL
parameters	NULL
to	NULL
exclude	NULL
sub-cellular	NULL
particles	NULL
.	NULL

Apoptotic	NULL
cells	NULL
were	NULL
identified	NULL
by	NULL
annexin	NULL
V	NULL
staining	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
36	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
cold	NULL
PBS	NULL
and	NULL
then	NULL
resuspended	NULL
in	NULL
a	NULL
binding	NULL
buffer	NULL
(	NULL
from	NULL
the	NULL
manufacturer	NULL
)	NULL
containing	NULL
HEPES	NULL
with	NULL
2.5	NULL
mM	NULL
CaCl	NULL
;	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
1	NULL
X	NULL
10	NULL
%	NULL
/ml	NULL
.	NULL

One	NULL
hundred	NULL
mi-croliters	NULL
of	NULL
this	NULL
suspension	NULL
was	NULL
reacted	NULL
with	NULL
10	NULL
gl	NULL
of	NULL
annexin	NULL
V-FITC	NULL
(	NULL
10	NULL
ug/tal	NULL
(	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
)	NULL
)	NULL
and	NULL
10	NULL
gl	NULL
of	NULL
propidium	NULL
iodide	NULL
reagent	NULL
(	NULL
50	NULL
pg/ml	NULL
in	NULL
PBS	NULL
)	NULL
.	NULL

The	NULL
mixture	NULL
was	NULL
gently	NULL
vortexed	NULL
and	NULL
then	NULL
incubated	NULL
for	NULL
15	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
the	NULL
dark	NULL
.	NULL

Following	NULL
incubation	NULL
,	NULL
400	NULL
ul	NULL
of	NULL
the	NULL
binding	NULL
buffer	NULL
(	NULL
1X	NULL
concentration	NULL
)	NULL
was	NULL
added	NULL
to	NULL
each	NULL
tube	NULL
.	NULL

Analysis	NULL
by	NULL
FACS	NULL
was	NULL
conducted	NULL
within	NULL
1	NULL
h	NULL
of	NULL
assay	NULL
completion	NULL
for	NULL
optimal	NULL
results	NULL
.	NULL

Controls	NULL
of	NULL
unreacted	NULL
cells	NULL
,	NULL
propidium	NULL
iodide-stained	NULL
cells	NULL
,	NULL
and	NULL
annexin-V-FITC-stained	NULL
cells	NULL
were	NULL
run	NULL
first	NULL
to	NULL
optimize	NULL
settings	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
FITC-dextran	NULL
uptake	NULL
Analysis	NULL
of	NULL
micropinocytosis	NULL
by	NULL
FITC-dextran	NULL
uptake	NULL
has	NULL
been	NULL
previously	NULL
described	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Activated	NULL
KG1	NULL
and	NULL
KG1a	NULL
cells	NULL
were	NULL
resuspended	NULL
at	NULL
10°/ml	NULL
in	NULL
IMDM/20	NULL
%	NULL
FCS	NULL
.	NULL

FITC-dextran	NULL
(	NULL
Sigma	NULL
)	NULL
was	NULL
added	NULL
at	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
1	NULL
mg/ml	NULL
,	NULL
and	NULL
the	NULL
mixture	NULL
was	NULL
incubated	NULL
at	NULL
either	NULL
4	NULL
or	NULL
37°C	NULL
for	NULL
30	NULL
min	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
washed	NULL
four	NULL
times	NULL
with	NULL
cold	NULL
PBS	NULL
containing	NULL
1	NULL
%	NULL
FCS	NULL
and	NULL
analyzed	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

T	NULL
cell	NULL
activation	NULL
Human	NULL
PBMC	NULL
were	NULL
obtained	NULL
by	NULL
leukapheresis	NULL
from	NULL
normal	NULL
healthy	NULL
adult	NULL
donors	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
purified	NULL
by	NULL
negative	NULL
selection	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
38	NULL
)	NULL
and	NULL
resuspended	NULL
in	NULL
RPMI	NULL
1640	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
heat-inactivated	NULL
FCS	NULL
,	NULL
2	NULL
mM	NULL
L-glutamine	NULL
,	NULL
100	NULL
U/ml	NULL
penicillin	NULL
,	NULL
100	NULL
mg/m	NULL
!	NULL

streptomycin	NULL
,	NULL
and	NULL
20	NULL
mM	NULL
HEPES	NULL
.	NULL

T	NULL
cells	NULL
(	NULL
1	NULL
X	NULL
10°/well	NULL
)	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
in	NULL
medium	NULL
)	NULL
or	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
indicated	NULL
number	NULL
of	NULL
gamma-irradiated	NULL
(	NULL
3000	NULL
rad	NULL
'*	NULL
``	NULL
Cs	NULL
)	NULL
,	NULL
in	NULL
vitro-generated	NULL
DC	NULL
or	NULL
DLC	NULL
.	NULL

Cultures	NULL
were	NULL
incubated	NULL
for	NULL
3	NULL
days	NULL
(	NULL
DC	NULL
)	NULL
or	NULL
5	NULL
days	NULL
(	NULL
DLC	NULL
)	NULL
at	NULL
37°C	NULL
in	NULL
a	NULL
humidified	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
in	NULL
air	NULL
atmosphere	NULL
.	NULL

T	NULL
cell	NULL
proliferation	NULL
induced	NULL
by	NULL
freshly	NULL
isolated	NULL
allogeneic	NULL
PBMC	NULL
was	NULL
used	NULL
as	NULL
a	NULL
reference	NULL
.	NULL

Proliferation	NULL
was	NULL
assessed	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
0.5	NULL
uCi/well	NULL
[	NULL
methy	NULL
]	NULL
-H	NULL
]	NULL
thymidine	NULL
(	NULL
New	NULL
England	NULL
Nuclear	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
for	NULL
the	NULL
final	NULL
24	NULL
h	NULL
of	NULL
culture	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
using	NULL
a	NULL
96-well	NULL
cell	NULL
harvester	NULL
,	NULL
and	NULL
[	NULL
methy	NULL
!	NULL

-H|thymidine	NULL
incorporation	NULL
was	NULL
measured	NULL
using	NULL
a	NULL
Beta	NULL
Plate	NULL
scintillation	NULL
counting	NULL
system	NULL
(	NULL
Pharmacia/LKB	NULL
,	NULL
Gaithersburg	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

All	NULL
determinations	NULL
were	NULL
performed	NULL
in	NULL
triplicate	NULL
and	NULL
expressed	NULL
as	NULL
the	NULL
mean	NULL
counts	NULL
per	NULL
minute	NULL
+	NULL
1	NULL
SD	NULL
.	NULL

RT-PCR	NULL
and	NULL
Northern	NULL
blot	NULL
analysis	NULL
Total	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
cultured	NULL
cells	NULL
by	NULL
the	NULL
RNA	NULL
STAT-60	NULL
(	NULL
Tel-Test	NULL
)	NULL
according	NULL
to	NULL
manufacturer	NULL
's	NULL
recommendations	NULL
.	NULL

Ten	NULL
micrograms	NULL
of	NULL
purified	NULL
RNA	NULL
was	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
15	NULL
min	NULL
with	NULL
100	NULL
U	NULL
of	NULL
RNase-free	NULL
DNase	NULL
in	NULL
a	NULL
reaction	NULL
,	NULL
followed	NULL
by	NULL
phenol/chloroform	NULL
extraction	NULL
and	NULL
ethanol	NULL
precipitation	NULL
.	NULL

Samples	NULL
of	NULL
4	NULL
ug	NULL
of	NULL
DNase-treated	NULL
RNA	NULL
were	NULL
reverse	NULL
transcribed	NULL
to	NULL
cDNA	NULL
by	NULL
random	NULL
primer	NULL
extension	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
0.1	NULL
Ci	NULL
of	NULL
[	NULL
«	NULL
-°P	NULL
]	NULL
4CTP	NULL
using	NULL
Superscript-II	NULL
Reverse	NULL
Transcriptase	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
following	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

The	NULL
RT	NULL
reaction	NULL
was	NULL
terminated	NULL
by	NULL
heating	NULL
at	NULL
70°C	NULL
for	NULL
5	NULL
min	NULL
,	NULL
and	NULL
radiolabeled	NULL
cDNA	NULL
was	NULL
then	NULL
purified	NULL
on	NULL
Spin-50	NULL
columns	NULL
(	NULL
International	NULL
Mould	NULL
Engineering	NULL
,	NULL
Oden-ton	NULL
,	NULL
MD	NULL
)	NULL
by	NULL
centrifugation	NULL
at	NULL
3500	NULL
rpm	NULL
for	NULL
3	NULL
min	NULL
.	NULL

To	NULL
normalize	NULL
the	NULL
input	NULL
in	NULL
all	NULL
cDNA	NULL
samples	NULL
,	NULL
equal	NULL
amounts	NULL
of	NULL
cDNA	NULL
counts	NULL
were	NULL
loaded	NULL
in	NULL
each	NULL
PCR	NULL
reaction	NULL
containing	NULL
0.5	NULL
M	NULL
gene-specific	NULL
primer	NULL
pairs	NULL
.	NULL

Oligonucleotide	NULL
primers	NULL
specific	NULL
for	NULL
human	NULL
DC-CK1	NULL
(	NULL
sense	NULL
,	NULL
AGT	NULL
CCC	NULL
ATC	NULL
TGC	NULL
TAT	NULL
GCC	NULL
CAG	NULL
;	NULL
antisense	NULL
,	NULL
TAC	NULL
GAA	NULL
GAG	NULL
TGG	NULL
AAG	NULL
GGA	NULL
AAG	NULL
)	NULL
and	NULL
the	NULL
housekeeping	NULL
gene	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
(	NULL
GAPDH	NULL
;	NULL
sense	NULL
,	NULL
ATG	NULL
GGG	NULL
AAG	NULL
GTG	NULL
AAG	NULL
GTC	NULL
GGA	NULL
GTC	NULL
AAC	NULL
GGA	NULL
;	NULL
antisense	NULL
,	NULL
AGG	NULL
GGG	NULL
CAG	NULL
AGA	NULL
TGA	NULL
TGA	NULL
CCC	NULL
TTT	NULL
TGG	NULL
CTC	NULL
)	NULL
were	NULL
used	NULL
.	NULL

PCR	NULL
was	NULL
performed	NULL
at	NULL
94°C	NULL
for	NULL
1	NULL
min	NULL
,	NULL
55°C	NULL
for	NULL
1	NULL
min	NULL
,	NULL
and	NULL
72°C	NULL
for	NULL
2	NULL
min	NULL
for	NULL
30	NULL
cycles	NULL
followed	NULL
by	NULL
a	NULL
final	NULL
extension	NULL
time	NULL
of	NULL
10	NULL
min	NULL
at	NULL
72°C	NULL
.	NULL

The	NULL
amplified	NULL
products	NULL
(	NULL
15	NULL
L1	NULL
)	NULL
were	NULL
then	NULL
incubated	NULL
at	NULL
94°C	NULL
for	NULL
5	NULL
min	NULL
with	NULL
1	NULL
X	NULL
10°	NULL
cpm	NULL
of	NULL
purified	NULL
[	NULL
y-P	NULL
]	NULL
dATP-labeled	NULL
gene-specific	NULL
probes	NULL
followed	NULL
by	NULL
an	NULL
incubation	NULL
at	NULL
55°C	NULL
for	NULL
10	NULL
min	NULL
.	NULL

Hybridized	NULL
PCR	NULL
products	NULL
were	NULL
then	NULL
resolved	NULL
on	NULL
6	NULL
%	NULL
PAGE	NULL
followed	NULL
by	NULL
quantitation	NULL
on	NULL
a	NULL
PhosphorImager	NULL
scanner	NULL
using	NULL
ImageQuant	NULL
software	NULL
(	NULL
Molecular	NULL
Dynam-ics	NULL
,	NULL
Sunnyvale	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
was	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
39	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
total	NULL
RNA	NULL
from	NULL
unstimulated	NULL
and	NULL
stimulated	NULL
KG1	NULL
and	NULL
KG1a	NULL
cells	NULL
was	NULL
isolated	NULL
at	NULL
the	NULL
times	NULL
indicated	NULL
and	NULL
equalized	NULL
by	NULL
serial	NULL
dilution	NULL
and	NULL
ethidium	NULL
bromide	NULL
visualization	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
RNA	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
formaldehyde/agarose	NULL
gel	NULL
,	NULL
transferred	NULL
to	NULL
nylon	NULL
membranes	NULL
,	NULL
and	NULL
hybridized	NULL
against	NULL
a	NULL
human	NULL
RelB	NULL
cDNA	NULL
probe	NULL
.	NULL

The	NULL
same	NULL
blots	NULL
were	NULL
then	NULL
probed	NULL
for	NULL
actin	NULL
to	NULL
assess	NULL
equal	NULL
loading	NULL
and	NULL
RNA	NULL
integrity	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
Cell	NULL
lysates	NULL
were	NULL
made	NULL
from	NULL
KG1	NULL
and	NULL
KG1a	NULL
cells	NULL
cultured	NULL
under	NULL
the	NULL
conditions	NULL
and	NULL
times	NULL
indicated	NULL
.	NULL

Samples	NULL
containing	NULL
equal	NULL
amounts	NULL
of	NULL
protein	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
(	NULL
4	NULL
%	NULL
stacking/7.5	NULL
%	NULL
resolving	NULL
)	NULL
;	NULL
electroblotted	NULL
to	NULL
nitrocellulose	NULL
;	NULL
probed	NULL
with	NULL
Abs	NULL
against	NULL
ReIB	NULL
and	NULL
PKCa	NULL
,	NULL
-I	NULL
,	NULL
-	NULL
BIL	NULL
,	NULL
and	NULL
-p	NULL
(	NULL
all	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
;	NULL
and	NULL
visualized	NULL
by	NULL
chemiluminescent	NULL
detection	NULL
(	NULL
ECL	NULL
,	NULL
Amersham	NULL
,	NULL
Aylesbury	NULL
,	NULL
U.K.	NULL
)	NULL
.	NULL

Electromobility	NULL
shift	NULL
assays	NULL
Cell	NULL
lysates	NULL
were	NULL
made	NULL
from	NULL
KG1	NULL
and	NULL
KG1a	NULL
cells	NULL
cultured	NULL
under	NULL
the	NULL
conditions	NULL
and	NULL
times	NULL
indicated	NULL
.	NULL

Samples	NULL
containing	NULL
equal	NULL
amounts	NULL
of	NULL
protein	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
**P-labeled	NULL
oligonucleotide	NULL
primer	NULL
containing	NULL
multiple	NULL
NFB	NULL
binding	NULL
sites	NULL
with	NULL
or	NULL
without	NULL
anti-ReIB	NULL
Ab	NULL
or	NULL
anti-NFxB	NULL
(	NULL
p50	NULL
)	NULL
.	NULL

Samples	NULL
were	NULL
then	NULL
separated	NULL
on	NULL
a	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
and	NULL
exposed	NULL
to	NULL
film	NULL
.	NULL

3239	NULL
Results	NULL
Inhibition	NULL
of	NULL
PKC	NULL
activation	NULL
blocks	NULL
cytokine-driven	NULL
CD34*	NULL
HPC-DC	NULL
differentiation	NULL
We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
PMA	NULL
activation	NULL
of	NULL
PKC	NULL
induces	NULL
human	NULL
CD34+~	NULL
HPC-DC	NULL
differentiation	NULL
,	NULL
which	NULL
could	NULL
be	NULL
blocked	NULL
by	NULL
the	NULL
PKC	NULL
inhibitor	NULL
staurosporine	NULL
.	NULL

To	NULL
assess	NULL
whether	NULL
cytokine-induced	NULL
CD34	NULL
``	NULL
*HPC-DC	NULL
differentiation	NULL
also	NULL
involves	NULL
PKC	NULL
intracellular	NULL
signaling	NULL
,	NULL
we	NULL
cultured	NULL
CD34*~	NULL
HPC	NULL
in	NULL
GM-CSF	NULL
and	NULL
TNF-a	NULL
@	NULL
for	NULL
14	NULL
days	NULL
with	NULL
or	NULL
without	NULL
0.2	NULL
nM	NULL
staurosporine	NULL
,	NULL
a	NULL
dose	NULL
3.5-fold	NULL
less	NULL
than	NULL
the	NULL
IC	NULL
,	NULL
,	NULL
of	NULL
PKC	NULL
(	NULL
0.7	NULL
nM	NULL
;	NULL
Calbiochem	NULL
Technical	NULL
Report	NULL
)	NULL
but	NULL
at	NULL
least	NULL
10-	NULL
to	NULL
200-fold	NULL
lower	NULL
than	NULL
the	NULL
IC	NULL
,	NULL
,	NULL
for	NULL
protein	NULL
kinase	NULL
A	NULL
and	NULL
tyrosine	NULL
kinases	NULL
(	NULL
40	NULL
)	NULL
.	NULL

Cell	NULL
viability	NULL
at	NULL
14	NULL
days	NULL
was	NULL
>	NULL
90	NULL
%	NULL
in	NULL
both	NULL
culture	NULL
conditions	NULL
,	NULL
but	NULL
there	NULL
was	NULL
a	NULL
greater	NULL
expansion	NULL
of	NULL
cell	NULL
number	NULL
without	NULL
staurosporine	NULL
(	NULL
3	NULL
%	NULL
input	NULL
number	NULL
vs	NULL
1	NULL
X	NULL
with	NULL
staurosporine	NULL
)	NULL
.	NULL

As	NULL
can	NULL
be	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

14	NULL
,	NULL
CD34	NULL
``	NULL
HPC	NULL
cultured	NULL
in	NULL
cytokine	NULL
alone	NULL
developed	NULL
characteristic	NULL
DC	NULL
morphology	NULL
(	NULL
Joosely	NULL
adherent	NULL
large	NULL
cells	NULL
with	NULL
irregular	NULL
shape	NULL
,	NULL
prominent	NULL
dendritic	NULL
processes	NULL
,	NULL
and	NULL
hair-like	NULL
cytoplasmic	NULL
projections	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
cultures	NULL
containing	NULL
staurosporine	NULL
lacked	NULL
cells	NULL
with	NULL
neurite	NULL
processes	NULL
and	NULL
had	NULL
greatly	NULL
reduced	NULL
numbers	NULL
with	NULL
hair-like	NULL
cytoplasmic	NULL
projections	NULL
.	NULL

Staurosporine	NULL
treatment	NULL
also	NULL
resulted	NULL
in	NULL
the	NULL
loss	NULL
of	NULL
cells	NULL
expressing	NULL
characteristic	NULL
DC	NULL
surface	NULL
markers	NULL
,	NULL
CD83	NULL
(	NULL
DC	NULL
lineage	NULL
specif-ic	NULL
)	NULL
,	NULL
MHC	NULL
class	NULL
II	NULL
(	NULL
bright	NULL
)	NULL
,	NULL
and	NULL
the	NULL
costimulatory	NULL
molecules	NULL
CD80	NULL
and	NULL
CD86	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Of	NULL
particular	NULL
significance	NULL
were	NULL
the	NULL
loss	NULL
of	NULL
CD83-	NULL
and	NULL
CD80-positive	NULL
cells	NULL
,	NULL
as	NULL
these	NULL
Ags	NULL
are	NULL
not	NULL
expressed	NULL
on	NULL
monocytes	NULL
(	NULL
resting	NULL
,	NULL
in	NULL
the	NULL
case	NULL
of	NULL
CD80	NULL
)	NULL
(	NULL
41	NULL
,	NULL
42	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
CD83	NULL
and	NULL
CD80	NULL
,	NULL
there	NULL
was	NULL
only	NULL
a	NULL
modest	NULL
decrease	NULL
in	NULL
CD14	NULL
*	NULL
(	NULL
monocyte	NULL
marker	NULL
)	NULL
cells	NULL
and	NULL
no	NULL
loss	NULL
of	NULL
CD33	NULL
*	NULL
(	NULL
myeloid	NULL
marker	NULL
)	NULL
cells	NULL
.	NULL

Cells	NULL
from	NULL
both	NULL
culture	NULL
conditions	NULL
were	NULL
CD34	NULL
negative	NULL
and	NULL
CD13	NULL
bright	NULL
,	NULL
demonstrating	NULL
that	NULL
staurosporine	NULL
did	NULL
not	NULL
nonspecifi-cally	NULL
block	NULL
all	NULL
differentiation	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
staurosporine	NULL
preferentially	NULL
inhibited	NULL
generation	NULL
of	NULL
CD83	NULL
DC	NULL
compared	NULL
with	NULL
CD14+*	NULL
monocytes	NULL
.	NULL

Given	NULL
that	NULL
DC	NULL
are	NULL
the	NULL
most	NULL
effective	NULL
APC	NULL
in	NULL
activating	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
decreased	NULL
numbers	NULL
of	NULL
DC	NULL
in	NULL
the	NULL
staurosporine-treated	NULL
cultures	NULL
should	NULL
be	NULL
reflected	NULL
in	NULL
a	NULL
similar	NULL
decrease	NULL
in	NULL
functional	NULL
potency	NULL
.	NULL

CD34	NULL
*	NULL
HPC	NULL
cultured	NULL
in	NULL
GM-CSF	NULL
and	NULL
TNF-a	NULL
with	NULL
staurosporine	NULL
were	NULL
significantly	NULL
less	NULL
effective	NULL
in	NULL
inducing	NULL
allogeneic	NULL
T	NULL
cell	NULL
proliferation	NULL
than	NULL
those	NULL
cultured	NULL
in	NULL
cytokine	NULL
alone	NULL
,	NULL
particularly	NULL
at	NULL
a	NULL
low	NULL
APC/T	NULL
cell	NULL
ratio	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

However	NULL
,	NULL
both	NULL
were	NULL
still	NULL
superior	NULL
to	NULL
an	NULL
unselected	NULL
population	NULL
of	NULL
PBMC	NULL
.	NULL

Together	NULL
these	NULL
data	NULL
suggest	NULL
that	NULL
inhibition	NULL
of	NULL
PKC	NULL
activation	NULL
preferentially	NULL
suppressed	NULL
generation	NULL
of	NULL
DC	NULL
from	NULL
CD34	NULL
*	NULL
HPC	NULL
by	NULL
GM-CSF	NULL
and	NULL
TNF-a	NULL
,	NULL
findings	NULL
consistent	NULL
with	NULL
the	NULL
differentiating	NULL
effects	NULL
of	NULL
phorbol	NULL
ester	NULL
.	NULL

However	NULL
,	NULL
the	NULL
scarcity	NULL
,	NULL
heterogeneity	NULL
,	NULL
and	NULL
difficulty	NULL
of	NULL
manipulating	NULL
primary	NULL
CD34	NULL
~	NULL
HPC	NULL
made	NULL
further	NULL
analysis	NULL
of	NULL
the	NULL
relevant	NULL
signaling	NULL
and	NULL
genetic	NULL
events	NULL
difficult	NULL
.	NULL

To	NULL
overcome	NULL
these	NULL
obstacles	NULL
we	NULL
sought	NULL
to	NULL
establish	NULL
a	NULL
human	NULL
cell	NULL
line	NULL
model	NULL
of	NULL
CD34	NULL
*	NULL
HPC-	NULL
>	NULL
DC	NULL
differentiation	NULL
.	NULL

Although	NULL
a	NULL
heterogeneous	NULL
lineage	NULL
,	NULL
DC	NULL
share	NULL
a	NULL
constellation	NULL
of	NULL
defining	NULL
characteristics	NULL
,	NULL
including	NULL
morphology	NULL
,	NULL
lineage	NULL
markers	NULL
,	NULL
function	NULL
,	NULL
and	NULL
gene	NULL
expression	NULL
,	NULL
that	NULL
can	NULL
be	NULL
used	NULL
to	NULL
identify	NULL
potential	NULL
DLC	NULL
.	NULL

KG1	NULL
develop	NULL
characteristic	NULL
DC	NULL
phenotype	NULL
(	NULL
morphology	NULL
,	NULL
surface	NULL
Ag	NULL
expression	NULL
)	NULL
in	NULL
response	NULL
to	NULL
cytokines	NULL
or	NULL
PMA	NULL
We	NULL
first	NULL
examined	NULL
the	NULL
PMA-responsive	NULL
CD34*	NULL
myeloblast	NULL
cell	NULL
line	NULL
KG1	NULL
.	NULL

KG1	NULL
cells	NULL
in	NULL
medium	NULL
alone	NULL
were	NULL
typically	NULL
round	NULL
nonadherent	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

When	NULL
cultured	NULL
in	NULL
GM-CSF	NULL
and	NULL
TNF-	NULL
@	NULL
(	NULL
with	NULL
or	NULL
without	NULL
IL-4	NULL
)	NULL
,	NULL
PMA	NULL
or	NULL
PMA	NULL
plus	NULL
TNF-a	NULL
(	NULL
and	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
;	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
KG1	NULL
became	NULL
loosely	NULL
adherent	NULL
and	NULL
a	NULL
subset	NULL
developed	NULL
long	NULL
neurite	NULL
processes	NULL
and	NULL
hair-like	NULL
cytoplasmic	NULL
projections	NULL
(	NULL
best	NULL
seen	NULL
by	NULL
Wright	NULL
staining	NULL
;	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
morphology	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
3240	NULL
A	NULL
minus	NULL
staurosporine	NULL
B	NULL
-	NULL
staurosporine	NULL
+	NULL
staurosporine	NULL
CD83	NULL
MHC	NULL
II	NULL
CD80	NULL
CD86	NULL
CD14	NULL
CD33	NULL
FIGURE	NULL
1	NULL
.	NULL

T	NULL
cell	NULL
proliferation	NULL
(	NULL
SH	NULL
TdR	NULL
)	NULL
A	NULL
CELL	NULL
LINE	NULL
MODEL	NULL
OF	NULL
HUMAN	NULL
DENDRITIC	NULL
CELL	NULL
DIFFERENTIATION	NULL
plus	NULL
staurosporine	NULL
9	NULL
&	NULL
5	NULL
?	NULL

tod	NULL
op	NULL
ico	NULL
*	NULL
“	NULL
S	NULL
.	NULL

.	NULL

5:9	NULL
it	NULL
:	NULL
y*	NULL
-	NULL
F	NULL
R	NULL
t	NULL
tﬁ/	NULL
f	NULL
}	NULL
:	NULL
is	NULL
“	NULL
?	NULL

p*	NULL
h	NULL
)	NULL
fe	NULL
ﬁa	NULL
‘	NULL
tﬁr	NULL
'	NULL
v	NULL
M	NULL
Pos	NULL
w	NULL
Aeey	NULL
:	NULL
~	NULL
8000	NULL
{	NULL
-	NULL
|-	NULL
GM-CSF+TNFa	NULL
zim	NULL
GM-CSF	NULL
¥TNFa+staurosporine	NULL
amy	NULL
PBMC	NULL
6000	NULL
4000	NULL
o	NULL
10°	NULL
number	NULL
of	NULL
APC/A1O*®	NULL
T	NULL
cells	NULL
10°	NULL
Primary	NULL
CD34*	NULL
HPC	NULL
cultured	NULL
for	NULL
14	NULL
days	NULL
in	NULL
GM-CSF	NULL
(	NULL
200	NULL
U/ml	NULL
)	NULL
and	NULL
TNF-	NULL
«	NULL
(	NULL
2.5	NULL
ng/ml	NULL
)	NULL
with	NULL
or	NULL
without	NULL
staurosporine	NULL
(	NULL
0.2	NULL
nM	NULL
)	NULL
.	NULL

A	NULL
,	NULL
Morphology	NULL
.	NULL

Photomicrograph	NULL
of	NULL
the	NULL
cultures	NULL
.	NULL

Black	NULL
dots	NULL
are	NULL
magnetic	NULL
beads	NULL
used	NULL
in	NULL
the	NULL
initial	NULL
CD34*	NULL
purification	NULL
.	NULL

Arrows	NULL
point	NULL
to	NULL
the	NULL
characteristic	NULL
neurite	NULL
processes	NULL
.	NULL

B	NULL
,	NULL
Surface	NULL
Ag	NULL
phenotype	NULL
.	NULL

HPC	NULL
were	NULL
cultured	NULL
as	NULL
described	NULL
above	NULL
,	NULL
and	NULL
adherent	NULL
and	NULL
nonadherent	NULL
cells	NULL
were	NULL
analyzed	NULL
by	NULL
flow	NULL
cytometry	NULL
with	NULL
the	NULL
Abs	NULL
indicated	NULL
(	NULL
solid	NULL
line	NULL
)	NULL
vs	NULL
isotype	NULL
control	NULL
(	NULL
dotted	NULL
line	NULL
)	NULL
.	NULL

The	NULL
x-axis	NULL
is	NULL
log	NULL
fluorescence	NULL
,	NULL
and	NULL
the	NULL
y-axis	NULL
is	NULL
cell	NULL
number	NULL
.	NULL

C	NULL
,	NULL
Induction	NULL
of	NULL
allogeneic	NULL
T	NULL
cell	NULL
proliferation	NULL
.	NULL

CD34	NULL
*	NULL
cells	NULL
cultured	NULL
with	NULL
or	NULL
without	NULL
staurosporine	NULL
as	NULL
described	NULL
above	NULL
were	NULL
harvested	NULL
on	NULL
day	NULL
14	NULL
,	NULL
washed	NULL
three	NULL
times	NULL
in	NULL
PBS	NULL
,	NULL
plated	NULL
in	NULL
triplicate	NULL
in	NULL
the	NULL
numbers	NULL
indicated	NULL
,	NULL
and	NULL
gamma	NULL
irradiated	NULL
(	NULL
3000	NULL
rad	NULL
*°°Cs	NULL
)	NULL
.	NULL

Allogeneic	NULL
irradiated	NULL
PBMC	NULL
were	NULL
used	NULL
for	NULL
comparison	NULL
.	NULL

Purified	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
(	NULL
1	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
added	NULL
to	NULL
each	NULL
well	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
purified	NULL
from	NULL
leukapheresis	NULL
collections	NULL
of	NULL
healthy	NULL
donors	NULL
by	NULL
negative	NULL
selection	NULL
(	NULL
38	NULL
)	NULL
and	NULL
were	NULL
free	NULL
of	NULL
accessory	NULL
cells	NULL
as	NULL
demonstrated	NULL
by	NULL
Con	NULL
A	NULL
unresponsiveness	NULL
.	NULL

After	NULL
54	NULL
h	NULL
of	NULL
culture	NULL
,	NULL
cells	NULL
were	NULL
pulsed	NULL
with	NULL
0.5	NULL
uCi/well	NULL
[	NULL
methy/-*H|thymidine	NULL
before	NULL
being	NULL
harvested	NULL
at	NULL
72	NULL
h.	NULL
[	NULL
°HJTdR	NULL
incorporation	NULL
was	NULL
measured	NULL
using	NULL
a	NULL
Beta	NULL
Plate	NULL
scintillation	NULL
counting	NULL
system	NULL
.	NULL

reported	NULL
to	NULL
be	NULL
characteristic	NULL
of	NULL
DC	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Morphologic	NULL
changes	NULL
began	NULL
within	NULL
30	NULL
min	NULL
of	NULL
stimulation	NULL
,	NULL
were	NULL
fully	NULL
manifested	NULL
within	NULL
48	NULL
h	NULL
,	NULL
and	NULL
were	NULL
stable	NULL
over	NULL
at	NULL
least	NULL
2	NULL
wk	NULL
in	NULL
culture	NULL
.	NULL

Development	NULL
of	NULL
the	NULL
dendrite/neurite	NULL
morphology	NULL
was	NULL
progressively	NULL
more	NULL
prevalent	NULL
and	NULL
pronounced	NULL
with	NULL
GM-CSF	NULL
plus	NULL
TNF-a-	NULL
>	NULL
PMA-PMA	NULL
plus	NULL
TNF-	NULL
«	NULL
(	NULL
and	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
}	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
these	NULL
stimuli	NULL
,	NULL
there	NULL
was	NULL
no	NULL
effect	NULL
of	NULL
individual	NULL
cytokines	NULL
(	NULL
GM-CSF	NULL
,	NULL
IL-4	NULL
,	NULL
or	NULL
TNF-a	NULL
@	NULL
)	NULL
,	NULL
a	NULL
cytokine	NULL
combination	NULL
that	NULL
does	NULL
not	NULL
induce	NULL
DC	NULL
differentiation	NULL
(	NULL
GM-CSF	NULL
,	NULL
IL-3	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
SCF	NULL
)	NULL
,	NULL
ionomycin	NULL
alone	NULL
,	NULL
or	NULL
ionomycin	NULL
plus	NULL
TNF-	NULL
«	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

While	NULL
KG1a	NULL
also	NULL
became	NULL
adherent	NULL
when	NULL
similarly	NULL
stimulated	NULL
,	NULL
they	NULL
did	NULL
not	NULL
change	NULL
morphology	NULL
.	NULL

Mature	NULL
DC	NULL
are	NULL
typically	NULL
characterized	NULL
by	NULL
expression	NULL
of	NULL
MHC	NULL
class	NULL
I	NULL
,	NULL
MHC	NULL
class	NULL
II	NULL
(	NULL
high	NULL
)	NULL
,	NULL
the	NULL
costimulatory	NULL
molecules	NULL
CD80	NULL
(	NULL
B7-1	NULL
)	NULL
and	NULL
CD86	NULL
(	NULL
B7-2	NULL
)	NULL
,	NULL
and	NULL
the	NULL
DC	NULL
lineage	NULL
marker	NULL
CD83	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

12	NULL
)	NULL
.	NULL

Unstimulated	NULL
KG1	NULL
cells	NULL
expressed	NULL
MHC	NULL
I	NULL
,	NULL
MHC	NULL
II	NULL
(	NULL
bright	NULL
)	NULL
,	NULL
the	NULL
myeloid	NULL
markers	NULL
CD13	NULL
and	NULL
CD33	NULL
,	NULL
CD34	NULL
,	NULL
CD45RA	NULL
,	NULL
and	NULL
CD86	NULL
(	NULL
dim	NULL
)	NULL
but	NULL
not	NULL
€D40	NULL
,	NULL
CD80	NULL
,	NULL
the	NULL
DC	NULL
marker	NULL
CD83	NULL
,	NULL
or	NULL
the	NULL
monocyte	NULL
marker	NULL
CD14	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

KG1a	NULL
had	NULL
lower	NULL
expression	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
and	NULL
no	NULL
CD86	NULL
staining	NULL
.	NULL

We	NULL
also	NULL
found	NULL
that	NULL
KG1	NULL
and	NULL
KG1a	NULL
differed	NULL
markedly	NULL
in	NULL
expression	NULL
of	NULL
TNF-	NULL
«	NULL
receptors	NULL
1	NULL
and	NULL
2	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
,	NULL
which	NULL
may	NULL
in	NULL
part	NULL
underlie	NULL
the	NULL
differences	NULL
in	NULL
TNF-	NULL
«	NULL
responsiveness	NULL
between	NULL
the	NULL
two	NULL
cell	NULL
lines	NULL
.	NULL

KG1	NULL
stimulated	NULL
with	NULL
GM-CSF	NULL
plus	NULL
TNF-	NULL
«	NULL
,	NULL
PMA	NULL
,	NULL
PMA	NULL
plus	NULL
TNF-	NULL
«	NULL
,	NULL
or	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
up-regulated	NULL
CD83	NULL
expression	NULL
with	NULL
the	NULL
same	NULL
temporal	NULL
kinetics	NULL
as	NULL
the	NULL
morphology	NULL
changes	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

The	NULL
level	NULL
of	NULL
CD83	NULL
expression	NULL
has	NULL
been	NULL
correlated	NULL
with	NULL
the	NULL
degree	NULL
of	NULL
DC	NULL
maturation	NULL
(	NULL
43	NULL
)	NULL
,	NULL
and	NULL
CD83	NULL
up-regulation	NULL
in	NULL
KG1	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
FIGURE	NULL
2	NULL
.	NULL

Morphology	NULL
of	NULL
KG1	NULL
stimulated	NULL
with	NULL
cytokines	NULL
and/or	NULL
PMA	NULL
.	NULL

Photomicrographs	NULL
of	NULL
day	NULL
7	NULL
cultures	NULL
of	NULL
KG1	NULL
in	NULL
medium	NULL
alone	NULL
,	NULL
GM-CSF	NULL
(	NULL
200	NULL
U/ml	NULL
)	NULL
plus	NULL
TNF-a	NULL
(	NULL
2.5	NULL
ng/ml	NULL
)	NULL
,	NULL
PMA	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
,	NULL
or	NULL
PMA	NULL
plus	NULL
TNF-a	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
.	NULL

Arrows	NULL
point	NULL
to	NULL
neurite	NULL
processes	NULL
.	NULL

KG1	NULL
in	NULL
medium	NULL
alone	NULL
were	NULL
nonadherent	NULL
;	NULL
in	NULL
all	NULL
other	NULL
conditions	NULL
they	NULL
were	NULL
adherent	NULL
.	NULL

was	NULL
typically	NULL
highest	NULL
with	NULL
PMA	NULL
and	NULL
TNF-	NULL
«	NULL
or	NULL
PMA	NULL
and	NULL
ionomycin	NULL
.	NULL

PMA	NULL
also	NULL
up-regulated	NULL
CD40	NULL
expression	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
and	NULL
modestly	NULL
down-regulated	NULL
MHC	NULL
II	NULL
,	NULL
which	NULL
was	NULL
reversed	NULL
by	NULL
addition	NULL
of	NULL
TNF-a	NULL
or	NULL
ionomycin	NULL
.	NULL

Up-regulation	NULL
of	NULL
CD86	NULL
was	NULL
most	NULL
pronounced	NULL
with	NULL
addition	NULL
of	NULL
ionomycin	NULL
,	NULL
and	NULL
ionomycin	NULL
alone	NULL
could	NULL
up-regulate	NULL
CD86	NULL
without	NULL
inducing	NULL
CD83	NULL
expression	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

PMA	NULL
plus	NULL
ionomycin	NULL
also	NULL
induced	NULL
expression	NULL
of	NULL
CD80	NULL
,	NULL
although	NULL
typically	NULL
at	NULL
low	NULL
levels	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
combination	NULL
of	NULL
PMA	NULL
,	NULL
ionomycin	NULL
,	NULL
and	NULL
TNF-a	NULL
was	NULL
no	NULL
different	NULL
from	NULL
PMA	NULL
plus	NULL
TNF-a	NULL
@	NULL
or	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
alone	NULL
,	NULL
suggesting	NULL
that	NULL
TNF-a	NULL
and	NULL
ionomycin	NULL
deliver	NULL
the	NULL
same	NULL
signal	NULL
.	NULL

Individual	NULL
cytokines	NULL
(	NULL
GM-CSF	NULL
,	NULL
IL-4	NULL
,	NULL
TNF-a	NULL
)	NULL
or	NULL
the	NULL
cytokine	NULL
combination	NULL
GM-CSF	NULL
,	NULL
IL-3	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
SCF	NULL
did	NULL
not	NULL
up-regulate	NULL
CD83	NULL
or	NULL
CD86	NULL
expression	NULL
on	NULL
KG1	NULL
.	NULL

None	NULL
of	NULL
the	NULL
stimuli	NULL
tested	NULL
induced	NULL
expression	NULL
of	NULL
CD1a	NULL
or	NULL
the	NULL
monocyte	NULL
marker	NULL
CD14	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
KG1	NULL
,	NULL
KG1a	NULL
did	NULL
not	NULL
respond	NULL
to	NULL
GM-CSF	NULL
plus	NULL
TNF-a	NULL
or	NULL
PMA	NULL
with	NULL
or	NULL
without	NULL
ionomy-	NULL
Table	NULL
I	NULL
.	NULL

-	NULL
Surface	NULL
Ag	NULL
expression	NULL
of	NULL
unstimulated	NULL
KG1	NULL
and	NULL
KG1a®	NULL
KG1	NULL
KGla	NULL
MHC	NULL
class	NULL
I	NULL
++++	NULL
++++	NULL
MHC	NULL
class	NULL
I	NULL
++++	NULL
+	NULL
CD1a	NULL
-	NULL
CD2	NULL
-	NULL
CD10	NULL
-	NULL
CD13	NULL
++	NULL
+++	NULL
CD14	NULL
-	NULL
CD28	NULL
-	NULL
CD33	NULL
++	NULL
+	NULL
CD34	NULL
++++	NULL
++++	NULL
C€CD40	NULL
-	NULL
CD45RA	NULL
+	NULL
+	NULL
CD80	NULL
(	NULL
B7-1	NULL
)	NULL
-	NULL
CD83	NULL
-	NULL
CD86	NULL
(	NULL
B7-2	NULL
)	NULL
+	NULL
©D90	NULL
(	NULL
Thy-1	NULL
)	NULL
-	NULL
CD152	NULL
(	NULL
CTLA4	NULL
)	NULL
-	NULL
CD154	NULL
(	NULL
CD4OL	NULL
)	NULL
-	NULL
¢-fms	NULL
+	NULL
_	NULL
``	NULL
Each	NULL
+	NULL
indicates	NULL
an	NULL
increase	NULL
of	NULL
0.5	NULL
logs	NULL
in	NULL
mean	NULL
fluorescent	NULL
intensity	NULL
vs.	NULL
isotype	NULL
matched	NULL
control	NULL
.	NULL

3241	NULL
-CSF+TNF-o+IL-4	NULL
cin	NULL
,	NULL
but	NULL
did	NULL
up-regulate	NULL
(	NULL
slight	NULL
)	NULL
CD83	NULL
in	NULL
response	NULL
to	NULL
PMA	NULL
and	NULL
TNF-	NULL
«	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Signals	NULL
that	NULL
induce	NULL
KG1I-DLC	NULL
differentiation	NULL
also	NULL
suppress	NULL
proliferation	NULL
and	NULL
trigger	NULL
programmed	NULL
cell	NULL
death	NULL
In	NULL
primary	NULL
CD34*	NULL
HPC	NULL
we	NULL
found	NULL
the	NULL
two	NULL
hallmarks	NULL
of	NULL
PMA-driven	NULL
DC	NULL
differentiation	NULL
are	NULL
the	NULL
complete	NULL
inhibition	NULL
of	NULL
proliferation	NULL
(	NULL
even	NULL
to	NULL
exogenous	NULL
cytokines	NULL
)	NULL
and	NULL
induction	NULL
of	NULL
apoptosis	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Proliferation	NULL
is	NULL
also	NULL
absent	NULL
in	NULL
monocyte-	NULL
>	NULL
DC	NULL
differentiation	NULL
driven	NULL
by	NULL
GM-CSF	NULL
,	NULL
IL-4	NULL
,	NULL
and	NULL
TNF-a	NULL
(	NULL
4	NULL
)	NULL
or	NULL
calcium	NULL
ionophore	NULL
(	NULL
11	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
KG1	NULL
proliferation	NULL
was	NULL
suppressed	NULL
by	NULL
factors	NULL
that	NULL
induce	NULL
DC/DLC	NULL
differentiation	NULL
(	NULL
PMA	NULL
(	NULL
consistent	NULL
with	NULL
the	NULL
findings	NULL
presented	NULL
in	NULL
Ref	NULL
.	NULL

44	NULL
)	NULL
,	NULL
TNF-a	NULL
,	NULL
and	NULL
most	NULL
significantly	NULL
by	NULL
PMA	NULL
plus	NULL
TNF-	NULL
«	NULL
@	NULL
)	NULL
,	NULL
but	NULL
not	NULL
by	NULL
a	NULL
cytokine	NULL
combination	NULL
(	NULL
GM-CSF	NULL
,	NULL
IL-3	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
SCF	NULL
)	NULL
that	NULL
does	NULL
not	NULL
generate	NULL
DC	NULL
.	NULL

Baseline	NULL
proliferation	NULL
of	NULL
KG1la	NULL
was	NULL
2.6-fold	NULL
higher	NULL
than	NULL
that	NULL
of	NULL
KG1	NULL
and	NULL
was	NULL
unaffected	NULL
by	NULL
these	NULL
stimuli	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Because	NULL
the	NULL
day	NULL
5	NULL
viability	NULL
of	NULL
KG1	NULL
was	NULL
decreased	NULL
in	NULL
PMA	NULL
(	NULL
75	NULL
%	NULL
viable	NULL
)	NULL
,	NULL
PMA	NULL
plus	NULL
TNF-	NULL
«	NULL
(	NULL
70	NULL
%	NULL
)	NULL
,	NULL
and	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
(	NULL
67	NULL
%	NULL
)	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
induction	NULL
of	NULL
apoptosis	NULL
by	NULL
these	NULL
stimuli	NULL
(	NULL
Table	NULL
II	NULL
)	NULL
.	NULL

In	NULL
KG1	NULL
,	NULL
apoptosis	NULL
was	NULL
triggered	NULL
within	NULL
4	NULL
h	NULL
by	NULL
PMA	NULL
plus	NULL
iono	NULL
and	NULL
within	NULL
24	NULL
h	NULL
by	NULL
PMA	NULL
plus	NULL
TNF-	NULL
«	NULL
.	NULL

Smaller	NULL
increases	NULL
in	NULL
apoptotic	NULL
cell	NULL
numbers	NULL
were	NULL
seen	NULL
at	NULL
24	NULL
h	NULL
in	NULL
cultures	NULL
treated	NULL
with	NULL
PMA	NULL
or	NULL
TNF-a	NULL
alone	NULL
,	NULL
TNFR1	NULL
;	NULL
©	NULL
KG1a	NULL
J	NULL
t	NULL
FIGURE	NULL
3	NULL
.	NULL

KG1	NULL
and	NULL
KG1a	NULL
expression	NULL
of	NULL
TNF-a	NULL
receptors	NULL
1	NULL
and	NULL
2	NULL
.	NULL

Unstimulated	NULL
KG1	NULL
and	NULL
KG1a	NULL
were	NULL
analyzed	NULL
by	NULL
FACS	NULL
for	NULL
TNF	NULL
receptor	NULL
1	NULL
and	NULL
2	NULL
expression	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
isotype-matched	NULL
control	NULL
is	NULL
the	NULL
dotted	NULL
line	NULL
,	NULL
and	NULL
Ag-specific	NULL
Ab	NULL
the	NULL
solid	NULL
line	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
3242	NULL
MHC	NULL
I1	NULL
CD86	NULL
CD83	NULL
KG1	NULL
|	NULL
media	NULL
GM-CSF+TNFa	NULL
'	NULL
PMA	NULL
PMA+TNF-o	NULL
.	NULL
'	NULL

5	NULL
Pt	NULL
%	NULL
..	NULL
PMA	NULL
+	NULL
ono	NULL
N	NULL
KG1a	NULL
|	NULL
;	NULL
PMA	NULL
A	NULL
«	NULL
[	NULL
\	NULL
m	NULL
FIGURE	NULL
4	NULL
.	NULL

Surface	NULL
Ag	NULL
phenotypes	NULL
of	NULL
KG1	NULL
and	NULL
KG1a	NULL
in	NULL
response	NULL
to	NULL
cytokine	NULL
and/or	NULL
PMA	NULL
stimulation	NULL
.	NULL

KG1	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
medium	NULL
alone	NULL
,	NULL
GM-CSF	NULL
(	NULL
200	NULL
U/ml	NULL
!	NULL
)	NULL

plus	NULL
TNF-a	NULL
(	NULL
2.5	NULL
ng/ml	NULL
)	NULL
,	NULL
PMA	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
,	NULL
PMA	NULL
plus	NULL
TNF-a	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
,	NULL
or	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
(	NULL
200	NULL
ng/ml	NULL
)	NULL
.	NULL

KGla	NULL
were	NULL
cultured	NULL
in	NULL
PMA	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
and	NULL
analyzed	NULL
by	NULL
FACS	NULL
.	NULL

Ag-specific	NULL
staining	NULL
is	NULL
indicated	NULL
by	NULL
the	NULL
solid	NULL
line	NULL
,	NULL
and	NULL
the	NULL
isotype-matched	NULL
control	NULL
is	NULL
shown	NULL
by	NULL
the	NULL
dotted	NULL
line	NULL
.	NULL

The	NULL
time	NULL
of	NULL
maximal	NULL
surface	NULL
expression	NULL
varied	NULL
depending	NULL
on	NULL
the	NULL
stimulus	NULL
,	NULL
shown	NULL
here	NULL
are	NULL
GM-CSF	NULL
plus	NULL
TNF-a	NULL
and	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
(	NULL
day	NULL
3	NULL
in	NULL
culture	NULL
)	NULL
,	NULL
and	NULL
medium	NULL
,	NULL
PMA	NULL
,	NULL
and	NULL
PMA	NULL
plus	NULL
TNF-a	NULL
(	NULL
day	NULL
7	NULL
in	NULL
culture	NULL
)	NULL
.	NULL

correlating	NULL
with	NULL
a	NULL
lesser	NULL
inhibition	NULL
of	NULL
cell	NULL
proliferation	NULL
by	NULL
these	NULL
single	NULL
factors	NULL
.	NULL

Also	NULL
consistent	NULL
with	NULL
the	NULL
proliferation	NULL
data	NULL
was	NULL
the	NULL
failure	NULL
of	NULL
any	NULL
stimuli	NULL
to	NULL
induce	NULL
apoptosis	NULL
in	NULL
KG1la	NULL
(	NULL
the	NULL
greater	NULL
baseline	NULL
percentage	NULL
of	NULL
apoptotic	NULL
cells	NULL
was	NULL
probably	NULL
due	NULL
to	NULL
the	NULL
higher	NULL
proliferative	NULL
rate	NULL
)	NULL
.	NULL

Fluid	NULL
phase	NULL
macromolecule	NULL
uptake	NULL
by	NULL
KG1	NULL
and	NULL
KGI-DLC	NULL
Ag	NULL
uptake	NULL
(	NULL
via	NULL
receptor-mediated	NULL
endocytosis	NULL
(	NULL
Fcy	NULL
,	NULL
mannose	NULL
re-ceptors	NULL
)	NULL
or	NULL
macropinocytosis	NULL
of	NULL
fluid	NULL
phase	NULL
molecules	NULL
)	NULL
is	NULL
a	NULL
func-	NULL
350000	NULL
-	NULL
_	NULL
-	NULL
@	NULL
-	NULL
media	NULL
-	NULL
&	NULL
-	NULL
GM-CSF+IL-3+IL-6+SCF	NULL
-yz-	NULL
PMA	NULL
-M-	NULL
TNF-a	NULL
-	NULL
}	NULL
-	NULL
PMA	NULL
+	NULL
TNF-a	NULL
300000	NULL
250000	NULL
200000	NULL
150000	NULL
100000	NULL
Proliferation	NULL
(	NULL
cpm	NULL
)	NULL
50000	NULL
10	NULL
'	NULL
10	NULL
10°	NULL
10°	NULL
10°	NULL
10°	NULL
number	NULL
of	NULL
cells	NULL
in	NULL
culture	NULL
FIGURE	NULL
5	NULL
.	NULL

Inhibition	NULL
of	NULL
KG1	NULL
proliferation	NULL
.	NULL

KG1	NULL
were	NULL
cultured	NULL
at	NULL
the	NULL
cell	NULL
numbers	NULL
and	NULL
in	NULL
the	NULL
conditions	NULL
noted	NULL
.	NULL

After	NULL
54	NULL
h	NULL
of	NULL
culture	NULL
,	NULL
cells	NULL
were	NULL
pulsed	NULL
with	NULL
0.5	NULL
uCi/well	NULL
[	NULL
methy	NULL
!	NULL

-*HJthymidine	NULL
before	NULL
being	NULL
harvested	NULL
at	NULL
72	NULL
h.	NULL
[	NULL
°H	NULL
]	NULL
TdR	NULL
incorporation	NULL
was	NULL
measured	NULL
using	NULL
a	NULL
Beta	NULL
Plate	NULL
scintillation	NULL
counting	NULL
system	NULL
.	NULL

A	NULL
CELL	NULL
LINE	NULL
MODEL	NULL
OF	NULL
HUMAN	NULL
DENDRITIC	NULL
CELL	NULL
DIFFERENTIATION	NULL
Table	NULL
II	NULL
.	NULL

-	NULL
Induction	NULL
of	NULL
apoptosis	NULL
in	NULL
KG1	NULL
and	NULL
KG1a°	NULL
%	NULL
Apoptotic	NULL
Cells	NULL
KG1	NULL
KGla	NULL
Condition	NULL
4	NULL
h	NULL
24	NULL
h	NULL
4	NULL
h	NULL
24	NULL
h	NULL
Media	NULL
5.3	NULL
5.8	NULL
11.9	NULL
9.4	NULL
PMA	NULL
7.2	NULL
9.9	NULL
9.8	NULL
5.6	NULL
Tono	NULL
6.8	NULL
4.4	NULL
9.6	NULL
8.5	NULL
TNF-a	NULL
5.5	NULL
7.9	NULL
9.5	NULL
9.6	NULL
PMA	NULL
+	NULL
TNF-a	NULL
8.7	NULL
17.9	NULL
7.4	NULL
8.7	NULL
PMA	NULL
+	NULL
iono	NULL
14.4	NULL
224	NULL
8.7	NULL
10.1	NULL
``	NULL
Cells	NULL
were	NULL
stimulated	NULL
as	NULL
indicated	NULL
and	NULL
assessed	NULL
for	NULL
induction	NULL
of	NULL
apoptosis	NULL
(	NULL
by	NULL
annexin	NULL
V	NULL
binding	NULL
)	NULL
at	NULL
the	NULL
times	NULL
indicated	NULL
.	NULL

tional	NULL
characteristic	NULL
of	NULL
both	NULL
DC	NULL
and	NULL
CD34	NULL
``	NULL
CD86	NULL
+	NULL
DC	NULL
precursors	NULL
(	NULL
7	NULL
,	NULL
37	NULL
)	NULL
.	NULL

Ag	NULL
capture	NULL
(	NULL
as	NULL
measured	NULL
by	NULL
FITC-dextran	NULL
uptake	NULL
)	NULL
changes	NULL
from	NULL
a	NULL
high	NULL
capacity	NULL
in	NULL
immature/unactivated	NULL
DC	NULL
to	NULL
a	NULL
lower	NULL
capacity	NULL
in	NULL
mature/activated	NULL
DC	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Unstimulated	NULL
KG1	NULL
took	NULL
up	NULL
FITC-dextran	NULL
,	NULL
and	NULL
PMA	NULL
did	NULL
not	NULL
affect	NULL
uptake	NULL
even	NULL
though	NULL
it	NULL
induced	NULL
other	NULL
characteristic	NULL
DC	NULL
changes	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

However	NULL
,	NULL
TNF-	NULL
«	NULL
@	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
PMA	NULL
down-modulated	NULL
macromolecule	NULL
uptake	NULL
,	NULL
suggesting	NULL
that	NULL
TNF-a	NULL
(	NULL
but	NULL
not	NULL
PKC	NULL
activation	NULL
)	NULL
delivers	NULL
a	NULL
distinct	NULL
signal	NULL
that	NULL
mediates	NULL
the	NULL
decreased	NULL
Ag	NULL
uptake	NULL
capability	NULL
associated	NULL
with	NULL
DC	NULL
maturation	NULL
.	NULL

KGI-DLC	NULL
induce	NULL
allogeneic	NULL
T	NULL
cell	NULL
proliferation	NULL
The	NULL
most	NULL
distinctive	NULL
functional	NULL
characteristic	NULL
of	NULL
DC	NULL
is	NULL
the	NULL
potent	NULL
ability	NULL
to	NULL
activate	NULL
T	NULL
cells	NULL
(	NULL
45	NULL
)	NULL
.	NULL

We	NULL
found	NULL
that	NULL
PMA-generated	NULL
KG1	NULL
media	NULL
37°C	NULL
PMA	NULL
37°C	NULL
l	NULL
media	NULL
37°C	NULL
TNF-a	NULL
37°C	NULL
a	NULL
1	NULL
h	NULL
too	NULL
tose	NULL
media	NULL
37°C	NULL
PMA+TNF-a	NULL
37°C	NULL
a	NULL
a	NULL
&	NULL
i	NULL
o	NULL
FIGURE	NULL
6	NULL
.	NULL

-	NULL
Fluid	NULL
phase	NULL
macromolecule	NULL
uptake	NULL
by	NULL
KG1	NULL
and	NULL
KG1-DLC	NULL
.	NULL

KG1	NULL
were	NULL
unstimulated	NULL
(	NULL
medium	NULL
)	NULL
or	NULL
cultured	NULL
in	NULL
PMA	NULL
,	NULL
TNF-a	NULL
,	NULL
or	NULL
PMA	NULL
plus	NULL
TNF-a	NULL
for	NULL
5	NULL
days	NULL
.	NULL

FITC-dextran	NULL
uptake	NULL
was	NULL
then	NULL
assayed	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
and	NULL
analyzed	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

FITC-dextran	NULL
uptake	NULL
at	NULL
4°C	NULL
by	NULL
unstimulated	NULL
KG1	NULL
served	NULL
as	NULL
the	NULL
negative	NULL
control	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
12000	NULL
1	NULL
-	NULL
memes	NULL
KG1a	NULL
(	NULL
--	NULL
-	NULL
KG1	NULL
<	NULL
maz	NULL
»	NULL
pbme	NULL
_L	NULL
,	NULL
19900	NULL
-__	NULL
APC	NULL
:	NULL
T	NULL
ratio	NULL
of	NULL
1:10	NULL
|	NULL
|	NULL
8000	NULL
6000	NULL
4	NULL
4000	NULL
-	NULL
|	NULL
|	NULL
cell	NULL
proliferation	NULL
(	NULL
cpm	NULL
)	NULL
2000	NULL
4	NULL
no	NULL
T	NULL
cells	NULL
_	NULL
media	NULL
iono	NULL
PMA	NULL
PMA+iono	NULL
_	NULL
pbme	NULL
KG1/KG1a	NULL
culture	NULL
condition	NULL
FIGURE	NULL
7	NULL
.	NULL

T	NULL
cell	NULL
proliferation	NULL
in	NULL
response	NULL
to	NULL
KG1	NULL
and	NULL
KG1a	NULL
cultured	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
conditions	NULL
.	NULL

KG1	NULL
and	NULL
KG1a	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
7	NULL
days	NULL
in	NULL
medium	NULL
,	NULL
ionomycin	NULL
(	NULL
50	NULL
ng/m	NULL
!	NULL
)	NULL

,	NULL
PMA	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
,	NULL
and	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
.	NULL

Cells	NULL
were	NULL
thoroughly	NULL
washed	NULL
and	NULL
added	NULL
to	NULL
purified	NULL
resting	NULL
allogeneic	NULL
T	NULL
cells	NULL
in	NULL
flat-bottom	NULL
microtiter	NULL
plates	NULL
at	NULL
an	NULL
APC	NULL
:	NULL
T	NULL
ratio	NULL
of	NULL
1:10	NULL
.	NULL

Freshly	NULL
isolated	NULL
allogeneic	NULL
PBMC	NULL
were	NULL
used	NULL
as	NULL
APC	NULL
for	NULL
comparison	NULL
.	NULL

Proliferation	NULL
was	NULL
measured	NULL
by	NULL
[	NULL
°HJTdR	NULL
incorporation	NULL
.	NULL

DLC	NULL
were	NULL
capable	NULL
of	NULL
stimulating	NULL
allogeneic	NULL
T	NULL
cell	NULL
proliferation	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
and	NULL
to	NULL
a	NULL
comparatively	NULL
greater	NULL
extent	NULL
than	NULL
unselected	NULL
PBMC	NULL
(	NULL
as	NULL
a	NULL
reference	NULL
population	NULL
of	NULL
APC	NULL
)	NULL
.	NULL

KG1	NULL
cultured	NULL
in	NULL
PMA	NULL
and	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
were	NULL
significantly	NULL
more	NULL
potent	NULL
at	NULL
inducing	NULL
T	NULL
cell	NULL
proliferation	NULL
than	NULL
KG1	NULL
cultured	NULL
in	NULL
medium	NULL
,	NULL
KG1a	NULL
cultured	NULL
in	NULL
PMA	NULL
with	NULL
or	NULL
without	NULL
ionomycin	NULL
,	NULL
or	NULL
unselected	NULL
PBMC	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
morphology	NULL
and	NULL
surface	NULL
phenotype	NULL
findings	NULL
above	NULL
,	NULL
ionomycin	NULL
appeared	NULL
to	NULL
drive	NULL
further	NULL
maturation/activation	NULL
over	NULL
PMA	NULL
alone	NULL
as	NULL
measured	NULL
by	NULL
alloproliferation	NULL
.	NULL

Lack	NULL
of	NULL
significant	NULL
T	NULL
cell	NULL
proliferation	NULL
with	NULL
PMA-treated	NULL
KG1a	NULL
cells	NULL
demonstrates	NULL
the	NULL
lack	NULL
of	NULL
PMA	NULL
carryover	NULL
from	NULL
the	NULL
original	NULL
KG1/KG1a	NULL
differentiation	NULL
cultures	NULL
.	NULL

KGI-DLC	NULL
express	NULL
characteristic	NULL
DC	NULL
genes	NULL
Characterization	NULL
of	NULL
DC	NULL
has	NULL
classically	NULL
relied	NULL
on	NULL
morphology	NULL
,	NULL
surface	NULL
Ag	NULL
expression	NULL
,	NULL
and	NULL
function	NULL
.	NULL

Recent	NULL
molecular	NULL
studies	NULL
have	NULL
identified	NULL
genes	NULL
that	NULL
are	NULL
expressed	NULL
predominantly	NULL
or	NULL
exclusively	NULL
by	NULL
DC	NULL
.	NULL

These	NULL
include	NULL
the	NULL
RelB	NULL
transcription	NULL
factor	NULL
(	NULL
see	NULL
below	NULL
)	NULL
and	NULL
the	NULL
chemokine	NULL
DC-CK1	NULL
.	NULL

The	NULL
DC-CK1	NULL
chemokine	NULL
is	NULL
expressed	NULL
only	NULL
by	NULL
DC	NULL
and	NULL
not	NULL
other	NULL
APC	NULL
,	NULL
and	NULL
appears	NULL
to	NULL
function	NULL
as	NULL
a	NULL
che-moattractant	NULL
for	NULL
naive	NULL
T	NULL
cells	NULL
(	NULL
46	NULL
)	NULL
.	NULL

Unstimulated	NULL
KG1	NULL
expressed	NULL
low	NULL
levels	NULL
of	NULL
DC-CK1	NULL
that	NULL
were	NULL
substantially	NULL
up-regulated	NULL
by	NULL
PMA	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
)	NULL
.	NULL

Unexpectedly	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
TNF-	NULL
«	NULL
inhibited	NULL
DC-CK1	NULL
up-regulation	NULL
in	NULL
KG1	NULL
.	NULL

The	NULL
converse	NULL
response	NULL
was	NULL
seen	NULL
in	NULL
KG1a	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
,	NULL
where	NULL
PMA	NULL
has	NULL
no	NULL
effect	NULL
on	NULL
DC-CK1	NULL
expression	NULL
but	NULL
PMA	NULL
plus	NULL
TNF-a	NULL
results	NULL
in	NULL
up-regulation	NULL
,	NULL
arguing	NULL
against	NULL
a	NULL
direct	NULL
inhibitory	NULL
effect	NULL
of	NULL
TNF-	NULL
@	NULL
.	NULL

Since	NULL
PMA	NULL
plus	NULL
TNF-a	NULL
induces	NULL
KGI	NULL
PMA	NULL
PMA+TNF	NULL
0	NULL
4	NULL
24	NULL
72	NULL
120	NULL
0	NULL
4	NULL
24	NULL
72	NULL
120hrs	NULL
3243	NULL
early	NULL
DLC	NULL
differentiation	NULL
in	NULL
KG1a	NULL
(	NULL
based	NULL
on	NULL
CD83	NULL
expression	NULL
)	NULL
,	NULL
these	NULL
findings	NULL
suggest	NULL
that	NULL
DC-CK1	NULL
expression	NULL
is	NULL
maximal	NULL
during	NULL
early/intermediate	NULL
stages	NULL
of	NULL
DC	NULL
maturation/activation	NULL
(	NULL
induced	NULL
by	NULL
PMA	NULL
in	NULL
KG1	NULL
,	NULL
PMA	NULL
plus	NULL
TNF-a	NULL
in	NULL
KG1a	NULL
)	NULL
with	NULL
much	NULL
less	NULL
expression	NULL
in	NULL
uncommitted	NULL
progenitors	NULL
(	NULL
KG1a	NULL
)	NULL
or	NULL
fully	NULL
mature/activated	NULL
DC	NULL
(	NULL
PMA-	NULL
plus	NULL
TNF-a-treated	NULL
KG1	NULL
)	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
findings	NULL
demonstrate	NULL
that	NULL
in	NULL
response	NULL
to	NULL
specific	NULL
stimuli	NULL
(	NULL
GM-CSF	NULL
plus	NULL
TNF-a	NULL
@	NULL
,	NULL
PMA	NULL
with	NULL
or	NULL
without	NULL
TNF-a	NULL
,	NULL
or	NULL
ionomycin	NULL
)	NULL
KG1	NULL
undergo	NULL
differentiation	NULL
to	NULL
cells	NULL
that	NULL
have	NULL
morphology	NULL
,	NULL
surface	NULL
Ag	NULL
phenotype	NULL
,	NULL
function	NULL
,	NULL
and	NULL
gene	NULL
expression	NULL
characteristic	NULL
of	NULL
DC	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
specific	NULL
aspects	NULL
of	NULL
this	NULL
differentiation	NULL
appear	NULL
to	NULL
be	NULL
mediated	NULL
by	NULL
specific	NULL
signals	NULL
.	NULL

Role	NULL
of	NULL
PKC	NULL
in	NULL
PMA-driven	NULL
KG1-DLC	NULL
differentiation	NULL
Although	NULL
PMA	NULL
is	NULL
a	NULL
stable	NULL
2,3-diacylglycerol	NULL
analogue	NULL
and	NULL
specific	NULL
activator	NULL
of	NULL
the	NULL
classical	NULL
and	NULL
new	NULL
isoforms	NULL
of	NULL
PKC	NULL
(	NULL
47	NULL
)	NULL
,	NULL
it	NULL
is	NULL
formally	NULL
possible	NULL
that	NULL
PMA	NULL
's	NULL
effects	NULL
in	NULL
KG1	NULL
are	NULL
due	NULL
to	NULL
activation	NULL
of	NULL
a	NULL
non-PKC	NULL
phorbol	NULL
ester	NULL
receptor	NULL
(	NULL
such	NULL
as	NULL
Unc-11	NULL
or	NULL
n-chimaerin	NULL
)	NULL
(	NULL
48-50	NULL
)	NULL
.	NULL

To	NULL
more	NULL
rigorously	NULL
prove	NULL
specific	NULL
PKC	NULL
activation	NULL
,	NULL
KG1	NULL
were	NULL
cultured	NULL
in	NULL
PMA	NULL
with	NULL
or	NULL
without	NULL
TNF-a	NULL
with	NULL
the	NULL
highly	NULL
selective	NULL
PKC	NULL
inhibitor	NULL
bis	NULL
.	NULL

Bis	NULL
inhibited	NULL
adhesion	NULL
and	NULL
morphologic	NULL
changes	NULL
in	NULL
KG1	NULL
cultured	NULL
in	NULL
PMA	NULL
without	NULL
affecting	NULL
cell	NULL
viability	NULL
(	NULL
Fig	NULL
.	NULL

94	NULL
)	NULL
.	NULL

By	NULL
FACS	NULL
,	NULL
bis	NULL
inhibited	NULL
up-regulation	NULL
of	NULL
CD83	NULL
and	NULL
CD86	NULL
in	NULL
response	NULL
to	NULL
both	NULL
PMA	NULL
and	NULL
PMA	NULL
plus	NULL
TNF-	NULL
«	NULL
(	NULL
Fig	NULL
.	NULL

9B	NULL
)	NULL
.	NULL

Bis	NULL
also	NULL
prevented	NULL
cell	NULL
death	NULL
induced	NULL
by	NULL
PMA	NULL
plus	NULL
TNF-	NULL
«	NULL
(	NULL
91	NULL
%	NULL
viable	NULL
with	NULL
PMA	NULL
,	NULL
TNF-a	NULL
,	NULL
and	NULL
bis	NULL
on	NULL
day	NULL
5	NULL
vs	NULL
37	NULL
%	NULL
viable	NULL
with	NULL
PMA	NULL
plus	NULL
TNF-a	NULL
alone	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
bis	NULL
inhibited	NULL
the	NULL
development	NULL
of	NULL
allostimulatory	NULL
capacity	NULL
in	NULL
KG1	NULL
cultured	NULL
in	NULL
PMA	NULL
or	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
(	NULL
Fig	NULL
.	NULL

9C	NULL
)	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
bis	NULL
inhibition	NULL
is	NULL
considerably	NULL
less	NULL
effective	NULL
with	NULL
the	NULL
addition	NULL
of	NULL
ionomycin	NULL
is	NULL
probably	NULL
due	NULL
to	NULL
a	NULL
lowered	NULL
PKC	NULL
activation	NULL
threshold	NULL
caused	NULL
by	NULL
increased	NULL
intracellular	NULL
calcium	NULL
.	NULL

To	NULL
further	NULL
determine	NULL
the	NULL
nature	NULL
of	NULL
PKC-mediated	NULL
signal	NULL
transduction	NULL
KG1-DLC	NULL
differentiation	NULL
,	NULL
we	NULL
asked	NULL
whether	NULL
the	NULL
differing	NULL
PMA	NULL
responsiveness	NULL
of	NULL
KG1	NULL
vs	NULL
KG1a	NULL
was	NULL
due	NULL
to	NULL
differing	NULL
PKC	NULL
isoform	NULL
expression	NULL
.	NULL

There	NULL
are	NULL
at	NULL
least	NULL
11	NULL
different	NULL
isoforms	NULL
of	NULL
PKC	NULL
(	NULL
47	NULL
)	NULL
,	NULL
with	NULL
individual	NULL
isoforms	NULL
appearing	NULL
to	NULL
mediate	NULL
specific	NULL
biological	NULL
function	NULL
(	NULL
51	NULL
,	NULL
52	NULL
)	NULL
.	NULL

As	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

10	NULL
,	NULL
unstimulated	NULL
KG1	NULL
expressed	NULL
substantially	NULL
more	NULL
PKCa	NULL
than	NULL
KGla	NULL
.	NULL

Unstimulated	NULL
KG1a	NULL
also	NULL
did	NULL
not	NULL
express	NULL
PKCBI	NULL
,	NULL
-BII	NULL
,	NULL
and	NULL
-m	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
KG1	NULL
.	NULL

Both	NULL
KG1	NULL
and	NULL
KG1a	NULL
expressed	NULL
PKCe	NULL
,	NULL
and	NULL
neither	NULL
expressed	NULL
PKCy	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Induction	NULL
of	NULL
RelB	NULL
expression	NULL
during	NULL
PMA-driven	NULL
KG1I-DLC	NULL
differentiation	NULL
RelB	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
NFB	NULL
transcription	NULL
factor	NULL
family	NULL
that	NULL
is	NULL
highly	NULL
expressed	NULL
in	NULL
DC	NULL
but	NULL
not	NULL
monocytes	NULL
(	NULL
2	NULL
)	NULL
and	NULL
may	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
DC	NULL
differentiation	NULL
and	NULL
function	NULL
.	NULL

Because	NULL
up-reg-ulation/activation	NULL
of	NULL
ReIB	NULL
by	NULL
PMA	NULL
may	NULL
represent	NULL
the	NULL
pathway	NULL
by	NULL
which	NULL
PKC-mediated	NULL
signaling	NULL
gains	NULL
access	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
we	NULL
KGla	NULL
PMA	NULL
PMA+TNF	NULL
0	NULL
4	NULL
24	NULL
72	NULL
120	NULL
0	NULL
4	NULL
24	NULL
72	NULL
120	NULL
hrs	NULL
Dres	NULL
ele	NULL
_	NULL
___	NULL
__	NULL
OOT	NULL
FIGURE	NULL
8	NULL
.	NULL

-	NULL
Up-regulation	NULL
of	NULL
DC-CK1	NULL
expression	NULL
during	NULL
PMA-driven	NULL
KG1-DLC	NULL
differentiation	NULL
.	NULL

KG1	NULL
and	NULL
KG1a	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
PMA	NULL
with	NULL
or	NULL
without	NULL
TNF-a	NULL
,	NULL
and	NULL
DNase-treated	NULL
RNA	NULL
were	NULL
made	NULL
at	NULL
the	NULL
times	NULL
indicated	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
cDNA	NULL
from	NULL
mRNA	NULL
were	NULL
amplified	NULL
by	NULL
PCR	NULL
with	NULL
gene-specific	NULL
primers	NULL
,	NULL
hybridized	NULL
to	NULL
internal	NULL
DC-CK	NULL
1-specific	NULL
oligonucleotide	NULL
,	NULL
separated	NULL
by	NULL
PAGE	NULL
,	NULL
exposed	NULL
,	NULL
and	NULL
visualized	NULL
on	NULL
a	NULL
phosphorimager	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
housekeeping	NULL
gene	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
(	NULL
GAPDH	NULL
)	NULL
in	NULL
the	NULL
same	NULL
samples	NULL
was	NULL
used	NULL
as	NULL
a	NULL
control	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
3244	NULL
MHC	NULL
I	NULL
PMA	NULL
”	NULL
A	NULL
PMA+bis	NULL
PMA+TNFa	NULL
m	NULL
PMA+TNFa+bis	NULL
C	NULL
12000	NULL
1.	NULL
memems	NULL
KG1a	NULL
--	NULL
KG1	NULL
m==3	NULL
ppme	NULL
APC	NULL
:	NULL
T	NULL
ratio	NULL
of	NULL
1:10	NULL
T	NULL
cell	NULL
proliferation	NULL
(	NULL
cpm	NULL
)	NULL
§	NULL
8	NULL
8	NULL
$	NULL
f	NULL
o	NULL
media	NULL
bis	NULL
PMA	NULL
KG1/KG1a	NULL
culture	NULL
condition	NULL
FIGURE	NULL
9	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
the	NULL
PKC	NULL
inhibitor	NULL
bis	NULL
on	NULL
PMA-driven	NULL
KG1-DLC	NULL
differentiation	NULL
.	NULL

KG1	NULL
and	NULL
KG1a	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
7	NULL
days	NULL
in	NULL
medium	NULL
;	NULL
bis	NULL
(	NULL
1	NULL
LM	NULL
)	NULL
;	NULL
PMA	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL
)	NULL

;	NULL
PMA	NULL
plus	NULL
bis	NULL
;	NULL
PMA	NULL
plus	NULL
TNF-a	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL

1	NULL
)	NULL
;	NULL
PMA	NULL
,	NULL
TNF-a	NULL
,	NULL
and	NULL
bis	NULL
;	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
;	NULL
and	NULL
PMA	NULL
,	NULL
ionomycin	NULL
,	NULL
and	NULL
bis	NULL
.	NULL

A	NULL
,	NULL
Morphology	NULL
.	NULL

Photomicrographs	NULL
of	NULL
KG1	NULL
cultured	NULL
in	NULL
PMA	NULL
or	NULL
PMA	NULL
plus	NULL
bis	NULL
are	NULL
shown	NULL
.	NULL

The	NULL
focal	NULL
plane	NULL
is	NULL
the	NULL
bottom	NULL
of	NULL
the	NULL
well	NULL
(	NULL
adherent	NULL
cells	NULL
)	NULL
.	NULL

Arrows	NULL
point	NULL
to	NULL
characteristic	NULL
neurite	NULL
processes	NULL
.	NULL

B	NULL
,	NULL
Surface	NULL
Ag	NULL
phenotype	NULL
.	NULL

Ten	NULL
thousand	NULL
day	NULL
7	NULL
cells	NULL
were	NULL
analyzed	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Dotted	NULL
lines	NULL
show	NULL
the	NULL
isotype	NULL
control	NULL
;	NULL
solid	NULL
lines	NULL
show	NULL
the	NULL
Ag-specific	NULL
Ab	NULL
.	NULL

C	NULL
,	NULL
Induction	NULL
of	NULL
allogeneic	NULL
T	NULL
cell	NULL
proliferation	NULL
.	NULL

KG1	NULL
and	NULL
KG1a	NULL
were	NULL
cultured	NULL
as	NULL
indicated	NULL
,	NULL
thoroughly	NULL
washed	NULL
,	NULL
and	NULL
added	NULL
to	NULL
purified	NULL
resting	NULL
allogeneic	NULL
T	NULL
cells	NULL
in	NULL
flat-bottom	NULL
microtiter	NULL
plates	NULL
at	NULL
an	NULL
APC	NULL
:	NULL
T	NULL
ratio	NULL
of	NULL
1:10	NULL
.	NULL

Freshly	NULL
isolated	NULL
PBMC	NULL
were	NULL
used	NULL
for	NULL
comparison	NULL
.	NULL

Proliferation	NULL
was	NULL
measured	NULL
by	NULL
[	NULL
°HJTdR	NULL
incorporation	NULL
.	NULL

The	NULL
data	NULL
in	NULL
this	NULL
figure	NULL
are	NULL
a	NULL
subset	NULL
of	NULL
those	NULL
for	NULL
the	NULL
experiment	NULL
presented	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

PMA+bis	NULL
-	NULL
PMAtiono	NULL
:	NULL
PMAonatbls	NULL
..	NULL
pbme	NULL
examined	NULL
the	NULL
kinetics	NULL
of	NULL
RelB	NULL
expression	NULL
following	NULL
PMA	NULL
activation	NULL
of	NULL
KG1	NULL
and	NULL
KG1a	NULL
.	NULL

As	NULL
can	NULL
be	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

114	NULL
,	NULL
ReIB	NULL
gene	NULL
expression	NULL
in	NULL
KG1	NULL
was	NULL
up-regulated	NULL
within	NULL
24	NULL
h	NULL
,	NULL
plateaued	NULL
through	NULL
72	NULL
h	NULL
,	NULL
and	NULL
then	NULL
declined	NULL
.	NULL

Unexpectedly	NULL
,	NULL
unstimulated	NULL
KG1a	NULL
constitutively	NULL
expressed	NULL
ReIB	NULL
message	NULL
,	NULL
which	NULL
also	NULL
declined	NULL
after	NULL
72	NULL
h	NULL
in	NULL
culture	NULL
with	NULL
PMA	NULL
.	NULL

Protein	NULL
expression	NULL
paralleled	NULL
the	NULL
inducible	NULL
KG1	NULL
or	NULL
constitutive	NULL
KG1a	NULL
gene	NULL
expression	NULL
of	NULL
RelB	NULL
(	NULL
Fig	NULL
.	NULL

11B	NULL
)	NULL
.	NULL

Of	NULL
note	NULL
is	NULL
the	NULL
rapidity	NULL
with	NULL
which	NULL
RelB	NULL
protein	NULL
was	NULL
induced	NULL
in	NULL
KG1	NULL
,	NULL
appearing	NULL
within	NULL
30	NULL
min	NULL
of	NULL
PMA	NULL
stimulation	NULL
.	NULL

The	NULL
persistence	NULL
of	NULL
RelB	NULL
protein	NULL
after	NULL
gene	NULL
down-regulation	NULL
suggests	NULL
a	NULL
A	NULL
CELL	NULL
LINE	NULL
MODEL	NULL
OF	NULL
HUMAN	NULL
DENDRITIC	NULL
CELL	NULL
DIFFERENTIATION	NULL
=t	NULL
so	NULL
©	NULL
5	NULL
y	NULL
y	NULL
PKC-a	NULL
.-PKC-BI	NULL
_	NULL
PKC-BII	NULL
|	NULL
===	NULL
.	NULL

PKC-p	NULL
FIGURE	NULL
10	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
of	NULL
PKC	NULL
isoform	NULL
expression	NULL
in	NULL
KG1	NULL
and	NULL
KG1a	NULL
cells	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
made	NULL
from	NULL
unstimulated	NULL
KG1	NULL
and	NULL
KG1a	NULL
cells	NULL
.	NULL

Samples	NULL
containing	NULL
20	NULL
ug	NULL
of	NULL
protein	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
(	NULL
5	NULL
%	NULL
stacking/10	NULL
%	NULL
resolving	NULL
)	NULL
,	NULL
electroblotted	NULL
to	NULL
nitrocellulose	NULL
,	NULL
probed	NULL
with	NULL
Abs	NULL
against	NULL
specific	NULL
PKC	NULL
isoforms	NULL
,	NULL
and	NULL
visualized	NULL
by	NULL
chemiluminescent	NULL
detection	NULL
.	NULL

The	NULL
same	NULL
results	NULL
were	NULL
obtained	NULL
using	NULL
equal	NULL
numbers	NULL
of	NULL
cells	NULL
per	NULL
lane	NULL
.	NULL

relatively	NULL
slow	NULL
turnover	NULL
rate	NULL
.	NULL

By	NULL
electromobility	NULL
shift	NULL
assays	NULL
the	NULL
levels	NULL
of	NULL
free	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
not	NULL
bound	NULL
to	NULL
IB	NULL
)	NULL
RelB	NULL
heterodimers	NULL
capable	NULL
of	NULL
binding	NULL
to	NULL
NFKB	NULL
sites	NULL
were	NULL
also	NULL
up-regulated	NULL
by	NULL
PMA	NULL
in	NULL
KG1	NULL
,	NULL
while	NULL
levels	NULL
in	NULL
KG1a	NULL
were	NULL
comparatively	NULL
stable	NULL
(	NULL
Fig	NULL
.	NULL

11C	NULL
,	NULL
upper	NULL
panels	NULL
)	NULL
.	NULL

Examination	NULL
of	NULL
other	NULL
NFB	NULL
family	NULL
members	NULL
in	NULL
KG1	NULL
and	NULL
KG1a	NULL
revealed	NULL
that	NULL
nearly	NULL
all	NULL
protein	NULL
capable	NULL
of	NULL
binding	NULL
NFB	NULL
sites	NULL
contained	NULL
p50	NULL
(	NULL
NFKBI	NULL
)	NULL
as	NULL
one	NULL
subunit	NULL
(	NULL
Fig	NULL
.	NULL

11C	NULL
,	NULL
lower	NULL
pan-els	NULL
)	NULL
as	NULL
evidenced	NULL
by	NULL
the	NULL
nearly	NULL
complete	NULL
supershifting	NULL
by	NULL
anti-p50	NULL
Abs	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
in	NULL
KG1/KG1a	NULL
RelB	NULL
exists	NULL
as	NULL
a	NULL
RelB/p50	NULL
heterodimer	NULL
.	NULL

Discussion	NULL
Why	NULL
hemopoietic	NULL
stem	NULL
cells	NULL
differentiate	NULL
(	NULL
or	NULL
do	NULL
not	NULL
)	NULL
into	NULL
a	NULL
specific	NULL
mature	NULL
lineage	NULL
remains	NULL
one	NULL
of	NULL
the	NULL
enduring	NULL
biological	NULL
riddles	NULL
.	NULL

Seminal	NULL
work	NULL
by	NULL
a	NULL
number	NULL
of	NULL
groups	NULL
(	NULL
53-68	NULL
)	NULL
have	NULL
identified	NULL
the	NULL
critical	NULL
receptor-mediated	NULL
stimuli	NULL
(	NULL
cytokines	NULL
,	NULL
CD40	NULL
)	NULL
that	NULL
induce	NULL
lineage	NULL
commitment	NULL
of	NULL
human	NULL
multipotential	NULL
CD34	NULL
~	NULL
HPC	NULL
to	NULL
DC	NULL
in	NULL
vitro	NULL
.	NULL

We	NULL
have	NULL
sought	NULL
to	NULL
further	NULL
characterize	NULL
the	NULL
intracellular	NULL
signaling	NULL
pathways	NULL
that	NULL
connect	NULL
these	NULL
receptor/membrane	NULL
events	NULL
to	NULL
the	NULL
nucleus	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
the	NULL
PKC	NULL
agonist	NULL
PMA	NULL
by	NULL
itself	NULL
directly	NULL
triggers	NULL
differentiation	NULL
of	NULL
human	NULL
CD34	NULL
*	NULL
HPC	NULL
to	NULL
DC	NULL
,	NULL
suggesting	NULL
a	NULL
critical	NULL
and	NULL
specific	NULL
role	NULL
of	NULL
this	NULL
pathway	NULL
in	NULL
lineage	NULL
commitment	NULL
to	NULL
DC	NULL
(	NULL
14	NULL
)	NULL
.	NULL

This	NULL
is	NULL
supported	NULL
by	NULL
observations	NULL
that	NULL
the	NULL
receptor-mediated	NULL
stimuli	NULL
(	NULL
GM-CSF	NULL
,	NULL
IL-4	NULL
,	NULL
TNF-a	NULL
,	NULL
and	NULL
CD40	NULL
cross-linking	NULL
)	NULL
that	NULL
induce	NULL
DC	NULL
differentiation	NULL
all	NULL
can	NULL
activate	NULL
PKC	NULL
as	NULL
part	NULL
of	NULL
their	NULL
intracellular	NULL
signaling	NULL
pathways	NULL
(	NULL
15-19	NULL
,	NULL
69	NULL
)	NULL
.	NULL

We	NULL
now	NULL
find	NULL
that	NULL
the	NULL
PKC	NULL
inhibitor	NULL
staurosporine	NULL
blocks	NULL
cytokine-driven	NULL
CD34	NULL
*~	NULL
HPC-DC	NULL
differentiation	NULL
,	NULL
indicating	NULL
that	NULL
PKC	NULL
is	NULL
part	NULL
of	NULL
the	NULL
signaling	NULL
cascade	NULL
initiated	NULL
by	NULL
GM-CSF	NULL
and	NULL
TNF-	NULL
«	NULL
@	NULL
.	NULL

Although	NULL
staurosporine	NULL
can	NULL
also	NULL
block	NULL
tyrosine	NULL
kinase	NULL
activity	NULL
,	NULL
this	NULL
is	NULL
typically	NULL
at	NULL
a	NULL
substantially	NULL
higher	NULL
dose	NULL
than	NULL
that	NULL
used	NULL
in	NULL
these	NULL
experiments	NULL
(	NULL
40	NULL
)	NULL
.	NULL

We	NULL
have	NULL
also	NULL
found	NULL
that	NULL
more	NULL
specific	NULL
PKC	NULL
inhibitors	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
bis	NULL
)	NULL
similarly	NULL
inhibit	NULL
CD34	NULL
``	NULL
*HPC-DC	NULL
differentiation	NULL
(	NULL
manuscript	NULL
in	NULL
preparation	NULL
)	NULL
.	NULL

Staurosporine	NULL
did	NULL
not	NULL
globally	NULL
block	NULL
differentiation	NULL
as	NULL
all	NULL
cells	NULL
lost	NULL
the	NULL
CD34	NULL
marker	NULL
,	NULL
and	NULL
the	NULL
generation	NULL
of	NULL
CD14	NULL
*	NULL
cells	NULL
(	NULL
most	NULL
likely	NULL
monocytes	NULL
)	NULL
was	NULL
comparatively	NULL
less	NULL
affected	NULL
.	NULL

Rather	NULL
,	NULL
the	NULL
generation	NULL
of	NULL
CD83	NULL
*	NULL
DC	NULL
was	NULL
preferentially	NULL
inhibited	NULL
.	NULL

When	NULL
considered	NULL
with	NULL
our	NULL
previous	NULL
findings	NULL
that	NULL
PMA	NULL
treatment	NULL
of	NULL
CD34	NULL
*	NULL
HPC	NULL
only	NULL
generates	NULL
DC	NULL
(	NULL
and	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
A	NULL
KG1	NULL
KG1a	NULL
te	NULL
oke	NULL
ke	NULL
ks	NULL
toot	NULL
&	NULL
Z	NULL
te	NULL
t	NULL
C	NULL
C	NULL
£	NULL
£	NULL
s	NULL
©	NULL
€	NULL
£	NULL
5	NULL
a	NULL
o	NULL
s	NULL
N	NULL
C	NULL
?	NULL

o	NULL
s	NULL
RN	NULL
N	NULL
C	NULL
Ti	NULL
in	NULL
abe	NULL
gn	NULL
Te	NULL
dn	NULL
ib	NULL
ft	NULL
it	NULL
-o-	NULL
o-	NULL
-o-	NULL
-	NULL
oioi	NULL
o-	NULL
E-Total	NULL
RNA	NULL
=	NULL
RelB	NULL
Actin	NULL
KG1	NULL
KG1a	NULL
E	NULL
E	NULL
E	NULL
E	NULL
o	NULL
o	NULL
©	NULL
o	NULL
o	NULL
o	NULL
i	NULL
2	NULL
i	NULL
)	NULL
-G	NULL
-	NULL
o	NULL
8	NULL
NS	NULL
2	NULL
L	NULL
s	NULL
-s	NULL
%	NULL
FPR	NULL
4	NULL
#	NULL
-	NULL
i	NULL
t	NULL
t	NULL
t-	NULL
£	NULL
£	NULL
i-	NULL
£	NULL
£	NULL
£	NULL
o	NULL
co	NULL
£	NULL
o	NULL
co	NULL
O	NULL
x	NULL
)	NULL
w	NULL
O	NULL
o	NULL
w	NULL
O	NULL
I	NULL
*-	NULL
*-	NULL
o	NULL
I-	NULL
+-	NULL
+	NULL
I1	NULL
I1	NULL
W	NULL
I1	NULL
U	NULL
U	NULL
U	NULL
It	NULL
i-	NULL
i-	NULL
i-	NULL
-	NULL
i-	NULL
i-	NULL
i-	NULL
i	NULL
anti-ReIB	NULL
-	NULL
+	NULL
-	NULL
+	NULL
-	NULL
+	NULL
-	NULL
+	NULL
-o	NULL
-	NULL
#	NULL
-	NULL
#	NULL
-	NULL
%	NULL
<	NULL
-	NULL
.	NULL

<	NULL
-	NULL
supershift	NULL
to	NULL
£	NULL
£	NULL
to	NULL
£	NULL
£	NULL
£	NULL
s	NULL
=	NULL
£	NULL
o	NULL
®	NULL
a	NULL
-	NULL
a	NULL
w	NULL
a_	NULL
a	NULL
»	NULL
o	NULL
I	NULL
x=	NULL
x-	NULL
[	NULL
«	NULL
]	NULL
I-	NULL
«	NULL
-	NULL
x-i	NULL
U	NULL
it	NULL
1	NULL
it	NULL
11	NULL
11	NULL
it	NULL
bn	NULL
makina	NULL
Stabiner	NULL
(	NULL
thiis	NULL
anti-p50	NULL
-	NULL
+	NULL
-	NULL
+	NULL
-	NULL
+	NULL
-	NULL
+	NULL
-o	NULL
-	NULL
#	NULL
0	NULL
-	NULL
#	NULL
-	NULL
%	NULL
i+	NULL
U	NULL
u	NULL
“	NULL
4—	NULL
“	NULL
be	NULL
u	NULL
<	NULL
-	NULL
supershift	NULL
1	NULL
.	NULL

vSuul®	NULL
«	NULL
FIGURE	NULL
11	NULL
.	NULL

Expression	NULL
of	NULL
RelB	NULL
in	NULL
PMA-stimulated	NULL
KG1	NULL
and	NULL
KG1a	NULL
.	NULL

KG1	NULL
and	NULL
KG1a	NULL
were	NULL
cultured	NULL
in	NULL
10	NULL
ng/ml	NULL
PMA	NULL
for	NULL
the	NULL
times	NULL
indicated	NULL
.	NULL

A	NULL
,	NULL
RelB	NULL
mRNA	NULL
expression	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
and	NULL
mRNA	NULL
isolated	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Total	NULL
mRNA	NULL
was	NULL
equalized	NULL
between	NULL
samples	NULL
by	NULL
ethidium	NULL
bromide	NULL
visualization	NULL
and	NULL
serial	NULL
dilution	NULL
.	NULL

Samples	NULL
were	NULL
separated	NULL
on	NULL
formaldehyde	NULL
agarose	NULL
gels	NULL
,	NULL
transferred	NULL
to	NULL
nylon	NULL
,	NULL
and	NULL
probed	NULL
with	NULL
*°P-labeled	NULL
RelB	NULL
cDNA	NULL
probe	NULL
.	NULL

The	NULL
same	NULL
blot	NULL
was	NULL
then	NULL
re-probed	NULL
for	NULL
actin	NULL
expression	NULL
to	NULL
verify	NULL
mRNA	NULL
equalization	NULL
and	NULL
integrity	NULL
.	NULL

B	NULL
,	NULL
RelB	NULL
protein	NULL
expression	NULL
.	NULL

Cell	NULL
lysates	NULL
from	NULL
the	NULL
indicated	NULL
times	NULL
points	NULL
were	NULL
made	NULL
,	NULL
and	NULL
equal	NULL
amounts	NULL
of	NULL
protein	NULL
were	NULL
loaded	NULL
onto	NULL
a	NULL
SDS-PAGE	NULL
gel	NULL
and	NULL
analyzed	NULL
by	NULL
Western	NULL
blotting	NULL
with	NULL
the	NULL
anti-RelB	NULL
Ab	NULL
C-19	NULL
.	NULL

C	NULL
,	NULL
RelB	NULL
and	NULL
p50	NULL
electromobility	NULL
shift	NULL
assay	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
made	NULL
at	NULL
the	NULL
times	NULL
indicated	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
protein	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
labeled	NULL
primer	NULL
containing	NULL
the	NULL
NFxB	NULL
binding	NULL
site	NULL
with	NULL
or	NULL
without	NULL
anti-ReIB	NULL
or	NULL
anti-p50	NULL
mAb	NULL
.	NULL

Samples	NULL
were	NULL
separated	NULL
on	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
and	NULL
exposed	NULL
to	NULL
film	NULL
.	NULL

Complexes	NULL
that	NULL
specifically	NULL
contain	NULL
the	NULL
labeled	NULL
primer	NULL
,	NULL
Rel	NULL
B	NULL
(	NULL
or	NULL
p50	NULL
)	NULL
,	NULL
and	NULL
anti-ReIB	NULL
(	NULL
or	NULL
p50	NULL
)	NULL
Ab	NULL
are	NULL
indicated	NULL
by	NULL
the	NULL
supershift	NULL
arrow	NULL
.	NULL

3245	NULL
no	NULL
other	NULL
myeloid	NULL
lineages	NULL
)	NULL
,	NULL
these	NULL
data	NULL
indicate	NULL
that	NULL
the	NULL
intracellular	NULL
pathway	NULL
that	NULL
specifically	NULL
initiates	NULL
DC	NULL
lineage	NULL
commitment	NULL
goes	NULL
through	NULL
PKC	NULL
.	NULL

This	NULL
``	NULL
wiring	NULL
``	NULL
may	NULL
be	NULL
unique	NULL
to	NULL
CD34	NULL
*	NULL
HPC	NULL
,	NULL
as	NULL
CD34	NULL
negative	NULL
progenitors	NULL
and	NULL
monocytes	NULL
have	NULL
different	NULL
responses	NULL
to	NULL
PMA	NULL
(	NULL
K.	NULL
P.	NULL
Lee	NULL
and	NULL
K.	NULL
Schlienger	NULL
,	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

To	NULL
further	NULL
study	NULL
the	NULL
intracellular	NULL
events	NULL
involved	NULL
in	NULL
DC	NULL
differentiation	NULL
and	NULL
to	NULL
circumvent	NULL
the	NULL
problems	NULL
of	NULL
studying	NULL
this	NULL
in	NULL
primary	NULL
CD34*	NULL
HPC	NULL
,	NULL
we	NULL
established	NULL
a	NULL
human	NULL
leukemic	NULL
cell	NULL
line	NULL
model	NULL
of	NULL
CD34*	NULL
HPC-DC	NULL
differentiation	NULL
.	NULL

Work	NULL
demonstrating	NULL
that	NULL
primary	NULL
chronic	NULL
myelogenous	NULL
leukemia	NULL
cells	NULL
differentiated	NULL
in	NULL
vitro	NULL
to	NULL
functional	NULL
DC	NULL
suggested	NULL
that	NULL
this	NULL
was	NULL
feasible	NULL
(	NULL
70	NULL
)	NULL
.	NULL

Examination	NULL
of	NULL
the	NULL
PMA	NULL
responsiveness	NULL
of	NULL
a	NULL
panel	NULL
of	NULL
CD34	NULL
*	NULL
leukemic	NULL
cell	NULL
lines	NULL
revealed	NULL
that	NULL
KG1	NULL
differentiated	NULL
into	NULL
cells	NULL
with	NULL
DC	NULL
characteristics	NULL
.	NULL

KG1	NULL
was	NULL
isolated	NULL
from	NULL
a	NULL
patient	NULL
with	NULL
erythroleu-kemia	NULL
(	NULL
FAB	NULL
M7	NULL
)	NULL
undergoing	NULL
myeloblastic	NULL
relapse	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Serial	NULL
passage	NULL
of	NULL
KG1	NULL
gave	NULL
rise	NULL
to	NULL
the	NULL
KG1a	NULL
subline	NULL
(	NULL
71	NULL
)	NULL
,	NULL
which	NULL
by	NULL
a	NULL
number	NULL
of	NULL
criteria	NULL
(	NULL
surface	NULL
phenotype	NULL
,	NULL
gene	NULL
expression	NULL
,	NULL
and	NULL
growth	NULL
factor	NULL
unresponsiveness	NULL
)	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
arrested	NULL
at	NULL
a	NULL
less	NULL
differentiated	NULL
stage	NULL
than	NULL
KG1	NULL
(	NULL
32	NULL
,	NULL
72	NULL
,	NULL
73	NULL
)	NULL
.	NULL

In	NULL
response	NULL
to	NULL
PMA	NULL
KG1	NULL
was	NULL
initially	NULL
characterized	NULL
to	NULL
differentiate	NULL
into	NULL
macrophages	NULL
(	NULL
74	NULL
)	NULL
,	NULL
although	NULL
these	NULL
original	NULL
morphologic	NULL
(	NULL
adherent	NULL
cells	NULL
with	NULL
long	NULL
pseudopodia	NULL
)	NULL
,	NULL
histochemical	NULL
(	NULL
nonspecific	NULL
esterase-positive	NULL
,	NULL
my-eloperoxidase-negative	NULL
)	NULL
,	NULL
surface	NULL
Ag	NULL
(	NULL
MHC	NULL
II-	NULL
and	NULL
Fc	NULL
receptor-positive	NULL
)	NULL
,	NULL
and	NULL
functional	NULL
(	NULL
phagocytosis	NULL
)	NULL
findings	NULL
have	NULL
since	NULL
been	NULL
found	NULL
to	NULL
also	NULL
be	NULL
characteristic	NULL
of	NULL
DC	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

12	NULL
)	NULL
.	NULL

PMA	NULL
does	NULL
not	NULL
induce	NULL
differentiation	NULL
in	NULL
KG1a	NULL
,	NULL
and	NULL
although	NULL
KG1	NULL
and	NULL
KG1a	NULL
have	NULL
similar	NULL
numbers	NULL
of	NULL
phorbol	NULL
ester	NULL
binding	NULL
sites	NULL
,	NULL
they	NULL
differ	NULL
in	NULL
PKC	NULL
activity	NULL
,	NULL
translocation	NULL
,	NULL
and	NULL
substrate	NULL
phosphorylation	NULL
(	NULL
30	NULL
,	NULL
33	NULL
,	NULL
34	NULL
,	NULL
74	NULL
)	NULL
.	NULL

We	NULL
believe	NULL
that	NULL
recharacterization	NULL
of	NULL
the	NULL
KG1	NULL
response	NULL
to	NULL
PMA	NULL
reveals	NULL
it	NULL
to	NULL
actually	NULL
recapitulate	NULL
differentiation	NULL
of	NULL
the	NULL
committed	NULL
CD34	NULL
*	NULL
myeloid	NULL
DC/macrophage	NULL
progenitor	NULL
to	NULL
DC	NULL
.	NULL

Like	NULL
the	NULL
committed	NULL
DC/macrophage	NULL
progenitor	NULL
(	NULL
7	NULL
)	NULL
,	NULL
KG1	NULL
express	NULL
MHC	NULL
II	NULL
,	NULL
CD34	NULL
,	NULL
and	NULL
CD86	NULL
,	NULL
whereas	NULL
KG1a	NULL
are	NULL
MHC	NULL
II~-CD34	NULL
``	NULL
CD86_~	NULL
.	NULL

Unstimulated	NULL
KG1	NULL
express	NULL
little	NULL
or	NULL
no	NULL
CD40	NULL
,	NULL
but	NULL
up-regulate	NULL
expression	NULL
following	NULL
culture	NULL
in	NULL
PMA	NULL
.	NULL

Stimuli	NULL
shown	NULL
to	NULL
induce	NULL
CD34	NULL
*HPC-DC	NULL
differentiation	NULL
(	NULL
GM-CSF	NULL
plus	NULL
TNF-	NULL
«	NULL
,	NULL
PMA	NULL
)	NULL
also	NULL
induce	NULL
differentiation	NULL
of	NULL
KG1	NULL
to	NULL
DLC	NULL
(	NULL
KG1-DLC	NULL
)	NULL
,	NULL
while	NULL
non-DC	NULL
cytokine	NULL
(	NULL
s	NULL
)	NULL
(	NULL
GM-CSF	NULL
or	NULL
TNF-a	NULL
alone	NULL
or	NULL
GM-CSF	NULL
,	NULL
IL-3	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
SCF	NULL
)	NULL
do	NULL
not	NULL
.	NULL

Unlike	NULL
monocytes	NULL
,	NULL
ionomycin	NULL
alone	NULL
does	NULL
not	NULL
induce	NULL
DC	NULL
differentiation	NULL
in	NULL
KG1	NULL
(	NULL
or	NULL
primary	NULL
CD34	NULL
``	NULL
HPC	NULL
)	NULL
,	NULL
and	NULL
likewise	NULL
,	NULL
PMA	NULL
(	NULL
as	NULL
a	NULL
single	NULL
agent	NULL
)	NULL
does	NULL
not	NULL
drive	NULL
DC	NULL
differentiation	NULL
in	NULL
monocytes	NULL
.	NULL

Suppression	NULL
of	NULL
KG1	NULL
cell	NULL
proliferation	NULL
and	NULL
induction	NULL
of	NULL
apoptosis	NULL
by	NULL
PMA	NULL
are	NULL
also	NULL
characteristics	NULL
we	NULL
reported	NULL
for	NULL
primary	NULL
CD34*	NULL
HPC-DC	NULL
differentiation	NULL
driven	NULL
by	NULL
PMA	NULL
.	NULL

Stimulation	NULL
of	NULL
KG1	NULL
with	NULL
GM-CSF	NULL
and	NULL
TNF-a	NULL
or	NULL
PMA	NULL
(	NULL
with	NULL
or	NULL
without	NULL
TNF-a	NULL
or	NULL
ionomycin	NULL
)	NULL
generates	NULL
cells	NULL
with	NULL
a	NULL
constellation	NULL
of	NULL
DC	NULL
characteristics	NULL
.	NULL

Morphologically	NULL
,	NULL
KG1-DLC	NULL
are	NULL
adherent	NULL
with	NULL
long	NULL
neurite	NULL
processes	NULL
in	NULL
culture	NULL
and	NULL
have	NULL
hair-like	NULL
processes/	NULL
veils	NULL
on	NULL
cytospin	NULL
.	NULL

By	NULL
surface	NULL
Ag	NULL
phenotype	NULL
,	NULL
KG1-DLC	NULL
have	NULL
characteristic	NULL
DC	NULL
expression	NULL
of	NULL
MHC	NULL
I	NULL
,	NULL
MHC	NULL
II	NULL
(	NULL
high	NULL
)	NULL
,	NULL
CD13	NULL
,	NULL
CD33	NULL
,	NULL
the	NULL
DC-specific	NULL
lineage	NULL
marker	NULL
CD83	NULL
,	NULL
and	NULL
the	NULL
costimulatory	NULL
li-gand	NULL
CD86	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

12	NULL
)	NULL
.	NULL

They	NULL
do	NULL
not	NULL
express	NULL
CD1a	NULL
or	NULL
the	NULL
monocyte	NULL
marker	NULL
CD14	NULL
.	NULL

Expression	NULL
of	NULL
CD80	NULL
is	NULL
present	NULL
but	NULL
low	NULL
,	NULL
suggesting	NULL
that	NULL
KG1-DLC	NULL
are	NULL
not	NULL
fully	NULL
mature	NULL
or	NULL
activated	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Functionally	NULL
,	NULL
unstimulated	NULL
KG1	NULL
can	NULL
take	NULL
up	NULL
fluid	NULL
phase	NULL
Ag	NULL
as	NULL
measured	NULL
by	NULL
FITC-dextran	NULL
uptake	NULL
.	NULL

TNF-	NULL
@	NULL
appears	NULL
to	NULL
deliver	NULL
a	NULL
signal	NULL
that	NULL
down-regulates	NULL
Ag	NULL
uptake	NULL
,	NULL
a	NULL
hallmark	NULL
of	NULL
DC	NULL
maturation/activation	NULL
(	NULL
37	NULL
)	NULL
consistent	NULL
with	NULL
the	NULL
other	NULL
effects	NULL
(	NULL
morphology	NULL
,	NULL
surface	NULL
Ag	NULL
phenotype	NULL
)	NULL
that	NULL
TNF-a	NULL
has	NULL
on	NULL
PMA-driven	NULL
KG1-DLC	NULL
differentiation	NULL
.	NULL

Most	NULL
importantly	NULL
,	NULL
KG1-DLC	NULL
can	NULL
function	NULL
to	NULL
activate	NULL
T	NULL
cells	NULL
as	NULL
evidenced	NULL
by	NULL
proliferation	NULL
in	NULL
an	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
3246	NULL
allo-MLR	NULL
.	NULL

This	NULL
proliferation	NULL
is	NULL
substantially	NULL
higher	NULL
than	NULL
that	NULL
induced	NULL
by	NULL
either	NULL
allogeneic	NULL
PBMC	NULL
or	NULL
similarly	NULL
cultured	NULL
KG1a	NULL
.	NULL

It	NULL
is	NULL
interesting	NULL
to	NULL
note	NULL
that	NULL
even	NULL
though	NULL
unstimulated	NULL
KG1	NULL
express	NULL
MHC	NULL
II	NULL
and	NULL
CD86	NULL
,	NULL
they	NULL
do	NULL
not	NULL
stimulate	NULL
significant	NULL
T	NULL
cell	NULL
proliferation	NULL
.	NULL

Because	NULL
MHC	NULL
II	NULL
and	NULL
CD86	NULL
expression	NULL
are	NULL
not	NULL
substantially	NULL
up-regulated	NULL
by	NULL
PMA	NULL
,	NULL
this	NULL
suggests	NULL
the	NULL
enhanced	NULL
allostimulatory	NULL
properties	NULL
of	NULL
KG1-DLC	NULL
are	NULL
due	NULL
to	NULL
other	NULL
components	NULL
not	NULL
measured	NULL
.	NULL

Assessment	NULL
of	NULL
cytokine	NULL
production	NULL
(	NULL
especially	NULL
IL-12	NULL
)	NULL
is	NULL
currently	NULL
underway	NULL
.	NULL

Finally	NULL
,	NULL
KG1-DLC	NULL
express	NULL
genes	NULL
that	NULL
are	NULL
predominantly	NULL
(	NULL
ReIB	NULL
)	NULL
or	NULL
exclusively	NULL
(	NULL
DC-CK1	NULL
)	NULL
found	NULL
in	NULL
DC	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
four	NULL
levels	NULL
of	NULL
characterization	NULL
all	NULL
point	NULL
to	NULL
the	NULL
conclusion	NULL
GM-CSF	NULL
plus	NULL
TNF-a	NULL
or	NULL
PMA	NULL
stimulation	NULL
of	NULL
KG	NULL
!	NULL

1	NULL
generates	NULL
cells	NULL
of	NULL
the	NULL
DC	NULL
lineage	NULL
.	NULL

The	NULL
inability	NULL
to	NULL
induce	NULL
DLC	NULL
differentiation	NULL
in	NULL
KG1a	NULL
allows	NULL
for	NULL
comparison	NULL
with	NULL
KG1	NULL
of	NULL
potential	NULL
signaling	NULL
pathways	NULL
.	NULL

Blockade	NULL
of	NULL
DC	NULL
differentiation	NULL
in	NULL
both	NULL
KG1	NULL
and	NULL
primary	NULL
CD34*	NULL
HPC	NULL
by	NULL
PKC	NULL
inhibitors	NULL
establishes	NULL
a	NULL
central	NULL
role	NULL
for	NULL
PKC	NULL
.	NULL

PKC	NULL
activation	NULL
most	NULL
likely	NULL
plays	NULL
a	NULL
direct	NULL
role	NULL
and	NULL
does	NULL
not	NULL
simply	NULL
induce	NULL
autocrine	NULL
secretion	NULL
of	NULL
cytokines	NULL
;	NULL
for	NULL
example	NULL
,	NULL
we	NULL
find	NULL
no	NULL
evidence	NULL
(	NULL
by	NULL
PCR	NULL
)	NULL
for	NULL
induction	NULL
of	NULL
TNF-a	NULL
expression	NULL
in	NULL
KG1	NULL
.	NULL

However	NULL
,	NULL
the	NULL
difference	NULL
between	NULL
KG1	NULL
and	NULL
KG1a	NULL
can	NULL
not	NULL
simply	NULL
be	NULL
the	NULL
absence	NULL
of	NULL
PKC	NULL
signaling	NULL
in	NULL
KG1a	NULL
given	NULL
that	NULL
both	NULL
cell	NULL
lines	NULL
have	NULL
bio-chemically	NULL
measurable	NULL
PKC	NULL
activity	NULL
(	NULL
75	NULL
)	NULL
.	NULL

Likewise	NULL
,	NULL
we	NULL
have	NULL
found	NULL
that	NULL
although	NULL
both	NULL
CD34*	NULL
HPC	NULL
and	NULL
CD34~	NULL
HPC	NULL
respond	NULL
to	NULL
PMA	NULL
,	NULL
only	NULL
CD34	NULL
~	NULL
HPC	NULL
differentiate	NULL
to	NULL
DC	NULL
while	NULL
CD34~	NULL
HPC	NULL
become	NULL
macrophages	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
there	NULL
is	NULL
a	NULL
qualitative	NULL
component	NULL
of	NULL
PKC	NULL
activation	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
is	NULL
the	NULL
differing	NULL
expression	NULL
of	NULL
specific	NULL
PKC	NULL
isoforms	NULL
in	NULL
the	NULL
cell	NULL
lines	NULL
.	NULL

KG1a	NULL
express	NULL
less	NULL
PKCa	NULL
and	NULL
no	NULL
PKCBI	NULL
,	NULL
-BII	NULL
,	NULL
or	NULL
-p	NULL
compared	NULL
with	NULL
KG1	NULL
.	NULL

Given	NULL
that	NULL
specific	NULL
PKC	NULL
isoforms	NULL
have	NULL
been	NULL
associated	NULL
with	NULL
specific	NULL
biological	NULL
events	NULL
in	NULL
other	NULL
systems	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
PKCO	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
(	NULL
51	NULL
)	NULL
and	NULL
PKC	NULL
in	NULL
macrophage	NULL
differentiation	NULL
of	NULL
HL-60	NULL
(	NULL
52	NULL
)	NULL
)	NULL
,	NULL
these	NULL
findings	NULL
suggest	NULL
that	NULL
the	NULL
same	NULL
may	NULL
be	NULL
true	NULL
for	NULL
DC	NULL
differentiation	NULL
.	NULL

Examination	NULL
of	NULL
the	NULL
roles	NULL
of	NULL
specific	NULL
PKC	NULL
isoforms	NULL
is	NULL
currently	NULL
underway	NULL
.	NULL

KG1a	NULL
also	NULL
differ	NULL
from	NULL
KG1	NULL
in	NULL
the	NULL
response	NULL
to	NULL
TNF-a	NULL
;	NULL
this	NULL
is	NULL
most	NULL
evident	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
apoptosis	NULL
.	NULL

This	NULL
difference	NULL
may	NULL
be	NULL
due	NULL
to	NULL
comparatively	NULL
lower	NULL
expression	NULL
of	NULL
both	NULL
TNF	NULL
receptors	NULL
1	NULL
and	NULL
2	NULL
on	NULL
KG1la	NULL
,	NULL
and	NULL
this	NULL
membrane	NULL
``	NULL
defect	NULL
``	NULL
is	NULL
consistent	NULL
with	NULL
previous	NULL
reports	NULL
demonstrating	NULL
that	NULL
apoptotic	NULL
responses	NULL
in	NULL
KG1a	NULL
can	NULL
be	NULL
restored	NULL
by	NULL
directly	NULL
manipulating	NULL
the	NULL
sphingomyelin-cer-amide	NULL
pathway	NULL
triggered	NULL
by	NULL
TNF-a	NULL
(	NULL
76	NULL
,	NULL
77	NULL
)	NULL
.	NULL

The	NULL
roles	NULL
of	NULL
ceramide	NULL
(	NULL
and	NULL
intracellular	NULL
calcium	NULL
flux	NULL
)	NULL
in	NULL
both	NULL
apoptosis	NULL
and	NULL
DC	NULL
differentiation	NULL
are	NULL
under	NULL
study	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
differences	NULL
between	NULL
KG1	NULL
and	NULL
KG1a	NULL
,	NULL
we	NULL
found	NULL
that	NULL
distinct	NULL
signals	NULL
appeared	NULL
to	NULL
mediate	NULL
distinct	NULL
,	NULL
nonoverlapping	NULL
biological	NULL
phenomena	NULL
during	NULL
KG1-DLC	NULL
differentiation	NULL
.	NULL

PKC	NULL
activation	NULL
by	NULL
PMA	NULL
appears	NULL
to	NULL
be	NULL
a	NULL
requisite	NULL
inductive	NULL
signal	NULL
,	NULL
initiating	NULL
morphology	NULL
changes	NULL
,	NULL
surface	NULL
Ag	NULL
expression	NULL
,	NULL
and	NULL
allostimulatory	NULL
capacity	NULL
for	NULL
T	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
a	NULL
TNF-a	NULL
or	NULL
calcium	NULL
flux	NULL
signal	NULL
is	NULL
necessary	NULL
for	NULL
full	NULL
maturation/activation	NULL
(	NULL
as	NULL
assessed	NULL
by	NULL
morphology	NULL
,	NULL
surface	NULL
Ag	NULL
expression	NULL
,	NULL
and	NULL
T	NULL
cell	NULL
pro-liferation	NULL
)	NULL
and	NULL
inhibition	NULL
of	NULL
cell	NULL
proliferation/induction	NULL
of	NULL
apoptosis	NULL
.	NULL

Down-regulation	NULL
of	NULL
soluble	NULL
macromolecule	NULL
uptake	NULL
appears	NULL
to	NULL
be	NULL
mediated	NULL
entirely	NULL
by	NULL
TNF-	NULL
«	NULL
@	NULL
and	NULL
to	NULL
be	NULL
independent	NULL
of	NULL
PKC	NULL
activation	NULL
.	NULL

The	NULL
possibility	NULL
that	NULL
TNF-a	NULL
and	NULL
ionomycin	NULL
are	NULL
signaling	NULL
through	NULL
the	NULL
same	NULL
pathway	NULL
is	NULL
suggested	NULL
by	NULL
the	NULL
lack	NULL
of	NULL
an	NULL
additive	NULL
effect	NULL
when	NULL
the	NULL
two	NULL
are	NULL
combined	NULL
(	NULL
PMA	NULL
,	NULL
TNF-a	NULL
@	NULL
,	NULL
and	NULL
ionomycin	NULL
)	NULL
and	NULL
is	NULL
being	NULL
examined	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
data	NULL
suggest	NULL
that	NULL
there	NULL
are	NULL
discrete	NULL
signaling	NULL
pathways	NULL
involved	NULL
in	NULL
specific	NULL
aspects	NULL
of	NULL
DC	NULL
differentiation	NULL
;	NULL
PKC	NULL
activation	NULL
is	NULL
required	NULL
to	NULL
initiate	NULL
differentiation	NULL
,	NULL
and	NULL
TNF-a	NULL
(	NULL
which	NULL
initiates	NULL
several	NULL
intracellular	NULL
pathways	NULL
)	NULL
and/or	NULL
intracellular	NULL
calcium	NULL
flux	NULL
is	NULL
required	NULL
for	NULL
terminal	NULL
maturation/activation	NULL
and	NULL
apoptosis	NULL
.	NULL

However	NULL
,	NULL
this	NULL
does	NULL
not	NULL
explain	NULL
why	NULL
A	NULL
CELL	NULL
LINE	NULL
MODEL	NULL
OF	NULL
HUMAN	NULL
DENDRITIC	NULL
CELL	NULL
DIFFERENTIATION	NULL
some	NULL
single	NULL
signals	NULL
(	NULL
PMA	NULL
or	NULL
CD40	NULL
cross-linking	NULL
in	NULL
primary	NULL
CD34*	NULL
HPC	NULL
,	NULL
calcium	NULL
ionophore	NULL
in	NULL
monocytes	NULL
)	NULL
are	NULL
capable	NULL
of	NULL
driving	NULL
complete	NULL
DC	NULL
differentiation/maturation	NULL
from	NULL
progenitors	NULL
.	NULL

One	NULL
possibility	NULL
is	NULL
that	NULL
those	NULL
particular	NULL
pathways	NULL
in	NULL
those	NULL
particular	NULL
progenitors	NULL
are	NULL
directly	NULL
linked	NULL
to	NULL
the	NULL
genetic	NULL
DC	NULL
differentiation	NULL
program	NULL
.	NULL

Another	NULL
possibility	NULL
is	NULL
that	NULL
the	NULL
primary	NULL
signal	NULL
in	NULL
these	NULL
specific	NULL
progenitors	NULL
triggers	NULL
autocrine	NULL
secretion	NULL
of	NULL
additional	NULL
cy-tokines/factors	NULL
that	NULL
drive	NULL
terminal	NULL
maturation	NULL
.	NULL

We	NULL
are	NULL
currently	NULL
examining	NULL
whether	NULL
PMA	NULL
induces	NULL
TNF-a	NULL
expression	NULL
or	NULL
calcium	NULL
flux	NULL
in	NULL
primary	NULL
HPC	NULL
.	NULL

Regardless	NULL
of	NULL
the	NULL
specific	NULL
pathway	NULL
,	NULL
differentiation	NULL
signals	NULL
have	NULL
to	NULL
cross	NULL
into	NULL
the	NULL
nucleus	NULL
to	NULL
initiate	NULL
the	NULL
requisite	NULL
genetic	NULL
programs	NULL
.	NULL

Such	NULL
bridges	NULL
are	NULL
very	NULL
often	NULL
preformed	NULL
transcription	NULL
factors	NULL
,	NULL
of	NULL
which	NULL
the	NULL
NFB	NULL
family	NULL
is	NULL
one	NULL
of	NULL
the	NULL
best	NULL
characterized	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

78	NULL
)	NULL
.	NULL

Critical	NULL
involvement	NULL
of	NULL
NFKB-responsive	NULL
genes	NULL
in	NULL
DC	NULL
differentiation	NULL
has	NULL
been	NULL
found	NULL
in	NULL
chicken	NULL
bone	NULL
marrow	NULL
cell	NULL
lines	NULL
(	NULL
79	NULL
)	NULL
.	NULL

Involvement	NULL
of	NULL
rel/NFxB	NULL
family	NULL
transcription	NULL
factors	NULL
in	NULL
DC	NULL
differentiation	NULL
is	NULL
further	NULL
suggested	NULL
by	NULL
the	NULL
observations	NULL
that	NULL
RelB	NULL
(	NULL
80	NULL
,	NULL
81	NULL
)	NULL
is	NULL
expressed	NULL
at	NULL
high	NULL
levels	NULL
in	NULL
murine	NULL
DC	NULL
(	NULL
82	NULL
)	NULL
and	NULL
that	NULL
RelB	NULL
knockout	NULL
mice	NULL
have	NULL
significant	NULL
reductions	NULL
in	NULL
mature	NULL
DC	NULL
number	NULL
and	NULL
APC	NULL
function	NULL
(	NULL
83	NULL
,	NULL
84	NULL
)	NULL
.	NULL

In	NULL
human	NULL
DC	NULL
nuclear	NULL
localization	NULL
of	NULL
RelB	NULL
is	NULL
associated	NULL
with	NULL
enhanced	NULL
APC	NULL
function	NULL
(	NULL
85	NULL
)	NULL
.	NULL

Both	NULL
PMA	NULL
and	NULL
TNF-a	NULL
@	NULL
up-regulate	NULL
the	NULL
activity	NULL
of	NULL
NFB	NULL
family	NULL
members	NULL
(	NULL
including	NULL
RelB	NULL
by	NULL
PMA	NULL
)	NULL
(	NULL
86	NULL
)	NULL
,	NULL
and	NULL
RelIB	NULL
up-regulation	NULL
is	NULL
seen	NULL
during	NULL
CD34*	NULL
HPC-DC	NULL
(	NULL
14	NULL
)	NULL
and	NULL
monocyte-	NULL
>	NULL
DC	NULL
(	NULL
2	NULL
)	NULL
differentiation	NULL
.	NULL

This	NULL
is	NULL
also	NULL
true	NULL
for	NULL
KG1-DLC	NULL
differentiation	NULL
.	NULL

However	NULL
,	NULL
constitutive	NULL
expression	NULL
of	NULL
RelB	NULL
in	NULL
KG1la	NULL
suggests	NULL
that	NULL
DC	NULL
differentiation	NULL
may	NULL
not	NULL
simply	NULL
be	NULL
due	NULL
to	NULL
activation	NULL
of	NULL
RelB	NULL
.	NULL

It	NULL
is	NULL
also	NULL
possible	NULL
that	NULL
tonic	NULL
expression	NULL
of	NULL
ReIB	NULL
somehow	NULL
blocks	NULL
induction	NULL
of	NULL
NFKB-responsive	NULL
genes	NULL
as	NULL
has	NULL
been	NULL
suggested	NULL
for	NULL
conditional	NULL
v-re	NULL
?	NULL

expression	NULL
(	NULL
79	NULL
)	NULL
.	NULL

It	NULL
is	NULL
unclear	NULL
why	NULL
ReIB	NULL
expression	NULL
is	NULL
not	NULL
regulated	NULL
in	NULL
KG1a	NULL
,	NULL
but	NULL
this	NULL
suggests	NULL
that	NULL
some	NULL
negative	NULL
feedback	NULL
signal	NULL
has	NULL
been	NULL
lost	NULL
.	NULL

The	NULL
rapid	NULL
up-regulation	NULL
of	NULL
RelB	NULL
expression	NULL
induced	NULL
by	NULL
PMA	NULL
in	NULL
KG1	NULL
may	NULL
indicate	NULL
the	NULL
involvement	NULL
of	NULL
a	NULL
more	NULL
immediate	NULL
transcription	NULL
factor	NULL
,	NULL
although	NULL
NFB	NULL
can	NULL
mediate	NULL
its	NULL
own	NULL
transcription	NULL
(	NULL
78	NULL
)	NULL
.	NULL

Together	NULL
,	NULL
the	NULL
data	NULL
presented	NULL
in	NULL
this	NULL
report	NULL
corroborate	NULL
an	NULL
important	NULL
role	NULL
for	NULL
PKC	NULL
activation	NULL
in	NULL
DC	NULL
differentiation	NULL
from	NULL
CD34	NULL
*	NULL
HPC	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
KG1	NULL
cell	NULL
line	NULL
model	NULL
of	NULL
CD34	NULL
*HPC-DC	NULL
differentiation	NULL
allows	NULL
for	NULL
a	NULL
more	NULL
detailed	NULL
study	NULL
of	NULL
the	NULL
signal	NULL
transduction	NULL
pathways	NULL
involved	NULL
.	NULL

Our	NULL
initial	NULL
studies	NULL
indicate	NULL
that	NULL
the	NULL
PKC	NULL
,	NULL
TNF-	NULL
«	NULL
,	NULL
and/or	NULL
intracellular	NULL
calcium	NULL
signaling	NULL
pathways	NULL
mediate	NULL
specific	NULL
phenomenon	NULL
during	NULL
this	NULL
differentiation	NULL
.	NULL

A	NULL
potential	NULL
connection	NULL
of	NULL
these	NULL
pathways	NULL
to	NULL
the	NULL
RelB	NULL
transcription	NULL
factor	NULL
may	NULL
provide	NULL
a	NULL
doorway	NULL
into	NULL
uncovering	NULL
the	NULL
genes	NULL
that	NULL
control	NULL
DC	NULL
differentiation	NULL
and	NULL
underlie	NULL
the	NULL
unique	NULL
function	NULL
of	NULL
this	NULL
lineage	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Banchereau	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
R.	NULL
M.	NULL
Steinman	NULL
.	NULL

1998	NULL
.	NULL

Dendritic	NULL
cells	NULL
and	NULL
the	NULL
control	NULL
of	NULL
immunity	NULL
.	NULL

Nature	NULL
392:245	NULL
.	NULL

2	NULL
.	NULL

Akagawa	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
N.	NULL
Takasuka	NULL
,	NULL
Y.	NULL
Nozaki	NULL
,	NULL
I.	NULL
Komuro	NULL
,	NULL
M.	NULL
Azuma	NULL
,	NULL
M.	NULL
Ueda	NULL
,	NULL
M.	NULL
Naito	NULL
,	NULL
and	NULL
K.	NULL
Takahashi	NULL
.	NULL

1996	NULL
.	NULL

Generation	NULL
of	NULL
CD1*	NULL
ReIB*	NULL
dendritic	NULL
cells	NULL
and	NULL
tartrate-resistant	NULL
acid	NULL
phosphatase-positive	NULL
ostcoclast-like	NULL
multinucleated	NULL
giant	NULL
cells	NULL
from	NULL
human	NULL
monocytes	NULL
.	NULL

Blood	NULL
88:4029	NULL
.	NULL

3	NULL
.	NULL

Pick	NULL
]	NULL
,	NULL
W.	NULL
F.	NULL
,	NULL
O.	NULL
Majdic	NULL
,	NULL
P.	NULL
Kohl	NULL
,	NULL
J	NULL
.	NULL

Stock	NULL
,	NULL
E.	NULL
Riedl	NULL
,	NULL
C.	NULL
Scheinecker	NULL
,	NULL
C.	NULL
Bello-Fernandez	NULL
,	NULL
and	NULL
W.	NULL
Knapp	NULL
.	NULL

1996	NULL
.	NULL

Molecular	NULL
and	NULL
functional	NULL
characteristics	NULL
of	NULL
dendritic	NULL
cells	NULL
generated	NULL
from	NULL
highly	NULL
purified	NULL
CD14*	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

157:3850	NULL
.	NULL

4	NULL
.	NULL

Zhou	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
and	NULL
T.	NULL
F.	NULL
Tedder	NULL
.	NULL

1996	NULL
.	NULL

CD14*	NULL
blood	NULL
monocytes	NULL
can	NULL
differentiate	NULL
into	NULL
functionally	NULL
mature	NULL
CD83*	NULL
dendritic	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93	NULL
:	NULL
2588	NULL
.	NULL

5	NULL
.	NULL

Kiertscher	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
and	NULL
M.	NULL
D.	NULL
Roth	NULL
.	NULL

1996	NULL
.	NULL

Human	NULL
CD14	NULL
leukocytes	NULL
acquire	NULL
the	NULL
phenotype	NULL
and	NULL
function	NULL
of	NULL
antigen-presenting	NULL
dendritic	NULL
cells	NULL
when	NULL
cultured	NULL
in	NULL
GM-CSF	NULL
and	NULL
IL-4	NULL
.	NULL

J.	NULL
Leukocyte	NULL
Biol	NULL
.	NULL

59:208	NULL
.	NULL

6	NULL
.	NULL

Galy	NULL
,	NULL
A.	NULL
,	NULL
M.	NULL
Travis	NULL
,	NULL
D.	NULL
Cen	NULL
,	NULL
and	NULL
B.	NULL
Chen	NULL
.	NULL

1995	NULL
.	NULL

Human	NULL
T	NULL
,	NULL
B	NULL
,	NULL
natural	NULL
killer	NULL
,	NULL
and	NULL
dendritic	NULL
cells	NULL
arise	NULL
from	NULL
a	NULL
common	NULL
bone	NULL
marrow	NULL
progenitor	NULL
cell	NULL
subset	NULL
.	NULL

Immunity	NULL
3:459	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33.	NULL
.	NULL

Ryncarz	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
and	NULL
C.	NULL
Anasetti	NULL
.	NULL

1998	NULL
.	NULL

Expression	NULL
of	NULL
CD86	NULL
on	NULL
human	NULL
marrow	NULL
CD34	NULL
(	NULL
+	NULL
)	NULL
cells	NULL
identifies	NULL
immunocompetent	NULL
committed	NULL
precursors	NULL
of	NULL
macrophages	NULL
and	NULL
dendritic	NULL
cells	NULL
.	NULL

Blood	NULL
91:3892.	NULL
.	NULL

Winzler	NULL
,	NULL
C.	NULL
,	NULL
P.	NULL
Rovere	NULL
,	NULL
M.	NULL
Rescigno	NULL
,	NULL
F.	NULL
Granucci	NULL
,	NULL
G.	NULL
Penna	NULL
,	NULL
L.	NULL
Adorini	NULL
,	NULL
V.	NULL
S.	NULL
Zimmermann	NULL
,	NULL
J.	NULL
Davoust	NULL
,	NULL
and	NULL
P.	NULL
Ricciardi-Castagnoli	NULL
.	NULL

1997	NULL
.	NULL

Maturation	NULL
stages	NULL
of	NULL
mouse	NULL
dendritic	NULL
cells	NULL
in	NULL
growth	NULL
factor-dependent	NULL
long-term	NULL
cultures	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

185:317.	NULL
.	NULL

Caux	NULL
,	NULL
C.	NULL
,	NULL
C.	NULL
Dezutter-Dambuyant	NULL
,	NULL
D.	NULL
Schmitt	NULL
,	NULL
and	NULL
J.	NULL
Banchereau	NULL
.	NULL

1992	NULL
.	NULL

GM-	NULL
CSF	NULL
and	NULL
TNF-a	NULL
cooperate	NULL
in	NULL
the	NULL
generation	NULL
of	NULL
dendritic	NULL
Langerhans	NULL
cells	NULL
.	NULL

Nature	NULL
360:258	NULL
.	NULL

Flores-Romo	NULL
,	NULL
L.	NULL
,	NULL
P.	NULL
Bjork	NULL
,	NULL
V.	NULL
Duvert	NULL
,	NULL
C.	NULL
Van	NULL
Kooten	NULL
,	NULL
S.	NULL
Sacland	NULL
,	NULL
and	NULL
J.	NULL
Banchereau	NULL
.	NULL

1997	NULL
.	NULL

CD40	NULL
ligation	NULL
on	NULL
human	NULL
cord	NULL
blood	NULL
CD34	NULL
hematopoietic	NULL
progenitors	NULL
induces	NULL
their	NULL
proliferation	NULL
and	NULL
differentiation	NULL
into	NULL
functional	NULL
dendritic	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

2:341	NULL
.	NULL

Czemiecki	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
C.	NULL
Carter	NULL
,	NULL
L.	NULL
Rivoltini	NULL
,	NULL
G.	NULL
K.	NULL
Koski	NULL
,	NULL
H.	NULL
I.	NULL
Kim	NULL
,	NULL
D.	NULL
E.	NULL
Weng	NULL
,	NULL
J.	NULL
G.	NULL
Roros	NULL
,	NULL
Y.	NULL
M.	NULL
Hijazi	NULL
,	NULL
S.	NULL
Wu	NULL
,	NULL
S.	NULL
A.	NULL
Rosenberg	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
.	NULL

Calcium	NULL
iono-phore-treated	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
and	NULL
dendritic	NULL
cells	NULL
rapidly	NULL
display	NULL
characteristics	NULL
of	NULL
activated	NULL
dendritic	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

159:3823	NULL
.	NULL

Hart	NULL
,	NULL
D.	NULL
N.	NULL
1998	NULL
.	NULL

Dendritic	NULL
cells	NULL
:	NULL
unique	NULL
leukocyte	NULL
populations	NULL
which	NULL
control	NULL
the	NULL
primary	NULL
immune	NULL
response	NULL
.	NULL

Blood	NULL
90:3245	NULL
.	NULL

Reddy	NULL
,	NULL
A.	NULL
,	NULL
M.	NULL
Sapp	NULL
,	NULL
M.	NULL
Feldman	NULL
,	NULL
M.	NULL
Subklewe	NULL
,	NULL
and	NULL
N.	NULL
Bhardwaj	NULL
.	NULL

1997	NULL
.	NULL

A	NULL
monocyte	NULL
conditioned	NULL
medium	NULL
is	NULL
more	NULL
effective	NULL
than	NULL
defined	NULL
cytokines	NULL
in	NULL
mediating	NULL
the	NULL
terminal	NULL
maturation	NULL
of	NULL
human	NULL
dendritic	NULL
cells	NULL
.	NULL

Blood	NULL
90:3640	NULL
.	NULL

Davis	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
Saini	NULL
,	NULL
P.	NULL
J.	NULL
Blair	NULL
,	NULL
B.	NULL
L.	NULL
Levine	NULL
,	NULL
N.	NULL
Craighead	NULL
,	NULL
D.	NULL
M.	NULL
Harlan	NULL
,	NULL
C.	NULL
H.	NULL
June	NULL
,	NULL
and	NULL
K.	NULL
P.	NULL
Lee	NULL
.	NULL

1998	NULL
.	NULL

Phorbol	NULL
esters	NULL
induce	NULL
differentiation	NULL
of	NULL
human	NULL
CD34*	NULL
hemopoietic	NULL
progenitors	NULL
to	NULL
dendritic	NULL
cells	NULL
:	NULL
evidence	NULL
for	NULL
protein	NULL
kinase	NULL
C-mediated	NULL
signaling	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

160:3689	NULL
.	NULL

Arruda	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
J.	NULL
L.	NULL
Ho	NULL
.	NULL

1992	NULL
.	NULL

IL-4	NULL
receptor	NULL
signal	NULL
transduction	NULL
in	NULL
human	NULL
monocytes	NULL
is	NULL
associated	NULL
with	NULL
protein	NULL
kinase	NULL
C	NULL
translocation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

149:1258	NULL
.	NULL

Harnett	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
M.	NULL
J.	NULL
Holman	NULL
,	NULL
and	NULL
G.	NULL
G.	NULL
Klaus	NULL
.	NULL

1991	NULL
.	NULL

IL-4	NULL
promotes	NULL
anti-Ig-mediated	NULL
protein	NULL
kinase	NULL
C	NULL
translocation	NULL
and	NULL
reverses	NULL
phorbol	NULL
ester-mediated	NULL
protein	NULL
kinase	NULL
C	NULL
down-	NULL
regulation	NULL
in	NULL
murine	NULL
B	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

147:3831	NULL
.	NULL

Finney	NULL
,	NULL
M.	NULL
,	NULL
G.	NULL
R.	NULL
Guy	NULL
,	NULL
R.	NULL
H.	NULL
Michell	NULL
,	NULL
J.	NULL
Gordon	NULL
,	NULL
B.	NULL
Dugas	NULL
,	NULL
K.	NULL
P.	NULL
Rigley	NULL
,	NULL
and	NULL
R.	NULL
E.	NULL
Callard	NULL
.	NULL

1990	NULL
.	NULL

Interleukin	NULL
4	NULL
activates	NULL
human	NULL
B	NULL
lymphocytes	NULL
via	NULL
transient	NULL
inositol	NULL
lipid	NULL
hydrolysis	NULL
and	NULL
delayed	NULL
cyclic	NULL
adenosine	NULL
monophosphate	NULL
generation	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

20:151	NULL
.	NULL

Schutze	NULL
,	NULL
S.	NULL
,	NULL
T.	NULL
Machleidt	NULL
,	NULL
and	NULL
M.	NULL
Kronke	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
role	NULL
of	NULL
diacylglycerol	NULL
and	NULL
ceramide	NULL
in	NULL
tumor	NULL
necrosis	NULL
factor	NULL
and	NULL
interleukin-1	NULL
signal	NULL
transduction	NULL
.	NULL

J.	NULL
Lex-kocyte	NULL
Biol	NULL
.	NULL

56:533	NULL
.	NULL

Ren	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
S.	NULL
M.	NULL
Fu	NULL
,	NULL
R.	NULL
S.	NULL
Geha	NULL
,	NULL
and	NULL
T.	NULL
Morio	NULL
.	NULL

1994	NULL
.	NULL

Protein	NULL
tyrosine	NULL
kinase	NULL
activation	NULL
and	NULL
protein	NULL
kinase	NULL
C	NULL
translocation	NULL
are	NULL
functional	NULL
components	NULL
of	NULL
CD40	NULL
signal	NULL
transduction	NULL
in	NULL
resting	NULL
human	NULL
B	NULL
cells	NULL
:	NULL
signal	NULL
transduction	NULL
via	NULL
CD40	NULL
involves	NULL
activation	NULL
of	NULL
Lyn	NULL
kinase	NULL
and	NULL
phosphatidylinositol-3-kinase	NULL
,	NULL
and	NULL
phosphorylation	NULL
of	NULL
phospholipase	NULL
Cy2	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

179:673	NULL
.	NULL

Sallusto	NULL
,	NULL
F.	NULL
,	NULL
C.	NULL
Nicolo	NULL
,	NULL
R.	NULL
De	NULL
Maria	NULL
,	NULL
S.	NULL
Corinti	NULL
,	NULL
and	NULL
R.	NULL
Testi	NULL
.	NULL

1996	NULL
.	NULL

Ceramide	NULL
inhibits	NULL
antigen	NULL
uptake	NULL
and	NULL
presentation	NULL
by	NULL
dendritic	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

184	NULL
:	NULL
2411	NULL
.	NULL

Carrasco	NULL
,	NULL
D.	NULL
,	NULL
R.	NULL
P.	NULL
Ryseck	NULL
,	NULL
and	NULL
R.	NULL
Bravo	NULL
.	NULL

1993	NULL
.	NULL

Expression	NULL
of	NULL
ReIB	NULL
transcripts	NULL
during	NULL
lymphoid	NULL
organ	NULL
development	NULL
:	NULL
specific	NULL
expression	NULL
in	NULL
dendritic	NULL
antigen-presenting	NULL
cells	NULL
.	NULL

Development	NULL
118:1221	NULL
.	NULL

Bochmelt	NULL
,	NULL
G.	NULL
,	NULL
J.	NULL
Madruga	NULL
,	NULL
P.	NULL
Dorfler	NULL
,	NULL
K.	NULL
Briegel	NULL
,	NULL
H.	NULL
Schwarz	NULL
,	NULL
P.	NULL
J.	NULL
Enrictto	NULL
,	NULL
and	NULL
M.	NULL
Zenke	NULL
.	NULL

1995	NULL
.	NULL

Dendritic	NULL
cell	NULL
progenitor	NULL
is	NULL
transformed	NULL
by	NULL
a	NULL
conditional	NULL
v-Rel	NULL
estrogen	NULL
receptor	NULL
fusion	NULL
protein	NULL
v-ReIER	NULL
.	NULL

Cell	NULL
80:341	NULL
.	NULL

Feuillard	NULL
,	NULL
J.	NULL
,	NULL
M.	NULL
Korner	NULL
,	NULL
A.	NULL
Israel	NULL
,	NULL
J.	NULL
Vassy	NULL
,	NULL
and	NULL
M.	NULL
Raphael	NULL
.	NULL

1996	NULL
.	NULL

Differential	NULL
nuclear	NULL
localization	NULL
of	NULL
p50	NULL
,	NULL
p52	NULL
,	NULL
and	NULL
RelB	NULL
proteins	NULL
in	NULL
human	NULL
accessory	NULL
cells	NULL
of	NULL
the	NULL
immune	NULL
response	NULL
in	NULL
situ	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

26:2547	NULL
.	NULL

Lermbecher	NULL
,	NULL
T.	NULL
,	NULL
B.	NULL
Kistler	NULL
,	NULL
and	NULL
T.	NULL
Wirth	NULL
.	NULL

1994	NULL
.	NULL

Two	NULL
distinct	NULL
mechanisms	NULL
contribute	NULL
to	NULL
the	NULL
constitutive	NULL
activation	NULL
of	NULL
RelB	NULL
in	NULL
lymphoid	NULL
cells	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:4060	NULL
.	NULL

Burkly	NULL
,	NULL
L.	NULL
,	NULL
C.	NULL
Hession	NULL
,	NULL
L.	NULL
Ogata	NULL
,	NULL
C.	NULL
Reilly	NULL
,	NULL
L.	NULL
A.	NULL
Marconi	NULL
,	NULL
D.	NULL
Olson	NULL
,	NULL
R.	NULL
Tizard	NULL
,	NULL
R.	NULL
Cate	NULL
,	NULL
and	NULL
D.	NULL
Lo	NULL
.	NULL

1995	NULL
.	NULL

Expression	NULL
of	NULL
ReIB	NULL
is	NULL
required	NULL
for	NULL
the	NULL
development	NULL
of	NULL
thymic	NULL
medulla	NULL
and	NULL
dendritic	NULL
cells	NULL
.	NULL

Nature	NULL
373:531	NULL
.	NULL

Weih	NULL
,	NULL
F.	NULL
,	NULL
D.	NULL
Carrasco	NULL
,	NULL
S.	NULL
K.	NULL
Durham	NULL
,	NULL
D.	NULL
S.	NULL
Barton	NULL
,	NULL
C.	NULL
A.	NULL
Rizzo	NULL
,	NULL
R.	NULL
P.	NULL
Ryseck	NULL
,	NULL
S.	NULL
A.	NULL
Lira	NULL
,	NULL
and	NULL
R.	NULL
Bravo	NULL
.	NULL

1995	NULL
.	NULL

Multiorgan	NULL
inflammation	NULL
and	NULL
hematopoietic	NULL
abnormalities	NULL
in	NULL
mice	NULL
with	NULL
a	NULL
targeted	NULL
disruption	NULL
of	NULL
RelB	NULL
,	NULL
a	NULL
member	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B/Rel	NULL
family	NULL
.	NULL

Cell	NULL
80:331	NULL
.	NULL

Sekhar	NULL
,	NULL
M.	NULL
,	NULL
H.	NULL
Kotani	NULL
,	NULL
S.	NULL
Doren	NULL
,	NULL
R.	NULL
Agarwal	NULL
,	NULL
G.	NULL
McGarrity	NULL
,	NULL
and	NULL
C.	NULL
E.	NULL
Dunbar	NULL
.	NULL

1996	NULL
.	NULL

Retroviral	NULL
transduction	NULL
of	NULL
CD34-enriched	NULL
hematopoietic	NULL
progenitor	NULL
cells	NULL
under	NULL
serum-free	NULL
conditions	NULL
.	NULL

Hum	NULL
.	NULL

Gene	NULL
Ther	NULL
.	NULL

7:33	NULL
.	NULL

Koeffler	NULL
,	NULL
H.	NULL
P.	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Golde	NULL
.	NULL

1978	NULL
.	NULL

Acute	NULL
myelogenous	NULL
leukemia	NULL
:	NULL
a	NULL
human	NULL
cell	NULL
line	NULL
responsive	NULL
to	NULL
colony-stimulating	NULL
activity	NULL
.	NULL

Science	NULL
200:1153	NULL
.	NULL

Koeffler	NULL
,	NULL
H.	NULL
P.	NULL
,	NULL
M.	NULL
Bar-Eli	NULL
,	NULL
and	NULL
M.	NULL
C.	NULL
Territo	NULL
.	NULL

1981	NULL
.	NULL

Phorbol	NULL
ester	NULL
effect	NULL
on	NULL
differentiation	NULL
of	NULL
human	NULL
myeloid	NULL
leukemia	NULL
cell	NULL
lines	NULL
blocked	NULL
at	NULL
different	NULL
stages	NULL
of	NULL
maturation	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

41:919	NULL
.	NULL

Kiss	NULL
,	NULL
Z.	NULL
,	NULL
E.	NULL
Deli	NULL
,	NULL
M.	NULL
Shoji	NULL
,	NULL
H.	NULL
P.	NULL
Kocffler	NULL
,	NULL
G.	NULL
R.	NULL
Pettit	NULL
,	NULL
W.	NULL
R.	NULL
Vogler	NULL
,	NULL
and	NULL
J.	NULL
F.	NULL
Kuo	NULL
.	NULL

1987	NULL
.	NULL

Differential	NULL
effects	NULL
of	NULL
various	NULL
protein	NULL
kinase	NULL
C	NULL
activators	NULL
on	NULL
protein	NULL
phosphorylation	NULL
in	NULL
human	NULL
acute	NULL
myeloblastic	NULL
leukemia	NULL
cell	NULL
line	NULL
KG-1	NULL
and	NULL
its	NULL
phorbol	NULL
ester-resistant	NULL
subline	NULL
KG-1a	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

47:1302	NULL
.	NULL

Ferrero	NULL
,	NULL
D.	NULL
,	NULL
S.	NULL
Pessano	NULL
,	NULL
G.	NULL
L.	NULL
Pagliardi	NULL
,	NULL
and	NULL
G.	NULL
Rovera	NULL
.	NULL

1983	NULL
.	NULL

Induction	NULL
of	NULL
differentiation	NULL
of	NULL
human	NULL
myeloid	NULL
leukemias	NULL
:	NULL
surface	NULL
changes	NULL
probed	NULL
with	NULL
monoclonal	NULL
antibodies	NULL
.	NULL

Blood	NULL
61:171	NULL
.	NULL

Koeffler	NULL
,	NULL
H.	NULL
P.	NULL
,	NULL
R.	NULL
Billing	NULL
,	NULL
A.	NULL
J.	NULL
Lusis	NULL
,	NULL
R.	NULL
Sparkes	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Golde	NULL
.	NULL

1980	NULL
.	NULL

An	NULL
undifferentiated	NULL
variant	NULL
derived	NULL
from	NULL
the	NULL
human	NULL
acute	NULL
myelogenous	NULL
leukemia	NULL
cell	NULL
line	NULL
(	NULL
KG-1	NULL
)	NULL
.	NULL

Blood	NULL
56:265	NULL
.	NULL

Shoji	NULL
,	NULL
M.	NULL
,	NULL
P.	NULL
R.	NULL
Girard	NULL
,	NULL
P.	NULL
A.	NULL
Charp	NULL
,	NULL
H.	NULL
P.	NULL
Koeffler	NULL
,	NULL
W.	NULL
R.	NULL
Vogler	NULL
,	NULL
and	NULL
J.	NULL
F.	NULL
Kuo	NULL
.	NULL

1987	NULL
.	NULL

Effects	NULL
of	NULL
phorbol	NULL
ester	NULL
on	NULL
translocation	NULL
and	NULL
down-regulation	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
and	NULL
phosphorylation	NULL
of	NULL
endogenous	NULL
proteins	NULL
in	NULL
human	NULL
acute	NULL
myeloid	NULL
34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

3247	NULL
leukemia	NULL
cell	NULL
line	NULL
KG-1	NULL
and	NULL
its	NULL
phorbol	NULL
ester-resistant	NULL
subline	NULL
KG-1a	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

47:6363	NULL
.	NULL

Lehrer	NULL
,	NULL
R.	NULL
I.	NULL
,	NULL
L.	NULL
E.	NULL
Cohen	NULL
,	NULL
and	NULL
H.	NULL
P.	NULL
Koeffler	NULL
.	NULL

1983	NULL
.	NULL

Specific	NULL
binding	NULL
of	NULL
bol	NULL
dibutyrate	NULL
to	NULL
phorbol	NULL
diester-responsive	NULL
and	NULL
-resistant	NULL
clones	NULL
of	NULL
a	NULL
human	NULL
myeloid	NULL
leukemia	NULL
(	NULL
KG-1	NULL
)	NULL
line	NULL
1	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

43:3563	NULL
.	NULL

Davis	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
D.	NULL
H.	NULL
Robinson	NULL
,	NULL
K.	NULL
P.	NULL
Lee	NULL
,	NULL
and	NULL
S.	NULL
W.	NULL
Kessler	NULL
.	NULL

1995	NULL
.	NULL

Porcine	NULL
brain	NULL
microvascular	NULL
endothelial	NULL
cells	NULL
support	NULL
the	NULL
in	NULL
vitro	NULL
expansion	NULL
of	NULL
human	NULL
primitive	NULL
hematopoictic	NULL
bone	NULL
marrow	NULL
progenitor	NULL
cells	NULL
with	NULL
a	NULL
high	NULL
replating	NULL
potential	NULL
:	NULL
requirement	NULL
for	NULL
cell-to-cell	NULL
interactions	NULL
and	NULL
colony-stimulating	NULL
factors	NULL
.	NULL

Blood	NULL
85	NULL
:	NULL
1751	NULL
.	NULL

Koopman	NULL
,	NULL
G.	NULL
,	NULL
C.	NULL
P.	NULL
Reutelingsperger	NULL
,	NULL
G.	NULL
A.	NULL
Kuijten	NULL
,	NULL
R.	NULL
M.	NULL
Kechnen	NULL
,	NULL
S.	NULL
T.	NULL
Pals	NULL
,	NULL
and	NULL
M.	NULL
H.	NULL
van	NULL
Oers	NULL
.	NULL

1994	NULL
.	NULL

Annexin	NULL
V	NULL
for	NULL
flow	NULL
cytometric	NULL
detection	NULL
of	NULL
phos-phatidylserine	NULL
expression	NULL
on	NULL
B	NULL
cells	NULL
undergoing	NULL
apoptosis	NULL
.	NULL

Blood	NULL
84:1415	NULL
.	NULL

Sallusto	NULL
,	NULL
F.	NULL
,	NULL
M.	NULL
Cella	NULL
,	NULL
C.	NULL
Danieli	NULL
,	NULL
and	NULL
A.	NULL
Lanzavecchia	NULL
.	NULL

1995	NULL
.	NULL

Dendritic	NULL
cells	NULL
use	NULL
macropinocytosis	NULL
and	NULL
the	NULL
mannose	NULL
receptor	NULL
to	NULL
concentrate	NULL
macromolecules	NULL
in	NULL
the	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II	NULL
compartment	NULL
:	NULL
downregulation	NULL
by	NULL
cytokines	NULL
and	NULL
bacterial	NULL
products	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

182:389	NULL
.	NULL

June	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Ledbetter	NULL
,	NULL
M.	NULL
M.	NULL
Gillespie	NULL
,	NULL
T.	NULL
Lindsten	NULL
,	NULL
and	NULL
C.	NULL
B.	NULL
Thompson	NULL
.	NULL

1987	NULL
.	NULL

T-cell	NULL
proliferation	NULL
involving	NULL
the	NULL
CD28	NULL
pathway	NULL
is	NULL
associated	NULL
with	NULL
cyclos-porine-resistant	NULL
interleukin	NULL
2	NULL
gene	NULL
expression	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7:4472	NULL
.	NULL

Lee	NULL
,	NULL
K.	NULL
P.	NULL
,	NULL
C.	NULL
Taylor	NULL
,	NULL
B.	NULL
Petryniak	NULL
,	NULL
L.	NULL
A.	NULL
Turka	NULL
,	NULL
C.	NULL
H.	NULL
June	NULL
,	NULL
and	NULL
C.	NULL
B.	NULL
Thompson	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
genomic	NULL
organization	NULL
of	NULL
the	NULL
CD28	NULL
gene	NULL
:	NULL
implications	NULL
for	NULL
the	NULL
regulation	NULL
of	NULL
CD28	NULL
mRNA	NULL
expression	NULL
and	NULL
heterogeneity	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

145:344	NULL
.	NULL

Meggio	NULL
,	NULL
F.	NULL
,	NULL
A.	NULL
Donella	NULL
Deana	NULL
,	NULL
M.	NULL
Ruzzene	NULL
,	NULL
A.	NULL
M.	NULL
Brunati	NULL
,	NULL
L.	NULL
Cesaro	NULL
,	NULL
B.	NULL
Guerra	NULL
,	NULL
T.	NULL
Meyer	NULL
,	NULL
H.	NULL
Mett	NULL
,	NULL
D.	NULL
Fabbro	NULL
,	NULL
and	NULL
P.	NULL
Furet	NULL
.	NULL

1995	NULL
.	NULL

Different	NULL
susceptibility	NULL
of	NULL
protein	NULL
kinases	NULL
to	NULL
staurosporine	NULL
inhibition	NULL
:	NULL
kinetic	NULL
studies	NULL
and	NULL
molecular	NULL
bases	NULL
for	NULL
the	NULL
resistance	NULL
of	NULL
protein	NULL
kinase	NULL
CK2	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Biochem	NULL
.	NULL

234:317	NULL
.	NULL

Zhou	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
and	NULL
T.	NULL
F.	NULL
Tedder	NULL
.	NULL

1995	NULL
.	NULL

Human	NULL
blood	NULL
dendritic	NULL
cells	NULL
selectively	NULL
express	NULL
CD83	NULL
,	NULL
a	NULL
member	NULL
of	NULL
the	NULL
immunoglobulin	NULL
superfamily	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

154	NULL
:	NULL
3821	NULL
.	NULL

June	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Bluestone	NULL
,	NULL
L.	NULL
M.	NULL
Nadler	NULL
,	NULL
and	NULL
C.	NULL
B.	NULL
Thompson	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
B7	NULL
and	NULL
CD28	NULL
receptor	NULL
families	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
15:321	NULL
.	NULL

Fearnley	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
A.	NULL
D.	NULL
McLellan	NULL
,	NULL
S.	NULL
I.	NULL
Mannering	NULL
,	NULL
B.	NULL
D.	NULL
Hock	NULL
,	NULL
and	NULL
D.	NULL
N.	NULL
Hart	NULL
.	NULL

1997	NULL
.	NULL

Isolation	NULL
of	NULL
human	NULL
blood	NULL
dendritic	NULL
cells	NULL
using	NULL
the	NULL
CMRF-44	NULL
monoclonal	NULL
antibody	NULL
:	NULL
implications	NULL
for	NULL
studies	NULL
on	NULL
antigen-presenting	NULL
cell	NULL
function	NULL
and	NULL
immu-notherapy	NULL
.	NULL

Blood	NULL
89:3708	NULL
.	NULL

Territo	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
and	NULL
H.	NULL
P.	NULL
Koeffler	NULL
.	NULL

1981	NULL
.	NULL

Induction	NULL
by	NULL
phorbol	NULL
esters	NULL
of	NULL
macrophage	NULL
differentiation	NULL
in	NULL
human	NULL
leukaemia	NULL
cell	NULL
lines	NULL
does	NULL
not	NULL
require	NULL
cell	NULL
division	NULL
.	NULL

Br	NULL
.	NULL

J.	NULL
Haematol	NULL
.	NULL

47:479	NULL
.	NULL

Thomas	NULL
,	NULL
R.	NULL
,	NULL
L.	NULL
S.	NULL
Davis	NULL
,	NULL
and	NULL
P.	NULL
E.	NULL
Lipsky	NULL
.	NULL

1993	NULL
.	NULL

Comparative	NULL
accessory	NULL
cell	NULL
function	NULL
of	NULL
human	NULL
peripheral	NULL
blood	NULL
dendritic	NULL
cells	NULL
and	NULL
monocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

151:6840	NULL
.	NULL

Adema	NULL
,	NULL
G.	NULL
J.	NULL
,	NULL
F.	NULL
Hartgers	NULL
,	NULL
R.	NULL
Verstraten	NULL
,	NULL
E.	NULL
de	NULL
Vries	NULL
,	NULL
G.	NULL
Marland	NULL
,	NULL
S.	NULL
Menon	NULL
,	NULL
J	NULL
.	NULL

Foster	NULL
,	NULL
Y.	NULL
Xu	NULL
,	NULL
P.	NULL
Nooyen	NULL
,	NULL
T.	NULL
McClanahan	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
.	NULL

A	NULL
dendritic-cell-derived	NULL
C-C	NULL
chemokine	NULL
that	NULL
preferentially	NULL
attracts	NULL
naive	NULL
T	NULL
cells	NULL
.	NULL

Nature	NULL
387:713	NULL
.	NULL

Nishizuka	NULL
,	NULL
Y	NULL
.	NULL

1995	NULL
.	NULL

Protein	NULL
kinase	NULL
C	NULL
and	NULL
lipid	NULL
signaling	NULL
for	NULL
sustained	NULL
cellular	NULL
responses	NULL
.	NULL

FASEB	NULL
J	NULL
.	NULL

9:484	NULL
.	NULL

Kazanietz	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
N.	NULL
E.	NULL
Lewin	NULL
,	NULL
J.	NULL
D.	NULL
Bruns	NULL
,	NULL
and	NULL
P.	NULL
M.	NULL
Blumberg	NULL
.	NULL

1995	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
cysteine-rich	NULL
region	NULL
of	NULL
the	NULL
Caenorhabditis	NULL
elegans	NULL
protein	NULL
Unc-13	NULL
as	NULL
a	NULL
high	NULL
affinity	NULL
phorbol	NULL
ester	NULL
receptor	NULL
:	NULL
analysis	NULL
of	NULL
ligand-binding	NULL
in-teractions	NULL
,	NULL
lipid	NULL
cofactor	NULL
requirements	NULL
,	NULL
and	NULL
inhibitor	NULL
sensitivity	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:10777	NULL
.	NULL

Abmed	NULL
,	NULL
S.	NULL
,	NULL
J.	NULL
Lee	NULL
,	NULL
R.	NULL
Kozma	NULL
,	NULL
A	NULL
.	NULL

Best	NULL
,	NULL
C.	NULL
Monfries	NULL
,	NULL
and	NULL
L.	NULL
Lim	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
novel	NULL
functional	NULL
target	NULL
for	NULL
tumor-promoting	NULL
phorbol	NULL
esters	NULL
and	NULL
lysophosphatidic	NULL
acid	NULL
:	NULL
the	NULL
p21	NULL
``	NULL
``	NULL
*-GTPase	NULL
activating	NULL
protein	NULL
n-chimacrin	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:10709	NULL
.	NULL

Abmed	NULL
,	NULL
S.	NULL
,	NULL
I.	NULL
N.	NULL
Maruyama	NULL
,	NULL
R.	NULL
Kozma	NULL
,	NULL
J.	NULL
Lee	NULL
,	NULL
S.	NULL
Brenner	NULL
,	NULL
and	NULL
L.	NULL
Lim	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
Caenorhabditis	NULL
elegans	NULL
unc-13	NULL
gene	NULL
product	NULL
is	NULL
a	NULL
phospholipid-dependent	NULL
high-affinity	NULL
phorbol	NULL
ester	NULL
receptor	NULL
.	NULL

Biochem	NULL
.	NULL

J	NULL
.	NULL

287:995	NULL
.	NULL

Monks	NULL
,	NULL
C.	NULL
R.	NULL
F.	NULL
,	NULL
H.	NULL
Kupper	NULL
,	NULL
I.	NULL
Tamir	NULL
,	NULL
A.	NULL
Barlow	NULL
,	NULL
and	NULL
A.	NULL
Kupfer	NULL
.	NULL

1997	NULL
.	NULL

Selective	NULL
modulation	NULL
of	NULL
protein	NULL
kinase	NULL
c-0	NULL
during	NULL
T-cell	NULL
activation	NULL
.	NULL

Nature	NULL
385:83	NULL
.	NULL

Macfarlane	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
and	NULL
L.	NULL
Manzel	NULL
.	NULL

1994	NULL
.	NULL

Activation	NULL
of	NULL
B-isozyme	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
PKCB	NULL
)	NULL
is	NULL
necessary	NULL
and	NULL
sufficient	NULL
for	NULL
phorbol	NULL
ester-induced	NULL
differentiation	NULL
of	NULL
HL-60	NULL
promyelocytes	NULL
:	NULL
studies	NULL
with	NULL
PKCB-defective	NULL
PET	NULL
mutant	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:4327	NULL
.	NULL

Inaba	NULL
,	NULL
K.	NULL
,	NULL
M.	NULL
Inaba	NULL
,	NULL
M.	NULL
Deguchi	NULL
,	NULL
K.	NULL
Hagi	NULL
,	NULL
R.	NULL
Yasumizu	NULL
,	NULL
S.	NULL
Ikcehara	NULL
,	NULL
S.	NULL
Muramatsu	NULL
,	NULL
and	NULL
R.	NULL
M.	NULL
Steinman	NULL
.	NULL

1993	NULL
.	NULL

Granulocytes	NULL
,	NULL
macrophages	NULL
,	NULL
and	NULL
dendritic	NULL
cells	NULL
arise	NULL
from	NULL
a	NULL
common	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
I-neg-ative	NULL
progenitor	NULL
in	NULL
mouse	NULL
bone	NULL
marrow	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:3038	NULL
.	NULL

Inaba	NULL
,	NULL
K.	NULL
,	NULL
M.	NULL
Inaba	NULL
,	NULL
N.	NULL
Romani	NULL
,	NULL
H.	NULL
Aya	NULL
,	NULL
M.	NULL
Deguchi	NULL
,	NULL
S.	NULL
IKchara	NULL
,	NULL
S.	NULL
Muramatsu	NULL
,	NULL
and	NULL
R.	NULL
M.	NULL
Steinman	NULL
.	NULL

1992	NULL
.	NULL

Generation	NULL
of	NULL
large	NULL
numbers	NULL
of	NULL
dendritic	NULL
cells	NULL
from	NULL
mouse	NULL
bone	NULL
marrow	NULL
cultures	NULL
supplemented	NULL
with	NULL
granulocyte/macrophage	NULL
colony-stimulating	NULL
factor	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

176:1693	NULL
.	NULL

Caux	NULL
,	NULL
C.	NULL
,	NULL
C.	NULL
Dezutter-Dambuyant	NULL
,	NULL
D.	NULL
Schmitt	NULL
,	NULL
and	NULL
J.	NULL
Banchereau	NULL
.	NULL

1992	NULL
.	NULL

GM-CSF	NULL
and	NULL
TNF-a	NULL
cooperate	NULL
in	NULL
the	NULL
generation	NULL
of	NULL
dendritic	NULL
Langerhans	NULL
cells	NULL
.	NULL

Nature	NULL
360:258	NULL
.	NULL

Santiago-Schwarz	NULL
,	NULL
F.	NULL
,	NULL
E.	NULL
Belilos	NULL
,	NULL
B.	NULL
Diamond	NULL
,	NULL
and	NULL
S.	NULL
E.	NULL
Carsons	NULL
.	NULL

1992	NULL
.	NULL

TNF	NULL
in	NULL
combination	NULL
with	NULL
GM-CSF	NULL
enhances	NULL
the	NULL
differentiation	NULL
of	NULL
neonatal	NULL
cord	NULL
blood	NULL
stem	NULL
cells	NULL
into	NULL
dendritic	NULL
cells	NULL
and	NULL
macrophages	NULL
.	NULL

J.	NULL
Leukocyte	NULL
Biol	NULL
.	NULL

52:274	NULL
.	NULL

Reid	NULL
,	NULL
C.	NULL
D.	NULL
,	NULL
A.	NULL
Stackpoole	NULL
,	NULL
A	NULL
.	NULL

Meager	NULL
,	NULL
and	NULL
J.	NULL
Tikerpae	NULL
.	NULL

1992	NULL
.	NULL

Interactions	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
with	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
and	NULL
other	NULL
cytokines	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
dendritic	NULL
cell	NULL
growth	NULL
in	NULL
vitro	NULL
from	NULL
early	NULL
bipotent	NULL
CD34*	NULL
progenitors	NULL
in	NULL
human	NULL
bone	NULL
marrow	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

149:2681	NULL
.	NULL

Rosenzwajg	NULL
,	NULL
M.	NULL
,	NULL
B.	NULL
Canque	NULL
,	NULL
and	NULL
J.	NULL
C.	NULL
Gluckman	NULL
.	NULL

1996	NULL
.	NULL

Human	NULL
dendritic	NULL
cell	NULL
differentiation	NULL
pathway	NULL
from	NULL
CD34*	NULL
hematopoietic	NULL
precursor	NULL
cells	NULL
.	NULL

Blood	NULL
87	NULL
:	NULL
535	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
3248	NULL
59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

68	NULL
.	NULL

69	NULL
.	NULL

70	NULL
.	NULL

71	NULL
.	NULL

72	NULL
.	NULL

Caux	NULL
,	NULL
C.	NULL
,	NULL
S.	NULL
Sacland	NULL
,	NULL
C.	NULL
Favre	NULL
,	NULL
V.	NULL
Duvert	NULL
,	NULL
P.	NULL
Mannoni	NULL
,	NULL
and	NULL
J.	NULL
Banchereau	NULL
.	NULL

1990	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor-a	NULL
strongly	NULL
potentiates	NULL
interleukin-3	NULL
and	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor-induced	NULL
proliferation	NULL
of	NULL
human	NULL
CD34*	NULL
hematopoictic	NULL
progenitor	NULL
cells	NULL
.	NULL

Blood	NULL
75:2292	NULL
.	NULL

Scheicher	NULL
,	NULL
C.	NULL
,	NULL
M.	NULL
Mehlig	NULL
,	NULL
R.	NULL
Zecher	NULL
,	NULL
and	NULL
K.	NULL
Reske	NULL
.	NULL

1992	NULL
.	NULL

Dendritic	NULL
cells	NULL
from	NULL
mouse	NULL
bone	NULL
marrow	NULL
:	NULL
in	NULL
vitro	NULL
differentiation	NULL
using	NULL
low	NULL
doses	NULL
of	NULL
recombinant	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

Methods	NULL
154	NULL
:	NULL
253	NULL
.	NULL

Markowicz	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
E.	NULL
G.	NULL
Engleman	NULL
.	NULL

1990	NULL
.	NULL

Granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
promotes	NULL
differentiation	NULL
and	NULL
survival	NULL
of	NULL
human	NULL
peripheral	NULL
blood	NULL
dendritic	NULL
cells	NULL
in	NULL
vitro	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

85:955	NULL
.	NULL

Witmer-Pack	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
W.	NULL
Olivier	NULL
,	NULL
J.	NULL
Valinsky	NULL
,	NULL
G.	NULL
Schuler	NULL
,	NULL
and	NULL
R.	NULL
M.	NULL
Steinman	NULL
.	NULL

1987	NULL
.	NULL

Granulocyte/macrophage	NULL
colony-stimulating	NULL
factor	NULL
is	NULL
essential	NULL
for	NULL
the	NULL
viability	NULL
and	NULL
function	NULL
of	NULL
cultured	NULL
murine	NULL
epidermal	NULL
Langerhans	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

166:1484	NULL
.	NULL

Szabolcs	NULL
,	NULL
P.	NULL
,	NULL
M.	NULL
A.	NULL
Moore	NULL
,	NULL
and	NULL
J.	NULL
W.	NULL
Young	NULL
.	NULL

1995	NULL
.	NULL

Expansion	NULL
of	NULL
immunostimu-latory	NULL
dendritic	NULL
cells	NULL
among	NULL
the	NULL
myeloid	NULL
progeny	NULL
of	NULL
human	NULL
CD34	NULL
*	NULL
bone	NULL
marrow	NULL
precursors	NULL
cultured	NULL
with	NULL
c-Kit	NULL
ligand	NULL
,	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
,	NULL
and	NULL
TNF-a	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

154:5851	NULL
.	NULL

Young	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
P.	NULL
Szabolcs	NULL
,	NULL
and	NULL
M.	NULL
A.	NULL
Moore	NULL
.	NULL

1995	NULL
.	NULL

Identification	NULL
of	NULL
dendritic	NULL
cell	NULL
colony-forming	NULL
units	NULL
among	NULL
normal	NULL
human	NULL
CD34*	NULL
bone	NULL
marrow	NULL
progenitors	NULL
that	NULL
are	NULL
expanded	NULL
by	NULL
c-Kit-ligand	NULL
and	NULL
yield	NULL
pure	NULL
dendritic	NULL
cell	NULL
colonies	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
granulocyte/macrophage	NULL
colony-stimulating	NULL
factor	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a.	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

182:1111	NULL
.	NULL

Romani	NULL
,	NULL
N.	NULL
,	NULL
S.	NULL
Gruner	NULL
,	NULL
D.	NULL
Brang	NULL
,	NULL
E.	NULL
Kampgen	NULL
,	NULL
A.	NULL
Lenz	NULL
,	NULL
B.	NULL
Trockenbacher	NULL
,	NULL
G.	NULL
Konwalinka	NULL
,	NULL
P.	NULL
O.	NULL
Fritsch	NULL
,	NULL
R.	NULL
M.	NULL
Steinman	NULL
,	NULL
and	NULL
G.	NULL
Schuler	NULL
.	NULL

1994	NULL
.	NULL

Proliferating	NULL
dendritic	NULL
cell	NULL
progenitors	NULL
in	NULL
human	NULL
blood	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

180:83	NULL
.	NULL

Caux	NULL
,	NULL
C.	NULL
,	NULL
B.	NULL
Vanbervliet	NULL
,	NULL
C.	NULL
Massacrier	NULL
,	NULL
B.	NULL
Dubois	NULL
,	NULL
C.	NULL
Dezutter-Dambuyant	NULL
,	NULL
D.	NULL
Schmitt	NULL
,	NULL
and	NULL
J.	NULL
Banchereau	NULL
.	NULL

1995	NULL
.	NULL

Characterization	NULL
of	NULL
human	NULL
CD34*	NULL
derived	NULL
dendritic/Langerhans	NULL
cells	NULL
(	NULL
D-Lc	NULL
)	NULL
.	NULL

Adv	NULL
.	NULL

Exp	NULL
.	NULL

Med	NULL
.	NULL

Biol	NULL
.	NULL

378:1	NULL
.	NULL

Szabolcs	NULL
,	NULL
P.	NULL
,	NULL
D.	NULL
Avigan	NULL
,	NULL
S.	NULL
Gezelter	NULL
,	NULL
D.	NULL
H.	NULL
Ciocon	NULL
,	NULL
M.	NULL
A.	NULL
Moore	NULL
,	NULL
R.	NULL
M.	NULL
Steinman	NULL
,	NULL
and	NULL
J.	NULL
W.	NULL
Young	NULL
.	NULL

1996	NULL
.	NULL

Dendritic	NULL
cells	NULL
and	NULL
macrophages	NULL
can	NULL
mature	NULL
independently	NULL
from	NULL
a	NULL
human	NULL
bone	NULL
marrow-derived	NULL
,	NULL
post-colony-forming	NULL
unit	NULL
intermediate	NULL
.	NULL

Blood	NULL
87:4520	NULL
.	NULL

Flores-Romo	NULL
,	NULL
L.	NULL
,	NULL
P.	NULL
Bjork	NULL
,	NULL
V.	NULL
Duvert	NULL
,	NULL
C.	NULL
van	NULL
Kooten	NULL
,	NULL
S.	NULL
Sacland	NULL
,	NULL
and	NULL
J.	NULL
Banchereau	NULL
.	NULL

1997	NULL
.	NULL

CD40	NULL
ligation	NULL
on	NULL
human	NULL
cord	NULL
blood	NULL
CD34	NULL
hematopoietic	NULL
progenitors	NULL
induces	NULL
their	NULL
proliferation	NULL
and	NULL
differentiation	NULL
into	NULL
functional	NULL
dendritic	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

2:341	NULL
.	NULL

Mufson	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
role	NULL
of	NULL
serine/threonine	NULL
phosphorylation	NULL
in	NULL
hematopoietic	NULL
cytokine	NULL
receptor	NULL
signal	NULL
transduction	NULL
.	NULL

FASEB	NULL
J	NULL
.	NULL

11:37	NULL
.	NULL

Choudhury	NULL
,	NULL
A.	NULL
,	NULL
J.	NULL
L.	NULL
Gajewski	NULL
,	NULL
J.	NULL
C.	NULL
Liang	NULL
,	NULL
U.	NULL
Popat	NULL
,	NULL
D.	NULL
F.	NULL
Claxton	NULL
,	NULL
K.	NULL
O.	NULL
Kliche	NULL
,	NULL
M.	NULL
Andreeff	NULL
,	NULL
and	NULL
R.	NULL
E.	NULL
Champlin	NULL
.	NULL

1997	NULL
.	NULL

Use	NULL
of	NULL
leukemic	NULL
dendritic	NULL
cells	NULL
for	NULL
the	NULL
generation	NULL
of	NULL
antileukemic	NULL
cellular	NULL
cytotoxicity	NULL
against	NULL
Philadelphia	NULL
chromo-some-positive	NULL
chronic	NULL
myelogenous	NULL
leukemia	NULL
.	NULL

Blood	NULL
89:1133	NULL
.	NULL

Koeffler	NULL
,	NULL
H.	NULL
P.	NULL
,	NULL
R.	NULL
Billing	NULL
,	NULL
A.	NULL
J.	NULL
Lusis	NULL
,	NULL
R.	NULL
Sparkes	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Golde	NULL
.	NULL

1980	NULL
.	NULL

An	NULL
undifferentiated	NULL
variant	NULL
derived	NULL
from	NULL
the	NULL
human	NULL
acute	NULL
myelogenous	NULL
leukemia	NULL
cell	NULL
line	NULL
(	NULL
KG-1	NULL
)	NULL
.	NULL

Blood	NULL
56:265	NULL
.	NULL

Furley	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
B.	NULL
R.	NULL
Reeves	NULL
,	NULL
S.	NULL
Mizutani	NULL
,	NULL
L.	NULL
J.	NULL
Altass	NULL
,	NULL
S.	NULL
M.	NULL
Watt	NULL
,	NULL
M.	NULL
C.	NULL
Jacob	NULL
,	NULL
P.	NULL
van	NULL
den	NULL
Elsen	NULL
,	NULL
C.	NULL
Terhorst	NULL
,	NULL
and	NULL
M.	NULL
F.	NULL
Greaves	NULL
.	NULL

1986	NULL
.	NULL

Divergent	NULL
molecular	NULL
phenotypes	NULL
of	NULL
KG1	NULL
and	NULL
KG1a	NULL
myeloid	NULL
cell	NULL
lines	NULL
.	NULL

Blood	NULL
68:1101	NULL
.	NULL

73	NULL
.	NULL

74	NULL
.	NULL

75	NULL
.	NULL

76	NULL
.	NULL

77	NULL
.	NULL

78	NULL
.	NULL

79	NULL
.	NULL

80	NULL
.	NULL

81	NULL
.	NULL

82	NULL
.	NULL

83	NULL
.	NULL

84	NULL
.	NULL

85	NULL
.	NULL

86	NULL
.	NULL

A	NULL
CELL	NULL
LINE	NULL
MODEL	NULL
OF	NULL
HUMAN	NULL
DENDRITIC	NULL
CELL	NULL
DIFFERENTIATION	NULL
Fukuda	NULL
,	NULL
M.	NULL
,	NULL
H.	NULL
P.	NULL
Koeffler	NULL
,	NULL
and	NULL
J.	NULL
Minowada	NULL
.	NULL

1981	NULL
.	NULL

Membrane	NULL
differentiation	NULL
in	NULL
human	NULL
myeloid	NULL
cells	NULL
:	NULL
expression	NULL
of	NULL
unique	NULL
profiles	NULL
of	NULL
cell	NULL
surface	NULL
glycoproteins	NULL
in	NULL
myeloid	NULL
leukemic	NULL
cell	NULL
lines	NULL
blocked	NULL
at	NULL
different	NULL
stages	NULL
of	NULL
differentiation	NULL
and	NULL
maturation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
78:6299	NULL
.	NULL

Koeffler	NULL
,	NULL
H.	NULL
P.	NULL
,	NULL
M.	NULL
Bar-Eli	NULL
,	NULL
and	NULL
M.	NULL
C.	NULL
Territo	NULL
.	NULL

1981	NULL
.	NULL

Phorbol	NULL
ester	NULL
effect	NULL
on	NULL
differentiation	NULL
of	NULL
human	NULL
myeloid	NULL
leukemia	NULL
cell	NULL
lines	NULL
blocked	NULL
at	NULL
different	NULL
stages	NULL
of	NULL
maturation	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

41:919	NULL
.	NULL

Shoji	NULL
,	NULL
M.	NULL
,	NULL
P.	NULL
R.	NULL
Girard	NULL
,	NULL
P.	NULL
A.	NULL
Charp	NULL
,	NULL
H.	NULL
P.	NULL
Koeffler	NULL
,	NULL
W.	NULL
R.	NULL
Vogler	NULL
,	NULL
and	NULL
J.	NULL
F.	NULL
Kuo	NULL
.	NULL

1987	NULL
.	NULL

Effects	NULL
of	NULL
phorbol	NULL
ester	NULL
on	NULL
translocation	NULL
and	NULL
down-regulation	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
and	NULL
phosphorylation	NULL
of	NULL
endogenous	NULL
proteins	NULL
in	NULL
human	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
cell	NULL
line	NULL
KG-1	NULL
and	NULL
its	NULL
phorbol	NULL
ester-resistant	NULL
subline	NULL
KG-1a	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

47:6363	NULL
.	NULL

Bettaieb	NULL
,	NULL
A.	NULL
,	NULL
M.	NULL
Record	NULL
,	NULL
M.	NULL
G.	NULL
Come	NULL
,	NULL
A.	NULL
C.	NULL
Bras	NULL
,	NULL
H.	NULL
Chap	NULL
,	NULL
G.	NULL
Laurent	NULL
,	NULL
and	NULL
J.	NULL
P.	NULL
Jaffrezou	NULL
.	NULL

1996	NULL
.	NULL

Opposite	NULL
effects	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
on	NULL
the	NULL
sphin-gomyelin-ceramide	NULL
pathway	NULL
in	NULL
two	NULL
myeloid	NULL
leukemia	NULL
cell	NULL
lines	NULL
:	NULL
role	NULL
of	NULL
transverse	NULL
sphingomyelin	NULL
distribution	NULL
in	NULL
the	NULL
plasma	NULL
membrane	NULL
.	NULL

Blood	NULL
88:1465	NULL
.	NULL

Bezombes	NULL
,	NULL
C.	NULL
,	NULL
N.	NULL
Macsite	NULL
,	NULL
G.	NULL
Laurent	NULL
,	NULL
T.	NULL
Levade	NULL
,	NULL
A.	NULL
Bettaicb	NULL
,	NULL
and	NULL
J.	NULL
P.	NULL
Jaffrezou	NULL
.	NULL

1998	NULL
.	NULL

Restoration	NULL
of	NULL
TNF-	NULL
@	NULL
-induced	NULL
ceramide	NULL
generation	NULL
and	NULL
apoptosis	NULL
in	NULL
resistant	NULL
human	NULL
leukemia	NULL
KG1a	NULL
cells	NULL
by	NULL
the	NULL
P-glycoprotein	NULL
blocker	NULL
PSC833	NULL
.	NULL

FASEB	NULL
J	NULL
.	NULL

12	NULL
:	NULL
101	NULL
.	NULL

Sicbenlist	NULL
,	NULL
U.	NULL
,	NULL
G.	NULL
Franzoso	NULL
,	NULL
and	NULL
K.	NULL
Brown	NULL
.	NULL

1994	NULL
.	NULL

Structure	NULL
,	NULL
regulation	NULL
and	NULL
function	NULL
of	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

10:405	NULL
.	NULL

Bochmelt	NULL
,	NULL
G.	NULL
,	NULL
J.	NULL
Madruga	NULL
,	NULL
P.	NULL
Dorfler	NULL
,	NULL
K.	NULL
Briegel	NULL
,	NULL
H.	NULL
Schwarz	NULL
,	NULL
P.	NULL
J.	NULL
Enrictto	NULL
,	NULL
and	NULL
M.	NULL
Zenke	NULL
.	NULL

1995	NULL
.	NULL

Dendritic	NULL
cell	NULL
progenitor	NULL
is	NULL
transformed	NULL
by	NULL
a	NULL
conditional	NULL
v-Rel	NULL
estrogen	NULL
receptor	NULL
fusion	NULL
protein	NULL
v-ReIER	NULL
.	NULL

Cell	NULL
80:341	NULL
.	NULL

Ryseck	NULL
,	NULL
R.	NULL
P.	NULL
,	NULL
P.	NULL
Bull	NULL
,	NULL
M.	NULL
Takamiya	NULL
,	NULL
V.	NULL
Bours	NULL
,	NULL
U.	NULL
Sicbenlist	NULL
,	NULL
P.	NULL
Dobrzanski	NULL
,	NULL
and	NULL
R.	NULL
Bravo	NULL
.	NULL

1992	NULL
.	NULL

RelB	NULL
,	NULL
a	NULL
new	NULL
Rel	NULL
family	NULL
transcription	NULL
activator	NULL
that	NULL
can	NULL
interact	NULL
with	NULL
p50-NF-B	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:674	NULL
.	NULL

Tewari	NULL
,	NULL
M.	NULL
,	NULL
P.	NULL
Dobrzanski	NULL
,	NULL
K.	NULL
L.	NULL
Mohn	NULL
,	NULL
D.	NULL
E.	NULL
Cressman	NULL
,	NULL
J.	NULL
C.	NULL
Hsu	NULL
,	NULL
R.	NULL
Bravo	NULL
,	NULL
and	NULL
R.	NULL
Taub	NULL
.	NULL

1992	NULL
.	NULL

Rapid	NULL
induction	NULL
in	NULL
regenerating	NULL
liver	NULL
of	NULL
RL/IF-1	NULL
(	NULL
an	NULL
I	NULL
«	NULL
B	NULL
that	NULL
inhibits	NULL
NF-KB	NULL
,	NULL
RelB-p50	NULL
,	NULL
and	NULL
c-Rel-p50	NULL
)	NULL
and	NULL
PHF	NULL
,	NULL
a	NULL
novel	NULL
B	NULL
site-binding	NULL
complex	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:2898	NULL
.	NULL

Carrasco	NULL
,	NULL
D.	NULL
,	NULL
R.	NULL
P.	NULL
Ryseck	NULL
,	NULL
and	NULL
R.	NULL
Bravo	NULL
.	NULL

1993	NULL
.	NULL

Expression	NULL
of	NULL
re/B	NULL
transcripts	NULL
during	NULL
lymphoid	NULL
organ	NULL
development	NULL
:	NULL
specific	NULL
expression	NULL
in	NULL
dendritic	NULL
antigen-presenting	NULL
cells	NULL
.	NULL

Development	NULL
118:1221	NULL
.	NULL

Burkly	NULL
,	NULL
L.	NULL
,	NULL
C.	NULL
Hession	NULL
,	NULL
L.	NULL
Ogata	NULL
,	NULL
C.	NULL
Reilly	NULL
,	NULL
L.	NULL
A.	NULL
Marconi	NULL
,	NULL
D.	NULL
Olson	NULL
,	NULL
R.	NULL
Tizard	NULL
,	NULL
R.	NULL
Cate	NULL
,	NULL
and	NULL
D.	NULL
Lo	NULL
.	NULL

1995	NULL
.	NULL

Expression	NULL
of	NULL
ReIB	NULL
is	NULL
required	NULL
for	NULL
the	NULL
development	NULL
of	NULL
thymic	NULL
medulla	NULL
and	NULL
dendritic	NULL
cells	NULL
.	NULL

Nature	NULL
373:531	NULL
.	NULL

Weih	NULL
,	NULL
F.	NULL
,	NULL
D.	NULL
Carrasco	NULL
,	NULL
S.	NULL
K.	NULL
Durham	NULL
,	NULL
D.	NULL
S.	NULL
Barton	NULL
,	NULL
C.	NULL
A.	NULL
Rizzo	NULL
,	NULL
R.	NULL
P.	NULL
Ryseck	NULL
,	NULL
S.	NULL
A.	NULL
Lira	NULL
,	NULL
and	NULL
R.	NULL
Bravo	NULL
.	NULL

1995	NULL
.	NULL

Multiorgan	NULL
inflammation	NULL
and	NULL
hematopoietic	NULL
abnormalities	NULL
in	NULL
mice	NULL
with	NULL
a	NULL
targeted	NULL
disruption	NULL
of	NULL
RelB	NULL
,	NULL
a	NULL
member	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B/Rel	NULL
family	NULL
.	NULL

Cell	NULL
80:331	NULL
.	NULL

Pettit	NULL
,	NULL
A.	NULL
R.	NULL
,	NULL
C.	NULL
Quinn	NULL
,	NULL
K.	NULL
P.	NULL
A.	NULL
MacDonald	NULL
,	NULL
L.	NULL
L.	NULL
Cavanagh	NULL
,	NULL
G.	NULL
Thomas	NULL
,	NULL
W.	NULL
Townsend	NULL
,	NULL
M.	NULL
Handel	NULL
,	NULL
and	NULL
R.	NULL
Thomas	NULL
.	NULL

1997	NULL
.	NULL

Nuclear	NULL
localization	NULL
of	NULL
ReIB	NULL
is	NULL
associated	NULL
with	NULL
effective	NULL
antigen-presenting	NULL
cell	NULL
function	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

159:3681	NULL
.	NULL

Olashaw	NULL
,	NULL
N.	NULL
E.	NULL
1996	NULL
.	NULL

Inducible	NULL
activation	NULL
of	NULL
RelB	NULL
in	NULL
fibroblasts	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:30307	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL

